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Abstract 
Keratan sulfate (KS) is an elongated glycosaminoglycan (GAG) chain found throughout 
the cornea, the clear tissue at the front of the eye. It is thought that KS plays a 
specialized role in maintaining the ordered spatial arrangement of collagen fibrils that 
comprise the thickest layer of the cornea, the stroma. Repeating N-acetylglucosamine 
(GlcNAc) and galactose monosaccharides make up the fine structure of KS, and sulfate 
groups frequently modify their C-6 positions. Recent studies have linked improper 
sulfation of GlcNAc residues to macular corneal dystrophy, a vision condition 
characterized by a progressive loss of corneal transparency. Since then, in vitro 
experiments have implicated four enzymes in highly sulfated KS biosynthesis. It is 
currently believed that β-1,3-N-acetylglucosaminyltransferase 7 (β3GnT7), corneal 
GlcNAc 6-O sulfotransferase (CGn6ST), and β-1,4-galactosyltransferase 4 (β4GalT4) 
sequentially catalyze the addition of GlcNAc, transfer sulfate to its C-6 position, and link 
galactose to the growing KS backbone, respectively. The fourth enzyme, KS galactose 
6-O sulfotransferase (KSGal6ST) is thought to act last, sulfating galactose residues.  
Mutant mice deficient in CGn6ST, KSGal6ST, or β3GnT7 were recently developed to 
investigate the consequences of dysfunctional sulfo- or glycosyltransferases on corneal 
morphology. Electron microscopy and immunohistochemistry data in this thesis 
showed that the systemic absence of CGn6ST or β3GnT7 resulted in a corneal stroma 
devoid of KS, but mutation of only KSGal6ST led to a KS phenotype similar to that of 
wild type controls. Western blot analysis conducted on β3GnT7-null corneas indicated 
that KS assumed an unusually truncated form, as compared to wild type controls. A 
secondary result evident in electron micrographs was that in cases where KS levels 
dropped below the detectable threshold (i.e. in CGn6ST and β3GnT7 mutant corneas), 
a concurrent appearance of atypically elongated GAGs was visible, suggesting a 
compensatory mechanism to preserve corneal organization. Since the unusual GAGs 
were susceptible to chondroitinase ABC digestion, it is thought they are comprised of 
chondroitin/dermatan sulfate (CS/DS). Studies using high performance liquid 
chromatography were also undertaken to establish protocols in which future work 
could quantify the change in CS/DS expression observed in CGn6ST and β3GnT7 
mutant corneas.  
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CHAPTER 1 
1. Background and General Introduction 
1.1 The Extracellular Matrix 
Driving embryonic development, reinforcing tissues with macromolecular networks, 
and regulating cell differentiation, extracellular matrices (ECM) are much more than 
the static, cell-supporting scaffolds they were once thought to be. Contrarily, these 
dynamic meshworks of collagens, glycoproteins, and non-collagenous proteins 
provide tissues throughout the body with strength and flexibility necessary for 
proper form and function.  
Decades of ECM research has been conducted on tissues, such as cartilage and bone, 
to understand the complex relationship between the cell and each component of 
the ECM. Research carried out here used the cornea, the clear surface at the front of 
the eye (black arrow, Figure 1-1), as a model to investigate the biosynthesis and 
structure-function relationship of keratan sulfate (KS), a polysaccharide native to 
corneal ECM.  
Details of corneal extracellular organization and current understanding of KS 
structure and function are explained in this introductory chapter to provide a 
foundation on which to build in subsequent experimental chapters. 
 
Figure 1-1: Cross section of whole human eye. 
Taken from Häggström 2012, licensed under CC0 1.0. 
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1.1.1 The&Cornea&&
Traditionally, the cornea has been known to consist of five distinct layers which are 
arranged from anterior to posterior as follows: epithelium, Bowman’s layer, stroma, 
Descemet’s membrane, and endothelium (Figure 1-2). Recent research suggests that 
the presence of a sixth layer found between the stroma and Descemet’s membrane, 
called Dua’s layer or pre-Descemet’s layer (Dua et al. 2013, Dua et al. 2014a, Dua et al. 
2014b), but this finding is facing some scrutiny (Jester et al. 2013, Schlötzer-
Schrehardt et al. 2015). A brief overview of each corneal layer is discussed below, with 
emphasis on the stroma, as this corneal layer contains the KS glycosaminoglycans 
studied in this thesis.  
 
 
Figure 1-2: Cross section of the cornea showing constituent 
layers. From anterior to posterior they are: epithelium, 
Bowman’s layer, stroma, Descemet’s membrane, and 
endothelium. The proposed sixth layer is not labelled, but 
would be located just anterior to Descemet’s membrane in 
the above image. Taken from Gray 1918, no known copyright 
restrictions. 
 
1.1.1.1 Epithelium,
The most anterior layer of the cornea is the epithelium. Measuring 50 µm in thickness 
in humans, the epithelium is five to seven cell layers thick and consists of three types 
Epithelium 
Bowman’s Layer 
Stroma 
Descemet’s Membrane 
Endothelium 
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of cells (Guthoff et al. 2009). Most superficially, there are two or three layers of 
squamous cells that take on a flattened shape and, comparatively, contain very few 
organelles. The middle layer of epithelial cells is two or three cells thick; these cells 
are termed “wing cells” owing to their wing-like processes. Finally, the deepest and 
most mitotically active epithelial cells are columnar in shape and secrete the matrix 
that makes up the epithelial basement membrane, which is found posterior to the 
epithelium (Fischbarg 2006). The constant cell division that occurs in these cells helps 
replace those superficial epithelial cells that are sloughed off from blinking (Forrester 
et al. 2008). 
1.1.1.2 Bowman’s,Layer,
Bowman’s layer is an approximately 20 µm-thick (in humans) layer between the 
epithelial basement membrane and the stroma (Schmoll et al. 2012). This layer, while 
present in humans and other mammals (e.g. cattle, rabbits, mice), is not found in 
corneal tissue of all animals (e.g. cat) (Hayashi et al. 2002, Merindano et al. 2002). 
Similar to that of the stroma, the structural composition of Bowman’s layer is mainly 
of densely packed collagen fibrils. However, the collagen fibrils found in Bowman’s 
layer are not organised into bundles, as they are in the stroma (Remington 2011). In 
addition, Bowman’s layer is acellular, whereas the stroma contains corneal 
fibroblasts, called keratocytes.  
1.1.1.3 Stroma,
Comprising 90% of total corneal thickness, the stroma measures approximately 450 
µm in humans. It is composed predominantly of sheets of collagen bundles, termed 
lamellae, which are arranged in a near-orthogonal orientation (Figure 1-3). The 
thicknesses of these lamellae are depth-dependent: the anterior third of the stroma 
is characterized by thinner lamellae (0.2 – 1.2 µm) that are more interwoven and 
more densely packed, whereas the posterior stroma is made up of lamellae that are 
more than twice as thick (1 – 2.5 µm) as those found anteriorly (Komai and Ushiki 
1991), with less interweaving (Quantock et al. 2015). It is thought that the interwoven 
nature of the anterior stroma aids in maintenance of corneal curvature, as this region 
of the stroma resists swelling, even when the cornea is in an over-hydrated state 
(Müller et al. 2001). These lamellae are comprised of keratocytes (section 1.1.1.4) and 
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many macromolecules such as collagen (section 1.1.3), and proteoglycans (section 
1.1.4). Since research in this thesis focuses on the organization and macromolecular 
composition of the stroma, with particular interest in KS morphology, each of these 
stromal constituents will be discussed in greater detail in through this introductory 
chapter.  
 !
Figure 1-3: Transmission electron microscopy image of lamellar 
orientation in the human cornea. Five lamellae are shown in the 
above image. The top, middle, and bottom layers show 
collagen fibrils in transverse section, whereas the second and 
fourth layers show longitudinal sections of collagen. Taken from 
Ruberti and Zieske 2008 and reproduced with permission from the 
copyright holder, Elsevier (License No: 3867120118161). 
,
1.1.1.4 Keratocytes,
Corneal fibroblasts, or keratocytes, are cells generally found between lamellae of the 
stroma. The density of these cells is approximately 20,500 cells/mm3, with a greater 
concentration in the anterior 10% of the cornea. The number of cells per cubic 
volume is correlated to age, as this figure decreases by nearly 0.5% per year 
throughout life (Patel et al. 2001). Structurally, these cells are flattened, with long 
processes that interconnect throughout the stroma to allow for cell-to-cell 
communication (Nishida et al. 1988, Müller et al. 1995). Keratocytes are most 
functionally active early during organism development, synthesizing and secreting 
extracellular matrix components (Linsenmayer et al. 1983, Fini 1999) and guiding the 
deposition of collagen bundles into orthogonal sheets (Young et al. 2014). In adult 
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organisms, however, keratocytes are in a “quiescent”, or dormant, state (Hay 1980). 
These specialised fibroblasts only become mitotically active again if the cornea 
suffers damage that triggers a wound healing response. In that case, keratocytes at 
the site of the wound undergo programmed cell death, or apoptosis, and nearby 
keratocytes divide to replace those cells lost in the injured area (Wilson et al. 2007, 
Muthusubramaniam et al. 2012). 
1.1.1.5 Descemet’s,Membrane,
Descemet’s membrane is found directly anterior to the endothelium and has two 
structurally distinct regions: 1) the anterior banded zone is characterised by electron 
dense structures that show 110 nm periodicity and 2) the posterior non-banded 
zone, which lacks the electron-dense structures present in the anterior banded zone. 
Whereas the thickness and structure of the anterior zone remain three microns 
throughout the human lifetime, the posterior non-banded zone grows from three 
microns at birth to up to 18 microns in late adulthood (Johnson et al. 1982, Murphy et 
al. 1984). In addition to collagens IV, V, VI, VIII, XVIII (discussed further below), 
Descemet’s membrane is comprised of many non-collagenous molecules that are 
typical of basement membranes, such as laminin, fibronectin, heparan sulfate, and 
dermatan sulfate (Schittny et al. 1988, Schittny et al 1995). 
1.1.1.6 Endothelium,
The posterior border of the cornea is a five micron-thick single layer of hexagonally 
arranged cells, termed the endothelium (Figure 1-4) (Waring et al. 1982, Joyce 2003). 
The chief function of the endothelium is to maintain the partially dehydrated state of 
the cornea by acting as a “leaky barrier” between Descemet’s membrane, which is 
the basement membrane of the endothelium, and the aqueous humour of the eye’s 
anterior chamber. The monolayer is termed “leaky” because water and small 
molecules are allowed to pass without active transportation. In this way, nutrient 
flow from the aqueous humour across the endothelium helps to supply stromal and 
epithelial cells with molecules that are necessary to maintain normal metabolic 
processes. However, the free movement of water allowed by this monolayer must be 
opposed by a sodium bicarbonate pump to prevent overhydration of the stroma. 
One morphological feature of the endothelium which distinguishes endothelial cells 
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from other corneal cells is the extensive interdigitations of neighbouring cells 
(Ringvold et al. 1984). These unique, finger-like projections allow for cell-to-cell 
communication through gap junctions located at the lateral borders of the cells 
(Kreutziger 1976).  
 
 
Figure 1-4: En face image of human corneal 
endothelium captured with in vivo confocal microscopy. 
Endothelial cells take on a hexagonal shape and form a 
barrier at the posterior corneal surface.  Image kindly 
provided by Alise Kalteniece, Maryam Ferdousi, and 
Professor Rayaz Malik of the Early Neuropathy Group, 
University of Manchester.  
&
1.1.2 Corneal&Transparency&&
A unique feature of the cornea is its transparency. While the importance of 
maintaining transparency for visual function is apparent, how this is achieved and 
maintained is less so. Maurice (1957) put forward a widely cited theory to explain 
how the cornea transmits light, which hinged on constituent collagen fibrils of 
uniform diameter forming a highly ordered crystalline lattice (Figure 1-5).  
In this work, Maurice posited that each fibril would scatter incident light, but the 
hexagonally arranged of fibrils would promote destructive interference of scattered 
Chapter 1: Introduction 
   7 
light rays in every direction, except in the forward direction. Subsequent electron 
microscopy studies demonstrated that this perfect hexagonal arrangement of 
collagen fibrils is not present in the corneal stroma over great distances; rather fibrils 
only exhibit order over short ranges (Hart and Farrell 1969, Farrell et al. 1973). 
 
 
Figure 1-5: Schematic of transversely sectioned, equidistant 
collagen fibrils forming a hexagonal lattice. Taken from Maurice 
1957 and reproduced with permission from the copyright holder, 
John Wiley and Sons (License No: 3867121283476).  
 
Goldman et al. (1968) and Benedek (1971) argued that light scatter is not generated 
by a refractive index differential between collagen and ground substance (i.e. 
material including GAGs and water that envelope collagen fibrils) because the 
distance between the two in the cornea is less than half the wavelength of incoming 
light. To date, it is generally accepted that 1) uniformity of collagen fibril diameter 
(Maurice 1957), 2) consistency of interfibrillar distance (Hart and Farrell 1969), 3) 
collagen fibril density (Goldman et al. 1968), 4) tissue thickness (Farrell et al. 1973) 
and 5) refractive index differential between collagen and ground substance 
(Benedek 1971) all contribute to corneal transparency (Doutch et al. 2008). 
Proteoglycans have been implicated in the regulation of collagen fibril diameter to 
facilitate meeting these requirements; this aspect of corneal transparency is 
discussed further in section 1.1.4.  
Even when all these conditions are met, one must consider how keratocytes affect 
corneal clarity, given they are found throughout the depth of the stroma. Findings by 
Jester and colleagues (1999) demonstrated that keratocytes possess specialized 
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proteins, termed crystallins, that serve to decrease refractive index differentials that 
could generate excess light scatter. Other corneal layers, including the epithelium, 
Descemet’s membrane, and the endothelium only account for ~10% of corneal 
thickness and thereby do not largely influence corneal clarity. That said, studies have 
shown that epithelial cells have a homogenous refractive index (Dohlman 1971, 
Meek and Knupp 2015). 
1.1.3 Collagen&
Collagen is a robust structural protein with 29 distinct types, all of which can be 
categorized into one of three families based on their structural morphology. First, 
fibril-forming, or “fibrillar”, collagens have a triple helical structure, which consists of 
three polypeptide chains, termed α-helices, that twist around one another in right-
hand fashion. When these collagen molecules are linked together to form fibrils, they 
appear striated, which is a result of the staggered packing of constituent molecules 
(Figure 1-6a). The striations that comprise this repeating pattern are conventionally 
named a, b, c, d, and e bands (Hodge and Schmitt 1960) and can be identified along 
the fibril axis as shown in Figure 1-6b on the next page (Meek et al. 1979, Meek and 
Quantock 2001).  
Second, those collagens with intermittent domains of triple helices belong to the 
FACIT (fibril associated collagen with interrupted triple helices) family. These 
collagens are appropriately named for their preferential association with fibrillar 
collagen surfaces. While the role of FACIT collagens is largely elusive, it is thought 
that their association with fibrillar collagens influences fibril interactions with 
surrounding cells and ECM molecules (Michelacci 2003, Shaw and Olsen 1991). Third 
and finally, non-fibrillar collagens assume a variety of morphologies and physiologic 
roles. Table 1-1 lists collagen types belonging to each of these families. 
Not all 29 types of collagen are found in the cornea, however each of the three 
families of collagen is represented in the tissue. The next section describes those 
collagens found throughout the cornea. 
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Figure 1-6: An example of fibrillar collagen. (a) Three α-chains 
comprise the collagen molecule triple helix. These molecules are then 
linked in a staggered formation that creates a striated collagen fibril. 
Adapted from Heim et al. 2010. (b) Striations of collagen fibrils are 
labelled a – e as shown above. Adapted from Meek and Quantock 2001. 
Both figures were reproduced with permission from respective copyright 
holders, Royal Society of Chemistry (License No: 3870270393688) and 
Elsevier (License No: 3870271342825). 
 
 
Table 1-1: Collagen Types I  – XXVI are categorized according to 
their structure/function above. Collagens XXVII – XXIX were 
recently discovered and therefore were not included in the 
source above. Type XXVII and XXVIII are fibrillar collagens (Boot-
Handford et al. 2003, Plumb et al. 2007, Veit et al. 2006). Whereas 
the literature does not specifically state the family of collagen in 
which type XXIX belongs, it is closely related to type VI, and 
therefore may also be a microfibrillar collagen (Söderhäll et al. 
2007). Adapted from Michelacci 2003, licensed under CC BY 4.0.  
staggered helices 
form collagen fibril 
collagen triple helix 
striated collagen fibril 
a.  
b.  
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1.1.3.1 Corneal,Collagens,
Multiple types of collagen exist throughout the cornea, performing functions 
including connecting juxtaposed corneal layers and providing structural rigidity to 
the tissue (Alexander et al. 1991). Specifically, collagen types VI and VII work to 
anchor the epithelial cells to Bowman’s layer. Bowman’s layer itself contains types I, 
III, V and VI, but lack the lamellar and bundled organisation found in the stroma. 
Collagen is the second most abundant substance found in the stroma, making up 
15% of its total composition (Fischbarg 2006). The predominant stromal collagen is 
type I (Newsome et al. 1982) and is associated with collagen type V. Previous work 
suggests that the type V collagen fibrils in these type I/V hybrid molecules play a 
significant role in regulating the diameter of the fibrils to a consistent 30 nm (Birk et 
al. 1990, Birk 2001). Other stromal collagens include III, IV, V, VI, VIII, XII, and XIII, albeit 
they are present in a much lower concentration than type I (Forrester et al. 2008). 
Descemet’s membrane contains collagens typical of basement membranes, such as 
types IV, VIII, and XVIII (Sawada et al. 1990, Leung et al. 2000, Lin et al. 2001, Kato et al. 
2003). In addition, types III, IV, V, and VI are thought to play a role in connecting the 
posterior stroma with Descemet’s membrane (Marshall et al. 1991, Schlötzer-
Schrehardt et al. 2015). 
1.1.4 Proteoglycans&
Consisting of a protein core covalently linked to GAG side chains, proteoglycans 
(PGs) are hybrid protein-polysaccharide molecules that are found in the cornea on 
cell surfaces, throughout the extracellular matrix, and in basement membranes. PGs 
present in extracellular matrix are separated into three groups (e.g. CS/DS-PGs, KS-
PGs, or HS-PGs), depending on the GAG side chains that modify the six possible 
protein cores: Decorin and biglycan both contain chondroitin/dermatan sulfate GAGs 
(section 1.1.4.1.1) (Krusius and Ruoslahti 1986, Ruoslahti 1988, Fisher et al. 1989). 
Lumican, keratocan, mimecan, and fibromodulin, on the other hand, contain KS-
GAGs (section 1.1.4.1.2) (Oldberg et al. 1989, Funderburgh et al. 1991, Blochberger et 
al. 1992, Corpuz et al. 1996, Funderburgh et al. 1997, Funderburgh et al. 1998). 
Heparan sulfate (HS) GAGs are comprised of repeating N-acetylglucosamine and 
Glucuronic/Iduronic acid residues. HS-PGs are found in the corneal epithelial 
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basement membrane and Descemet’s membrane, but are not typically localized to 
the corneal stroma (Hassell et al. 1980). Since the primary focus of this thesis is on PGs 
within the corneal stroma, HS-PGs are not discussed in great detail here.  
KS- and CS/DS-PGs found in the corneal stroma are members of the small leucine-
rich proteglycan (SLRP) family of macromolecules. The SLRP domain is integral to the 
proper binding of PGs to collagen fibril surfaces and, structurally, is characterised by 
a chain of repeating leucine residues. The leucine rich repeats (LRRs) form a curved 
domain made up of a hydrophilic β-sheet interior, which binds to collagen fibrils 
(Figure 1-7). Forming the exterior structure, a hydrophobic, α-helical exterior 
provides a scaffold on which GAG chains are bound (Weber et al. 1996).  
 !
Figure 1-7: Model of decorin core protein (green) associating with a 
collagen fibril (yellow). Purple regions represent attachment sites for 
N-linked polysaccharides, whereas the red region indicates the serine 
residue to which a GAG side chain (CS/DS) would attach. Taken from 
Weber et al. 1996, © The American Society for Biochemistry and Molecular 
Biology. 
 
Because of their direct association with collagen fibrils, much work has been 
performed to investigate the influence of PGs on corneal stromal collagen 
development and transparency. Specifically, PG core proteins decorin and lumican, 
with or without their GAG side chains, have been shown to impede collagen 
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fibrillogenesis (Rada et al. 1993). Further work by Zhang and colleagues (2009) 
showed that relatively normal ultrastructure is observed if either decorin or biglycan 
is omitted from development in the murine cornea, suggesting that an up-regulation 
mechanism of the remaining CS/DS core protein can compensate for the functional 
loss of either decorin or biglycan. However, severe disruptions in collagen 
morphology, including highly variable fibril diameter and inconsistent interfibrillar 
spacing, were observed when both decorin and biglycan core proteins were 
inactivated during murine development. This result suggests collagen fibrillogenesis 
is in part regulated by a synergistic mechanism between the two CS/DS core proteins 
(Zhang et al., 2009). Additionally, lumican plays a critical role in maintaining collagen 
fibril spatial arrangement and therefore corneal transparency (Chakravarti et al. 1998, 
Chakravarti et al 2000, Quantock et al. 2001, Song et al. 2003, Beecher et al. 2006). 
Lumican has also been shown to regulate keratocan expression during transcription 
(Carlson et al. 2005) and prevent collagen fibril coalescence (Hayashida et al. 2006). 
Similarly, previous work has shown the absence of keratocan in the corneal stroma 
leads to an increase in collagen fibril diameter, coupled with a less organised spatial 
arrangement of fibrils (Liu et al. 2003, Meek et al. 2003b). However, few stromal 
architecture changes occur upon manipulation of mimecan expression (Beecher et al. 
2005). 
1.1.4.1 Glycosaminoglycans,
GAGs are highly sulfated carbohydrate chains that are bound to PG core proteins 
discussed above. Each of the GAGs—keratan sulfate, chondroitin sulfate, dermatan 
sulfate, and heparan sulfate—is comprised of a unique combination of 
monosaccharides that forms a characteristic repeating disaccharide unit (see section 
1.1.4.1.1, 1.1.4.1.2). The dense negative charges of KS- and CS/DS-GAGs are important 
for normal corneal ultrastructure. First, GAG chains in close proximity repel each 
other, owing to their like negative charges. Second, this repulsion is likely to be 
important in the maintenance of collagen interfibrillar distances, which in turn 
maintains tissue transparency and provides a durable matrix that is resistant to 
mechanical compressive forces (Eisenberg and McPherson 2009). In addition to 
providing important structural reinforcement to the corneal stroma, GAGs have 
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specific water-sorption and retention properties, which explain why the corneal 
stroma has an increasing amount of water from anterior to posterior (Turss et al. 
1971). Dermatan sulfate is found in higher concentration than keratan sulfate 
anteriorly (Castoro et al. 1988) and is less water-sorptive, yet more water retentive. 
Keratan sulfate, however, is very water-sorptive but weakly water-retentive 
(Bettelheim and Plessy 1975, Castoro et al. 1988) and is found in higher concentration 
in the posterior portion of the cornea (Bettelheim and Plessy 1976). Keratan sulfate’s 
low affinity for water and increased concentration in the posterior stroma allows for 
swelling and deswelling to occur in deep stromal lamellae (Edelhauser 2006).  
1.1.4.1.1 Chondroitin/Dermatan"Sulfate"
Chondroitin sulfate (CS) and dermatan sulfate (DS) are found along the same GAG 
chain, which is O-linked to serine (SER) residues of decorin and biglycan (Cheng et al. 
1994, Weber et al. 1996). The linkage region is comprised of four monosaccharides: 
xylose (Xyl) links to serine in an α-oriented glycosidic bond, two β-linked galactose 
residues are next, followed by the linkage glucuronic acid residue (Kitagawa et al. 
1995). Beyond the linkage region, CS is characterized by repeating N-
acetylgalactosamine (GalNAc) and glucuronic acids (GlcA) moieties. If the glucuronic 
acid typically found within the CS-GAG is epimerized to L-iduronic acid (IdoA), the 
disaccharide is then classed as DS (Figure 1-8) (Silbert and Sugumaran 2002). Because 
both CS and DS units are found along the same carbohydrate backbone, these GAGs 
are conventionally referred to as CS/DS-GAGs. Structural studies on bovine corneal 
CS/DS have shown that CS/DS-GAGs are ≥60% CS disaccharides with intermittent 
regions of DS disaccharides (Achur et al. 2004). Sulfation sites are found at C-4 and C-
6 in GalNAc residues of both CS- and DS-GAGs, and GlcA/IdoA each contains a single 
sulfation site on C-2 (Sugahara et al. 2003). Degree and location of sulfate groups 
varies widely along CS/DS chains. In the cornea, chondroitin-4-sulfate (C4S) is more 
common than chondroitin-6-sulfate (C6S) (Achur et al. 2004). In pathological cases, 
CS/DS-GAGs can take on an oversulfated phenotype where multiple sulfation sites 
are occupied within the same disaccharide (Nakazawa et al. 1984, Plaas et al. 2001). !
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Figure 1-8: Structure of CS/DS-GAGs. Xylose (red), two galactose residues (green), and GlcA (purple) comprise the linkage region that 
binds the core protein (black) via a hydroxyl group of serine or threonine amino acid residues. The CS repeating disaccharide is 
comprised of GalNAc (pink) and GlcA (purple), with potential sulfation sites on the 4- and 6- GalNAc carbons. GlcA has one potential 
sulfation site on carbon 2. DS is comprised of repeating GalNAc and IdoA (grey) disaccharides, with the same three sites for potential 
sulfation. The CS/DS backbone contains a variable number of disaccharide repeats, the majority of which are the CS unit.  
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1.1.4.1.2 Keratan+Sulfate++
KS is the predominant GAG chain found in the cornea (Axelsson and Heinegård 
1975). Figure 1-9 shows corneal KS is bound to its core protein via an N-linkage to 
asparagine (ASN) amino acid residues (black). Although, KS is linked to core proteins 
in tissues other than the cornea, such as cartilage, via O-linkage to serine or 
threonine residues (Funderburgh 2002). The linkage region of corneal KS is 
comprised of two N-acetylglucosamine (GlcNAc) residues, the proximal of which is 
substituted at the sixth carbon position with fucose (Oeben et al. 1987, Funderburgh 
2002). Three mannose residues divide the molecule into a biantennary structure 
containing a short arm and an elongated arm. Both short- and long-arm extensions 
of corneal KS contain 4-6 disaccharide repeats of galactose (green) glycosidically 
linked in β-1,4 conformation to GlcNAc (blue) (Meyer et al. 1953). Whereas the short 
arm typically terminates here with a sialic acid capping structure (not depicted 
below), the elongated arm contains additional regions of mono- and disulfated 
disaccharides before ending with sialic acid (Tai et al. 1996). GlcNAc and galactose 
repeat as described above in these regions; the 10-12 disaccharide-long 
monosulfated region contains a negatively charged sulfate group on the sixth 
carbon of GlcNAc residues. In the disulfated region, which varies widely in length 
(Funderburgh 2000), both GlcNAc and galactose monosaccharides are sulfated at the 
sixth carbon (Oeben et al. 1987). 
1.1.5 Keratan*Sulfate*Biosynthesis*
To date, the literature suggests that an intricate mechanism involving minimally two 
glycosyltransferases and two sulfotransferases plays a role in elongating corneal KS. 
In vitro studies on corneal epithelial cells have been particularly informative and have 
suggested that corneal GlcNAc 6-O sulfotransferase (CGn6ST), β-1,4-
galactosyltransferase 4 (β4GalT4), and β-1,3-N-acetylglucosaminyltransferase 7 
(β3GnT7) work in tandem to elongate the mono- and disulfated region of KS-GAG 
backbone (Akama et al. 2002, Kitayama et al. 2007). The hypothesized order of action 
proceeds beginning with the sulfation of the sixth carbon of the non-reducing end
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Figure 1-9: Structure of corneal KS-GAG. The linkage region of KS is comprised of two GlcNAc (blue) residues linked to asparagine (ASN) 
residues within the core protein sequence. Fucose (dark blue) modifies the 6th carbon of the innermost linkage GlcNAc. Three mannose 
(orange) residues create a branched structure that is followed by repeating galactose (green) and GlcNAc residues. Sulfation sites are 
found on carbon 6 of both GlcNAc and galactose. GlcNAc is most commonly sulfated on the elongated arm of KS, as it is sulfated in the 
disulfated and monosulfated regions of the GAG. Galactose, on the other hand, is only sulfated in the disulfated region of the molecule. 
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GlcNAc residue, followed by addition of galactose then GlcNAc by β4GalT4 and 
β3GnT7, respectively. These three steps repeat to create an elongated KS chain singly 
sulfated on only GlcNAc residues. To create the highly sulfated KS motif (i.e. 
disulfated repeating disaccharides), another sulfotransferase, termed keratan sulfate 
galactose-6-O-sulfotransferase (KSGal6ST), subsequently adds sulfate groups to 
internally located (i.e. not non-reducing end) galactose residues (Fukuta et al. 1997) 
(Figure 1-10). 
1.1.6 Macular*Corneal*Dystrophy*
The importance of the proper formation of KS-GAGs can be appreciated in context of 
the vision disorder called macular corneal dystrophy (MCD). In this eye disease, 
CGn6ST that typically sulfates KS GlcNAc residues is dysfunctional, owing to 
mutation of the human gene CHST6 (Akama et al. 2000, Liu et al. 2000, Liu et al. 2006). 
Without the action of this enzyme, the human cornea is thinner (Ehlers and Bramsen 
1978, Quantock et al. 1990) and eventually develops a haze that obstructs vision. 
Patients with this disorder must resort to corneal transplantation to restore vision 
(Klintworth 2009). Ultrastructural studies performed on human MCD tissue have 
revealed KS-PGs that are normally observable by electron microscopy are no longer 
present in sufficient quantities for visualization (Quantock et al. 1997a, Lewis et al. 
2000, Young et al. 2007). In addition, Quantock et al. (1997b) and Palka et al. (2010) 
reported the presence of collagen fibrils with abnormally large diameters in the 
posterior stroma. 
1.1.7 Transgenic*Mice*as*a*Means*to*Understand*KS*Biosynthesis*and*
Corneal*Organization*
Recent elucidation of the murine gene equivalent of human CHST6, Chst5 (Akama et 
al. 2001), has led to development of mice that are genetically and phenotypically 
analogous to humans with MCD. Hayashida and colleagues (2006) initially described 
the Chst5-null mouse, first confirming the absence of Chst5 mRNA by reverse 
transcription polymerase chain reaction (RT-PCR) experiments. Light microscopy 
revealed that corneal tissue of Chst5-null mice was notably thinner than Chst5-  
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!
 !
                               
Figure 1-10: Schematic of KS-GAG elongation. CGn6ST transfers 
a sulfate group to GlcNAc residues at C-6. β4GalT4 links 
galactose residues to sulfated GlcNAc residues, which is 
followed by enzymatic addition of GlcNac residues by β3GnT7. 
This process repeats, generating the elongated arm of KS singly 
sulfated on C-6 of GlcNac residues. Disulfated disaccharides are 
created by sulfate transfer to the C-6 position of galactose 
monosaccharides via KSGal6ST.  
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heterozygotes or wild types, a feature that reflects the reduced corneal thickness 
characteristic of human MCD tissue (Figure 1-11d-f). Additionally, electron 
microscopy and x-ray diffraction experiments demonstrated Chst5-null corneas 
lacked discernible KS-PGs and contained more densely packed collagen fibrils, 
respectively (Hayashida et al. 2006). Both the disappearance of KS-PGs and the 
condensed collagen packed are hallmarks of the human MCD phenotype (Quantock 
et al. 1990, Palka et al. 2010). Interestingly, whereas clinical symptoms of human MCD 
include the appearance of localized opacities and a progressive corneal haze, the 
Chst5-heterozygous and –null mice do not share this feature. Hayashida et al. (2006) 
instead showed the Chst5 mutant retained its corneal clarity despite the CGn6ST 
mutation (Figure 1-11a-c).  
 
 
The lack of KS-PGs from MCD and Chst5-null tissue, coupled with the hypothesized 
mechanism of KS biosynthesis described in section 1.1.5, suggests that sulfation of 
GlcNAc residues by CGn6ST is necessary for KS-GAG elongation. While the effect of 
defunct CGn6ST on corneal organization has been thoroughly studied (i.e., MCD and 
Chst5-null tissue have been characterized), the role of the remaining sulfotransferase 
(KSGal6ST) and glycosyltransferases (β3GnT7 and β4GalT4) is less understood. Since 
KSGal6ST expression has been attributed to the murine gene Chst1 (Fukuta et al. 
         
Figure 1-11: Corneal features of the Chst5-null mouse. Corneal tissue appeared 
consistently transparent in the WT, Chst5-heterozygous and –null mice (a-c). 
Chst5-null corneal tissue (f) was significantly thinner than that of WT (d) or Chst5-
heterozygotes (e). Adapted from Hayashida et al. 2006 and reproduced with 
permission from the copyright holder, © (2006) National Academy of Sciences, U.S.A. 
a.  b.  c.  
d.  e.  f.  
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1997, Hoshino et al. 2014), and β3GnT7 has been mapped to murine gene B3gnt7 
(Huang et al. 2004, Kitayama et al. 2007), null mice deficient in these two genes have 
been developed. In addition a Chst1/5-double knockout has recently been 
generated. The corneal ultrastructure and GAG composition of these newly created 
null mice will be characterized in this thesis with the intent to better understand the 
synthesis mechanism of corneal KS. 
 
1.2 Thesis Aims 
1. Study corneal ultrastructural organization in newly developed Chst1-, 
Chst1/5-, and B3gnt7-null mouse models using electron microscopy 
(Chapter 3). 
 
2. Determine if KS and CS/DS epitopes are affected by the aforementioned 
genetic mutations by immunohistochemical labelling (Chapter 4). 
 
3. Investigate KS chain length and sulfation patterns of KS-GAGs of the 
B3gnt7-null by Western blot analysis (Chapter 5).  
 
4. Optimize separation of disaccharides common to CS/DS-GAGs by high 
performance liquid chromatography to allow for eventual quantification 
of changes in CS/DS phenotype induced by sulfo- and glycosyltransferase 
mutations (Chapter 6). 
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1. CHAPTER 2 
2. Experimental Methodology 
2.1 Experimental Animals 
All animals used in this thesis were bred and raised by Dr. Tomoya Akama at Kansai 
Medical University in Osaka, Japan. Dr. Akama is a long-standing collaborator of my 
primary supervisor, Prof. Andrew Quantock.  
Because tissue in some experiments had to be transported from Japan to the UK, 
some pre-processing steps were carried out by Dr. Akama, Prof. Quantock, or myself 
in Dr. Akama’s lab at Kansai Medical University (Osaka, Japan) to prevent degradation 
of tissue during transit. Once the tissue was preserved via fixation or freezing, with or 
without prior enzyme digestion, it was shipped to Cardiff University where I carried 
out the subsequent steps of each experiment. I will explicitly state strains and ages of 
mice, in addition to who carried out each step of each experiment, in the appropriate 
Methods sections of the Results chapters (3-6). 
2.2 Electron Microscopy 
Electron microscopy (EM) is a technique that has improved since its advent in 1932 
by Knoll and Ruska (Dykstra and Reuss 2003). Offering high magnification and fine 
resolution, electron microscopes are capable of imaging specimens with detail far 
superior to that achieved by light microscopy, which maximally magnifies at 1000x 
(Payne 1988). The size of proteoglycans is on the nanometer scale, so individual 
molecules are impossible to observe by traditional light microscopy techniques.  
The resolving power of EM made this technique, specifically transmission electron 
microscopy (TEM), the ideal method to begin analysis of the mutant corneal tissue 
described in the introduction (see section 1.1.6). In this section, I will explain the 
components of the electron microscope and describe the processing protocol 
necessary to prepare tissue for TEM analysis.!
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2.2.1 Components!of!the!Electron!Microscope!
Shown on the next page is a diagram of an electron microscope. Whereas light 
microscopy uses visible light to illuminate a specimen, a TEM illuminates the sample 
using a beam of electrons, which irradiate from the area labelled “Electron Source” in 
Figure 2-1. Also known as the electron gun, the electron source contains a tungsten 
filament through which a current is applied to induce thermionic emission of 
electrons, which eventually create the final image (Egerton 2005). Following its 
release from the filament, the electron beam is shaped by electromagnetic forces 
that surround condenser lenses, which focus the beam onto the sample. Heavy 
metals used to prepare the specimen (discussed in section 2.2.3) interact with the 
electron beam by scattering them, whereas unstained areas allow passage of 
electrons without substantially altering their trajectory. The electrons that emerge 
from the specimen are focussed and magnified by the objective lens. The objective 
aperture serves to absorb electrons that have diverged away from the central 
electron beam. Finally, projector lenses magnify, focus, and cast the beam onto the 
viewing screen so that the sample can be observed via binoculars or captured with a 
digital camera that is housed below the viewing screen (Dykstra and Reuss 2003). 
The final image appears grayscale, where dark regions represent areas where 
electrons were scattered by the specimen. Light areas, then, correspond to regions 
within the tissue or plastic resin that allowed electrons to pass freely, thus 
illuminating the viewing screen or digital camera.  
Transmission electron microscopes must be fitted with a vacuum system to prevent 
deflection or premature absorption of electrons by atoms that comprise the 
atmosphere. Without this, sufficient brightness for image capture could not be 
achieved because electrons necessary for excitation of the screen or camera would 
be lost in the column. Samples, which are cut as thin dehydrated sections (100 nm 
thick), are placed in the evacuated column. Also, a cooling system is required to 
prevent overheating of the objective lens coil, which, if left uncontrolled, could 
deform the specimen stage (Egerton 2005). 
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Figure 2-1: The typical configuration of a transmission electron microscope. 
Electrons are expelled and accelerated from the Electron Source. Condenser 
Lenses shape the electron beam so that it becomes focussed on the Sample. The 
Objective Lens magnifies the beam of electrons that pass through the sample, 
while the Objective Aperture narrows the beam by filtering out electrons that 
have deviated from the microscope’s optical axis. Finally, at least two Projector 
Lenses magnify and focus the image on the Viewing Screen or digital camera for 
specimen observation. Taken from nanoComposix, reproduced with permission 
from the copyright holder, nanoComposix. 
 
2.2.2 Specimen!Preparation!in!Osaka,!Japan!
As mentioned previously, some processing steps were carried out in our 
collaborator’s lab at Kansai Medical University because Dr. Tomoya Akama generated 
the knockout mice of interest. The Methods section of Chapter 3 explains in detail 
who performed which steps of each experiment. Here, please note that tissue 
dissection, pre-fixation, and cupromeronic blue fixing/staining, and sodium 
tungstate washes were carried out in Japan to stabilize the tissue before transport to 
Cardiff University, where electron microscopy processing was completed. 
2.2.2.1 Tissue)Dissection)
Experimental tissue was harvested from freshly sacrificed mice by enucleating both 
eyes whole, then creating an incision at the equator of the eye to separate the 
anterior eye from the posterior portion. Undesired tissues from the anterior chamber, 
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including the iris and aqueous humour, were removed by blotting on a moist tissue. 
Scleral tissue surrounding the cornea was trimmed away with a scalpel, leaving 
isolated whole corneas. Dissection was performed on ice to preserve specimen 
structure. 
The processing steps that followed initial excision of whole corneas are summarized 
in Figure 2-2 on the next page. Details of the procedure and rationale supporting this 
method are explained in sections 2.2.2.2 – 2.2.4.3. 
2.2.2.2 Pre1Fixation)
Immediately following dissection, whole corneas were placed into universal test 
tubes containing pre-fixative solution—4% paraformaldehyde in 0.1 M Sorenson’s 
phosphate buffer, pH 7.4—where they were incubated for 10 -20 min. Pre-fixation 
was immediately followed by a brief rinse in 1x Tris Acetate buffer, pH 8.0. Gentle 
fixation with paraformaldehyde created sufficient rigidity for further dissection of the 
whole corneas into quarters and prevented excessive leaching of tissue components 
out into bathing fluids (Steps 1 – 3, Figure 2-2).  
2.2.2.2.1 Rationale,
The dissociation of paraformaldehyde molecules into constituent formaldehyde 
monomers allowed quick penetration of this fixative, hence the abbreviated 
incubation time (Dykstra and Reuss 2003). However, since formaldehyde is only a 
weak crosslinking agent, this pre-incubation must be followed up with a more 
permanent fixative described next.  
2.2.2.3 Cupromeronic)Blue)Fixation/Staining)
Subsequent to pre-fixation and rinsing, three of eight corneal quarters from a single 
mouse (four quarters per eye, two eyes per mouse) were placed directly into 2.5% 
(w/v) glutaraldehyde in 25 mM sodium acetate, pH 5.7, containing 0.05% (w/v) 
cupromeronic blue and 0.1 M magnesium chloride (MgCl2). The tissue was incubated 
overnight at room temperature under constant, gentle agitation (Step 4, Figure 2-2). 
After staining, these quarters were washed three times for five minutes each in 25 
mM sodium acetate with 0.1 M MgCl2, in which they were transported to Cardiff for 
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further processing (Step 5, Figure 2-2). These specimens comprised the “untreated 
control” group of experiments conducted in Chapter 3. The other corneal portions 
were used in the chondroitinase ABC experiment explained in section 2.2.2.4.  
!
 
Figure 2-2: Fixation and staining of corneal tissue in Osaka, Japan. Freshly excised 
whole corneas were pre-fixed and rinsed before dissecting into quarters. Untreated 
control tissue was placed directly into fixative/stain, whereas enzyme-digested 
tissue (ABC) was exposed to chondroitinase ABC, rinsed, then placed into 
fixative/stain. Buffer-treated (BUF) tissue was treated identically to enzyme-
digested, except no chondroitinase ABC was present in solution during the reaction 
incubation.  
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2.2.2.3.1 Rationale,
Cupromeronic blue (CB) was the dye of choice because it was developed specifically 
to enable histochemical visualization of polyanionic structures (Scott 1972). Since its 
introduction, CB has been widely used for proteoglycan staining in conjunction with 
Scott’s “critical electrolyte concentration” method (Scott 1980).  
The electrolytes to which Scott refers are supplied by the dissociation of magnesium 
chloride (MgCl2) in sodium acetate buffer during the fixation incubation. Because 
GAGs are densely negatively charged, and CB carries positive charges around a core 
copper atom (Scott 1972, Scott 1980), electrostatic force ensures immobilization of 
the heavy metal dye along anionic proteoglycan side chains. Therefore, once inside 
the electron microscope, copper atoms of CB, which are associated with GAGs in the 
specimen, will scatter electrons and create an image of GAG fine structure. The 
introduction of MgCl2 into the fixing buffer creates free negatively charged chloride 
ions that compete with GAGs for binding with the cationic CB stain.  
Whereas one might suspect that negatively charged chloride ions would decrease 
the amount of positively charged CB available to bind structures of interest, instead, 
chloride ions are thought to enhance image contrast by increasing the dye-to-
substrate ratio as follows:  
Theoretically, without added free anions, four positive charges that surround the 
copper atom could bind four negative charges along the GAG backbone, thereby 
making the dye-to-substrate ratio 1:4. However, in the competitive environment, 
chloride ions could occupy three of four binding sites on CB, leaving only a single 
binding locus to interact with the GAG. So, to fully occupy the four charges on the 
GAG, as in the previous example, four CB ions are required. The ratio becomes 1:1. 
Figure 2-3, recreated from Scott (1980), demonstrates this concept visually. 
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Figure 2-3: Mechanism of critical electrolyte concentration staining method. Above shows 
cationic cupromeronic blue (CB, blue) binding to anionic GAG (red) in absence or presence of 
chloride ions (green). (a) A single CB molecule occupies four binding sites along a GAG backbone. 
(b) Most CB binding sites are occupied with chloride ions, thus necessitating four CB molecules to 
saturate GAG binding sites. The latter will produce more electron scattering in the electron 
microscope because of increased heavy metal staining. Adapted from Scott 1980, reproduced in 
compliance with Portland Press Rights and Permissions. 
2.2.2.4 Chondroitinase)ABC)Digestion)
As stated in section 2.2.2.3, the remaining five of the original eight corneal quarters 
were used in the chondroitinase ABC experiment. Two quarters were placed into 1x 
Tris acetate buffer with 0.02% (w/v) bovine serum albumin (BSA) and 10 μl/ml 
protease inhibitors, pH 8.0. The other three quarters were placed in a solution 
identical to that above, only 1 U/ml of chondroitinase ABC was included in the 
mixture. The enzyme-digested and buffer-treated control incubated at 37°C for four 
hours, under constant, gentle agitation (Steps 3a, 3b, Figure 2-2).  
After enzymatic digestion was complete, ABC and BUF tissue was stained with 
cupromeronic blue and washed stated in section 2.2.2.3 for untreated control 
quarters (Figure 2-2, Steps 4, 5). 
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2.2.2.4.1 Rationale,
Since the late seventies, the use of chondroitinase ABC digestion has been a 
common approach to differentiating between types of PGs in electron micrographs 
(Hay 1981, Scott and Haigh 1985, Scott 1992, Young 2005, Ho 2014). The non-specific 
binding of CB to polyanionic structures means it is difficult to differentiate between 
corneal CS/DS-GAGs and KS-GAGs in electron micrographs when both are left intact.  
Chondroitinase ABC digests CS/DS-GAGs by hydrolyzing glycosidic linkages unique 
to its repeating disaccharide backbone (Derby and Pintar 1978, Saito et al. 1968, 
Yamagata et al. 1968), thereby purging the tissue of susceptible GAGs while leaving 
intact those that are resistant (i.e. KS-GAGs). In the absence of CS/DS-GAGs, the 
phenotype of solely KS-GAGs can be analyzed. This was especially important in our 
experiments because our hypothesis predicts an atypical KS-GAG phenotype 
resulting from mutations of enzymes active in KS-GAG biosynthesis.  
The buffer-treated control served to ensure that the decreased GAG content 
observed in ABC-treated tissue was a result of targeted CS/DS hydrolysis, rather than 
non-specific loss of both GAGs induced by the reaction conditions. 
2.2.3 Continued!Specimen!Preparation!in!Cardiff,!Wales!
Sections 2.2.3 and 2.2.4 explain remaining tissue processing steps (summarized 
below in Figure 2-4) carried out once the tissue arrived at Cardiff University. I 
performed these steps in all of the EM experiments. 
2.2.3.1 Sodium)Tungstate)Wash)
At this stage, corneal quarters were dissected into blocks approximately 3 mm wide 
and 5 mm long, which was a size conducive to embedding solution penetration 
(Step 1, Figure 2-4). After further dissection, corneal tissue belonging to all three 
groups (untreated, chondroitinase ABC-digested, buffer-treated) were washed three 
times, five minutes each, in 0.5% (w/v) sodium tungstate (Step 2, Figure 2-4).  
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2.2.3.1.1 Rationale,
Sodium tungstate dissociates into cations (2 Na+) and anions (WO42-) in solution, 
potentially competing with CB binding, as discussed in section 2.2.2.3.1 (Scott 1980). 
In addition, sodium tungstate has been used to stain polysaccharides and 
glycoproteins (Hayat 2000). Heavy metal tungsten atoms increase electron scatter, 
and therefore enhance contrast in electron micrographs.  
 
Figure 2-4: EM processing steps performed at Cardiff University. CB fixed/stained 
corneal quarters were dissected into small blocks, incubated in sodium tungstate, 
dehydrated with an ascending series of ethanol solutions, and embedded with 
Araldite resin. After polymerization, ultrathin sections were collected on copper grids.  
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2.2.3.2 Dehydration)
Following sodium tungstate washes, samples were dehydrated using increasingly 
concentrated ethanol solutions. The first 15 min incubation was a mixture of 50% 
ethanol containing 0.5% sodium tungstate. Subsequent ethanol washes were each 
15 min at the following concentrations: 70%, 90%, 100% (2x) (Step 3, Figure 2-4).  
2.2.3.2.1 Rationale,
Dehydration of tissue samples promotes complete infiltration of the tissue block with 
plastic resin, which is immiscible with water. Without removal of water, polymerized 
blocks assume a rubber-like texture that does not section adequately (Dykstra and 
Reuss 2003).  
2.2.3.3 Embedding)
Dehydration was followed by two 15 min incubations of propylene oxide, which 
evacuated remaining ethanol from specimen blocks (Step 5, Figure 2-4). Next, 
placing the tissue in a mixture of equal parts Araldite resin and propylene oxide for 
one hour created an intermediate step between highly volatile propylene oxide and 
viscous resin (Step 6, Figure 2-4). Finally, tissue blocks were embedded with Araldite 
resin, which was comprised of Araldite monomer CY212, dodecenyl succinic 
anhydride (DDSA) hardener, and benzyl dimethylamine (BDMA) accelerator in 
proportions recommended by the manufacturer (Agar Scientific, Essex, UK) (Table 2-
1). 
 
Resin Component Volume (ml) 
Araldite CY212 14  
DDSA 16  
BDMA 0.6  
Table 2-1: Resin mixture used to embed corneal blocks. 
 
The resin was exchanged six times overall, allowing ample time for complete 
infiltration of the resin into specimen blocks. The first three changes occurred every 
~3 hours. Between the third and fourth resin change, blocks submerged in resin were 
placed on a rotator at room temperature and left to incubate overnight. The next 
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morning, three more changes of resin were performed at ~3 hour intervals. Blocks 
were then situated in molds such that en face sectioning of the resin block yielded 
cross sections of the full thickness cornea. Molds were filled with resin left over from 
the final incubation, then underwent polymerization at 60°C for at least 24 hours 
(Step 8, Figure 2-4). When completely polymerized, ultrathin sections were collected 
as described in section 2.2.4. 
2.2.3.3.1 Rationale,
Residual ethanol is removed from blocks using propylene oxide because alcohols left 
in the tissue do not react well with Araldite resin, resulting in poor quality ultrathin 
sections (Hayat 2000). DDSA hardener and BDMA accelerator are added to the 
Araldite monomer to prevent an overly brittle block and speed the polymerization 
process, respectively (Hayat 2000). Araldite resin is a viscous gel-like solution that 
would penetrate very slowly if not for incubating the tissue in a 1:1 mixture of 
propylene oxide and resin.  
2.2.4 Ultramicrotomy!
2.2.4.1 Trimming)and)Selecting)an)Area)of)Interest)
Once embedded in plastic resin, sections were created on a Leica EM UC6 microtome 
(Leica Microsystems UK LTD, Milton Keynes, UK), which was fitted with a glass or 
diamond knife.  
First, excess resin was carved away from the tissue block using a razor blade, leaving 
a trapezoid shape block face containing the specimen. Next, the specimen block was 
rocked back and forth over a glass knife-edge to plane the trimmed surface. Once 
level, filtered distilled water was added to a water boat affixed to the glass knife 
(Figure 2-5). Semi-thin sections (0.2 - 0.3 μm) were cut with an unused area of the 
knife and collected from the water surface using an eyelash probe. Sections were 
transferred from the eyelash to a droplet of water that was situated on a plain glass 
slide. Wafting filter paper soaked in chloroform over the water drop stretched the 
sections to their original, flat conformation. Sections were immobilized to the slide 
by evaporating the water drop with a hot plate. Staining was achieved by covering 
sections in 1% toluidine blue and heating on a hot plate for 2-3 minutes, or until a 
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metallic green rim appeared around the stain edge. Once rinsed with distilled water 
and dried, stained semi-thin sections were observed on a compound light 
microscope.  
2.2.4.1.1 Rationale,
Toluidine blue stained corneal tissue with various shades of blue in cellular layers and 
in the stroma, allowing observation of the full thickness sections at low 
magnification. This preliminary observation of the specimen allowed me to select an 
area of interest, which was central corneal tissue that displayed preservation of all 
corneal layers. This step was necessary to avoid imaging sections that had lost their 
epithelium, posterior stroma, and/or endothelium throughout the handling process. 
All stromal locations (anterior, middle, and posterior) needed to be observed in case 
the genetic mutations relating to KS-PG synthesis presented with a localized 
phenotype.  
2.2.4.2 Ultrasectioning)
After designating an area of interest, the specimen was further trimmed with a razor 
blade to create a trapezoidal block face small enough for ultrasectioning, 
approximately 1-2 mm in height and width (Step 9, Figure 2-4). The newly created 
block face was again polished with a sharp (i.e. unused) area along the glass knife-
edge. Finally, the glass knife was once more adjusted so that the sharpest edge of the 
knife was used, or the glass knife used for trimming was replaced with a diamond 
knife embedded in a stainless steel boat. Glass or diamond knife boats were filled 
with filtered distilled water so that the water edge was level with the knife-edge. The 
microtome was set at a cutting speed of 1 mm/min and programmed to 
automatically advance over the knife-edge in 100 nm increments. Ribbons of gold- or 
silver-colored sections (Figure 2-5) were arranged on 3 mm copper grids as shown in 
Step 10 of Figure 2-4 and placed on filter paper inside a petri dish to dry. The color of 
the sections is indicative of section thickness based on interference effects; a 
silver/gold color indicates optimal thickness for viewing with TEM.  
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Figure 2-5: Image captured during ultrasectioning. Resin block 
immobilized in microtome chuck is indicated with white arrow. 
A golden ribbon of sections can be seen floating on water 
contained within a boat that is wax-affixed to a glass knife. 
 
2.2.4.3 Contrast)Enhancement)with)Uranyl)Acetate)
 Dried grids containing short stretches of sections were floated for 30 minutes on 25 
μl of saturated uranyl acetate (UA) solution, which had been filtered with a 0.2 μm 
syringe filter and subjected to 15 min centrifugation at 15,000x to remove potentially 
precipitated UA crystals. UA enhances contrast within the specimen by binding 
cationic and anionic structures, and it is known to have particular affinity for collagen 
(Hayat 2000, Watson 1958). Subsequent rinsing of the grids was accomplished by 
floating them sequentially on three drops of filtered distilled water for five minutes 
each. Uranyl acetate staining was conducted under an opaque shield, as UA is a 
photosensitive chemical (Dykstra and Reuss 2003). In addition, soaking filter paper in 
water to create a humid environment prevented evaporation and precipitation of UA 
during incubation. The moistened paper was overlaid with parafilm on which the UA 
and water drops were formed (Figure 2-6). Contrast-enhanced grids were placed in a 
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petri dish lined with filter paper and allowed to dry a minimum of 24 hours before 
observing with the electron microscope. 
 
 
Figure 2-6: Uranyl Acetate staining procedure. Above, six 
grids are positioned at the final stage of suspension rinsing. To 
the left, two more water drops represent previous rinse cycles. 
Each yellow drop is 25 μl of filtered saturated UA. The water-
soaked filter paper overlaid with wax created a humid staining 
environment. 
 
2.2.5 Image!Collection!and!Storage!
Grids were observed in a Jeol 1010 transmission electron microscope (Jeol UK, Herts, 
UK), operating at 80 keV. Images were captured with Gatan imaging software (Gatan, 
Inc., Abingdon, UK) in gatan (.dm3) format, then converted to TIFF (.tif) format for 
incorporation of images into this thesis, publications, and presentations.  
2.3 Use of Monoclonal Antibodies  
Monoclonal antibodies (mAb) specific to various corneal GAGs and proteins were 
used in immunohistochemistry and Western blot experiments in this thesis. Specific 
antibodies and their respective antigens are described in relevant experimental 
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chapters. Here, basic principles of monoclonal antibodies and how they are used in 
research methodology are described. 
2.3.1 Structure!of!an!Antibody!
Those antibodies used for GAG visualization in Chapters 4 and 5 belonged to the 
immunoglobulin-γ, more commonly known as “IgG”, class of antibodies. The generic 
structure of an IgG antibody is shown below (Figure 2-7).  
 
 
Figure 2-7: Structure of an IgG antibody. The above diagram 
shows the typical structure of an IgG antibody. Blue regions 
represent heavy chains, whereas green regions are light 
chains. Yellow bars bridging the chains represent disulfide 
bonds. Epitopes are recognized by heavy and light chains at 
the antigen binding site. Taken from Afaneh et al. 2012, 
licensed under CC BY 3.0. 
 
IgG antibodies are comprised of two identical heavy chains (blue, Figure 2-7) and two 
identical light chains (green, Figure 2-7) bridged together by disulfide bonds (yellow 
bars). Fab fragments contain the antigen binding site and are structurally specific to a 
single antigen or epitope. The Fc region, on the other hand, is common to all IgG 
antibodies (Afaneh et al. 2012). 
2.3.2 Common!Steps!in!Methods!that!Exploit!mAb!Specificity!
There are a multitude of uses for monoclonal antibodies in research. In this thesis, 
they were primarily used for localization of a particular molecule in tissue sections 
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(immunohistochemistry) or corneal extracts (Western blot). Despite offering different 
types of information, some processing steps are similar in the two techniques. These 
common steps are described below.  
2.3.2.1 Primary)Antibody)Labelling)
One of the first steps in labelling epitopes in immunohistochemistry and Western 
blot is application of a primary antibody to prepared samples. The primary antibody 
is antigenically specific to a single epitope; therefore binding can only occur when 
the desired epitope is present in the sample. Ideally, the experimental samples and 
primary antibody would not have been raised in the same species of animal (see 
below).  
2.3.2.1.1 Rationale,
Monoclonal antibodies are generated by inducing an immune response in animals 
(usually mice, but sometimes rats or hamsters) via immunization with a purified 
antigen (Leenaars and Hendriksen 2005). In selecting a monoclonal antibody for 
experimentation it is important to consider the details of the animal species in which 
the primary antibody was isolated. Primary antibodies used in this thesis were mouse 
IgG monoclonal antibodies, hence the use of an anti-mouse IgG secondary 
antibodies. While this experimental set up is perfectly functional for localizing 
epitopes in most animals used in corneal research, the use of knockout mouse tissue 
under investigation in this thesis presented challenges in keeping erroneous 
secondary labelling at bay. To circumvent those challenges, modified protocols for 
“mouse-on-mouse” experiments were undertaken where necessary (see Chapter 4, 
section 4.2.2).  
2.3.2.2 Blocking)Non1specific)Secondary)Labelling)
Once desired epitopes are labelled, unbound primary antibody is rinse thoroughly 
from tissue sections or extracts. Subsequent to the rinsing step, blocking reagents 
are applied. Whereas normal goat serum suspended in buffer was used for blocking 
in immunohistochemistry experiments, skim milk was applied to extracts for 
blocking in Western blots.  
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2.3.2.2.1 Rationale,
Blocking reagents serve to prevent erroneous binding of the secondary antibody 
onto experimental samples (Mahmood and Yang 2012). Since secondary antibodies 
contain the chromogen or fluorophore necessary for visualization, their non-specific 
binding would create falsely positive results.  
2.3.2.3 Secondary)Antibody)Selection)and)Labelling)
Secondary antibodies are conjugated to a molecule that is visible to some form of 
imaging system. When conjugated to a fluorophore, an epifluorescent microscope is 
required to excite, visualize, and image the primary-secondary complexes 
immobilized on the samples. When conjugated to horse radish peroxidase (HRP) 
substrate, brightfield microscopy can be used. This process of labelling the antigen 
with a primary antibody then subsequently labelling immobilized primary antibody 
with a secondary is termed indirect immunohistochemistry. This is because the 
observer is actually viewing the secondary antibody, rather than the desired epitope 
itself. Direct immunohistochemistry can only be achieved when the primary antibody 
is specific to the desired epitope and is conjugated to the fluorophore/HRP necessary 
for visualization. Direct immuno-labelling is advantageous because there is no need 
to block specimens from non-specific binding, however the antibodies used 
throughout were not available pre-conjugated to fluorophores/HRP. Therefore, 
immuno-labelling in this thesis was solely achieved via the indirect method.  
2.3.2.3.1 Rationale,
Fluorophores are often selected as conjugates to secondary antibodies because their 
excitation and emission spectra vary, meaning different colors are observed 
depending on the selected fluorophore. This is useful in a technique referred to as 
multichannel fluorescence because various epitopes can be labelled in a single 
specimen. For example, the goat anti-mouse secondary antibody employed in 
Chapter 3 to visualize GAGs was conjugated to Alexa fluor 488, which absorbs light at 
495 nm (blue) and emits at 519 (green). On the same sections, a nuclei stain (DAPI), 
was applied. Since DAPI absorbs at 360 nm (UV) and emits at ~450 nm (blue) (James 
and Jope 1978, Kapuscinski 1995), localization of GAGs was discernible from labelled 
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nuclei because the two fluorophores appeared different colors under the 
fluorescence microscope (i.e. Alexa fluor 488-labelled epitopes appeared green, 
whereas DAPI labelled epitopes appeared blue).  
2.4 Fluorescence Microscopy 
2.4.1 The!Epifluorescence!Microscope!
Epifluorescent microscopes provide a means to observe specimens labelled with the 
fluorophore-conjugated antibodies discussed previously. This is achieved using a 
complex optical system shown in Figure 2-8. A mercury arc lamp generates a range 
of wavelengths of light (visible and ultraviolet) at a high intensity, which travel 
through an excitation filter. The excitation filter prevents all wavelengths of light 
from traveling to the specimen. Instead, only those wavelengths that are known to 
excite fluorophores immobilized on the specimen may travel beyond the excitation 
filter. The filtered light then reaches what is called a dichroic mirror. The benefit of 
this component is its ability to reflect short wavelengths of light toward the 
specimen while allowing those longer, emitted wavelengths to pass through the 
filter, in turn reaching the detector. Light that is reflected from the dichroic filter is 
focussed onto the specimen using an objective lens. Fluorophores present on the 
specimen absorb then emit light at a longer wavelength, which travels back toward 
the dichroic filter. After leaving the dichroic filter, light reaches the emission filter, 
which allows the detector (either an observer or the camera) to view the labelled 
areas of the specimen (Spring and Davidson 2016). Most epifluorescent microscopes 
are fitted with a number of emission filters, from which the user selects one that is 
appropriate for a particular fluorophore. For example, 4',6-diamidino-2-phenylindole, 
more commonly known as DAPI, is a fluorophore which absorbs ultraviolet light and 
emits at ~450 nm (James and Jope 1978, Kapuscinski 1995), which requires a blue 
filter for visualization. Whereas eyepieces are used by the observer for selecting an 
area of interest in the specimen, light is redirected to the camera for viewing on a 
computer and/or image capture.  
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Figure 2-8: Schematic of filters within and epifluorescence 
microscope. A spectrum of wavelengths is generated by a light 
source. The excitation filter allows to pass only those wavelengths 
appropriate for exciting fluorophores immobilized on the 
specimen. The dichroic mirror directs light from the source to the 
specimen, which absorbs then emits light. Emitted light travels 
through the dichroic mirror to the microscope eyepieces or a 
camera system for viewing and image capture. Taken from 
Blachnicki and Mühlpfordt 2008, licensed under CC BY-SA 3.0.  
 
2.4.2 Whole!Eye!Dissection!and!Preservation!in!Osaka,!Japan!
Dr. Tomoya Akama performed these steps in Osaka, Japan. Whole eyes from WT and 
mutant mice were dissected fresh and oriented in molds partially filled with room 
temperature optimal cutting temperature (OCT) embedding compound (Figure 2-
9a). Once oriented such that the cornea faced the point of the mold’s pentagon-
shaped base, the mold was filled with OCT compound until the whole eye was 
submerged. Placing the molds on dry ice for 20 minutes solidified the OCT 
compound (Figure 2-9b). Frozen specimen blocks were shipped on dry ice to Cardiff 
University, where they were stored at -80°C. 
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Figure 2-9: Whole eye OCT embedding. (a) Mouse eyes were placed in room 
temperature OCT embedding compound and oriented such that the cornea 
was toward the point of the mold’s pentagon-shaped base. (b) The mold was 
filled with OCT embedding compound and allowed to solidify on dry ice for 
20 minutes, yielding frozen specimen blocks.   
)
2.4.2.1 Rationale)
OCT embedding medium is a compound specifically designed for embedding 
biological samples for immunohistochemistry. It is a viscous gel at room 
temperature, which allows for precise positioning of the specimen prior to freezing. 
In addition, its water solubility means excess compound will be rinsed away from 
sections in the early stages of immuno-labelling. This is particularly advantageous to 
reduce background signal when observing labelled sections under the fluorescence 
microscope.  
2.4.3 Cryomicrotomy!!
I collected whole-eye cryosections, ten microns thick, on poly-lysine coated glass 
slides, using a Bright OTF5000 Cryostat set at -20°C. To ensure 
immunohistochemistry was carried out on only central corneal tissue, sectioning was 
performed along the eye globe’s sagittal plane; sections were only kept for analysis if 
the iris was disconnected, indicating corneal tissue was centrally located over the 
pupil (Figure 2-10). If sections were not immunolabelled immediately, they were 
a. b. 
optic nerve 
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stored in foil-wrapped slide boxes at -80°C until experimentation (no more than two 
weeks). 
 
 
Figure 2-10: Diagram of mouse eye cross-section. When 
cryosectioning, the iris was used to monitor where in the 
cornea the sections originated. When the iris was 
disconnected in the center, it was reasoned that the cornea in 
the same section was from the central portion of the eye. 
Similarly, only the pre-pupillary region of the cornea was 
observed during image capture to avoid comparing GAG 
content of central vs. peripheral cornea. Adapted from Walls 
1942, no known copyright status. 
 
2.4.3.1 Rationale)
Poly-lysine coated slides are adhesive, so their use ensures tissue sections will not 
wash away during the many rinsing steps of immuno-labelling protocols (Huang et 
al. 1983). Cryosectioning occurs at -20°C because the OCT compound remains solid 
without becoming brittle and chipping while in contact with the knife. In addition, it 
was important to label and image a consistent, central region of the cornea because 
it has been shown that the composition of proteoglycans changes at different radial 
positions of the corneal stroma (Ho et al. 2014).  
2.4.4 Immunofluorescent!Labelling!!
2.4.4.1 Complexing)Primary)and)Secondary)Antibodies)
Probing mouse corneas with monoclonal antibodies raised in mice presents some 
difficulties in sufficiently reducing background labelling. This high background 
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occurs because the fluorophore-containing anti-mouse secondary antibody can non-
specifically bind IgG native to the tissue (Goodpaster and Randolph-Habecker 2014). 
To prevent this non-specific binding, primary and secondary antibodies were 
incubated in solution to encourage formation of antibody “complexes”, which were 
subsequently applied to tissue sections. Both primary and secondary antibodies 
were suspended in 1x phosphate buffered saline (PBS) with 0.1% TWEEN-20 (PBS-T) 
and 2% BSA (see Chapter 4, Table 4-2) for exact volumes and concentrations). The 
secondary antibody was added such that its concentration exceeded that of the 
primary antibody; this ensured all primary antibody was bound to secondary (Figure 
2-11, step 1). Normal mouse serum (NMS) was added to the mixture the following 
morning (Figure 2-11, step 2) to saturate binding sites of free secondary antibody, 
further reducing the likelihood of erroneous labelling (Figure 2-3, step 3). This 
mixture was allowed to incubate for a minimum of 30 minutes prior to tissue section 
application. 
 
 
Figure 2-11: Formation of antibody complexes. Secondary antibody 
(red) is added in excess of primary antibody (blue) in PBS-T with BSA 
(1). Primary and secondary antibodies bind during the overnight 
incubation period (2). Normal mouse serum (black) is added to 
mixture to bind potentially unbound secondary antibody (3). 
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2.4.4.1 Labelling)Corneal)Sections))
Slides containing tissue sections were recovered from -80°C storage and brought to 
room temperature. Since sections were arranged on slides in two groups of 4 -6 
sections each during cryosectioning, these were used as control and experimental 
groups during each experiment. To ensure there was no mixing of solutions on the 
same slide during experimentation, a border was drawn around each group using a 
wax pen. In addition to keeping experimental and control groups separate, this 
technique also decreased the volume of each buffer and antibody mixture required 
throughout the experiment. For each of the subsequent steps described here, slides 
were housed in a humid chamber to prevent evaporation of buffers during 
incubation times.  
First, tissue was rehydrated by applying PBS-T to each group of sections for five 
minutes. Next, 1% Triton in 1x PBS was applied to sections for 30 minutes to prevent 
background fluorescence, which was rinsed away using 1x PBS-T. To achieve 
labelling of CS/DS-GAGs, an enzyme preincubation with chondroitinase ABC, AC, or B 
was necessary to first reveal CS/DS-GAG neoepitopes. These enzyme digestion steps 
were carried out for two hours at 37°C (details of antibodies and their respective 
enzyme preincubations are fully described in Chapter 4, section 4.2.3). Enzyme 
 
solutions were rinsed from sections using PBS-T + 2% BSA, and then blocked with 
10% normal goat serum in PBS-T + 2% BSA for 30 minutes. Labelling of KS-GAGs did 
not necessitate an enzyme predigestion, so those sections were immediately placed 
in blocking solution following the 1% Triton incubation period. After rinsing the 
blocking reagent from sections using PBS-T + 2% BSA, primary-secondary complex 
solutions were applied for four hours at room temperature. PBS-T was again used to 
thoroughly rinse away antibody mixtures before applying a dual mountant-DAPI 
stain and coverslip. If slides were not imaged immediately, they were placed in foil-
wrapped slide boxes and placed at 4°C.  
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2.4.5 Imaging!
Labelled sections were imaged using an Olympus BX40 fluorescent microscope 
equipped with an SIS F-View black and white digital camera, no more than 24 hours 
after labelling. Three images were collected for each specimen: Brightfield, which 
showed tissue morphology; fluorescence, which showed localization of the primary-
secondary complexes on GAG epitopes; and DAPI, which showed nuclei localization.  
2.5 Western Blot Analyses 
Western blot is a technique that involves separating biological extracts by molecular 
weight via application of an electrical current. In order to visualize the separated 
molecules by antibody labelling, the separated extracts are transferred from the gel 
used during SDS-PAGE to a membrane that can be probed and imaged. Steps to 
generate these data are described below. 
2.5.1 Corneal!Tissue!Extraction!
Before macromolecules can be visualized by Western blot, they must first be isolated 
from the tissue of interest. To this end, corneal tissue was dissected as described in 
section 2.2.2.1. Once whole corneas were isolated, they were manually minced using 
two scalpel blades in a petri dish resting on ice. From there, minced corneas were 
placed in extraction solution containing 8 M guanidine hydrochloride (GuHCl); 1 M 
Tris/hydrochloride (Tris/HCl), pH: 8.0; 0.5 M ethylenediaminetetraacetic acid (EDTA); 
50 mM phenylmethanesulfonyl fluoride (PMSF); and 1x proteinase inhibitors. A 
bench-top homogenizer was used to rapidly pulverize corneas suspended in 
extraction solution. After homogenization, corneal solutions were placed at 4°C 
overnight on a rotator. The following day, samples were centrifuged and the 
supernatant collected for future analysis. Additional homogenizing solution was 
added to the pellet, which was then subjected to overnight rotation a second time. 
Centrifugation followed the second extraction period, and the two supernatants 
were pooled. The samples were dialyzed and concentration using 6 M urea and a 
series of centrifugation steps as described in Chapter 5, section 5.2.2. 
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2.5.1.1 Rationale)
Chemicals found in the extraction solution identified above were used here because 
of their long-standing use in chemical extraction of tissues. The appeal of GuHCl is its 
ability to denature proteins (Haas et al. 1965), thereby degrading tissue beyond that 
which can be achieved by physical means (i.e. mincing or homogenizing). Both PMSF 
and protease inhibitors are included above to prevent hydrolysis of peptide bonds 
(James 1978), which might seem counterintuitive in the presence of strong protein 
denaturing agents. However, the purpose of GuHCl is limited to protein unfolding, 
rather than cleaving into constituent peptides or amino acids, which might occur in 
the absence of PMSF and additional protease inhibitors.  
2.5.2 Sodium! Dodecyl! Sulfate! Polyacrylamide! Gel! Electrophoresis!
(SDSOPAGE)!!
Reagents, including 4x NuPAGE® LDS sample buffer and 10x reducing agent, were 
supplied by the SDS-PAGE kit manufacturer (Thermo Fisher Scientific, 
Loughborough, UK) and added to corneal extracts at the appropriate dilution (see 
Chapter 5, section 5.2.8). Once mixed and denatured by heating to 100°C for 10 
minutes, samples were dispensed into a 4 - 12% Bis-Tris Invitrogen polyacrylamide 
gel. Voltage was set to 200 V and was applied for 45 minutes, or until samples 
reached the bottom of the gel (Figure 2-12).  
2.5.1 Western!Blot!
Following SDS-PAGE, separated samples were transferred to an Invitrolon™ 
polyvinylidene fluoride (PVDF) membrane. Similar to SDS-PAGE, Western blot 
requires a power supply, cathode, and anode to encourage the negatively charged 
molecules to migrate from the gel the membrane. In this case, 30 V were applied for 
1 hour. Sample-laden membranes are treated similarly to immuno-labelled tissue 
sections in that a blocking step is required before applying primary and secondary 
antibodies. To block, the membrane was submerged in 5% skim milk for 1.5 hours. 
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Figure 2-12: Schematic of SDS-PAGE experiment. Extracted tissue samples are 
pipetted into wells of electrophoretic gel. Voltage is applied to the system, 
encouraging negatively charged biomolecules to travel toward the anode (positively 
charged) at the base of the gel. Resulting samples are separated by molecular weight 
such that high molecular weight molecules remain near the top of the gel and low 
molecular weight constituents are toward the bottom.  
 
Primary antibodies were subsequently diluted in 5% skim milk and applied to the 
membrane for 1 hour. Next, secondary antibodies were also diluted in 5% skim milk 
and applied to the membrane surface for 1 hour. Depending on the secondary 
antibody in use, a Luminata Forte Western HRP substrate or chemi-lumi One 
chemiluminescence substrate was applied to the membrane for 2 minutes to 
develop the membranes for imaging (see section 2-13). 
 
 
Figure 2-13: Diagram of Western blot. Samples are separated by SDS-PAGE, 
and subsequently transferred to a membrane. Finally, antibody reactions are 
used to visualize molecules of interest. Taken from Bio-Rad. 
This image has been redacted to 
avoid copyright infringement. The 
interested reader should visit the 
website provided in the references 
list to view the original figure. 
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2.5.1.1 Rationale)
PVDF membranes are effective tools in Western blotting because of their ability to 
bind amino acids (Pluskal et al. 1986), and therefore proteins present in tissue 
extracts. Primary and secondary antibody labelling aids in visualization of molecules 
of interest. Instead of fluorophore-conjugated secondary antibodies, they are instead 
conjugated to HRP. The addition of the developing substrate generates a 
precipitation reaction, resulting in the build-up of a visible product (Figure 2-14).  
 
Figure 2-14: Schematic of labelling protein/GAG epitopes on 
PVDF membrane. Following the blocking step, primary 
antibodies are applied to label specific epitopes of interest. HRP-
conjugated secondary antibodies are added next to bind 
immobilized primary antibodies. The HRP substrate added 
subsequent to secondary antibody labelling generates a signal 
visible to an imaging system. Adapted from The University of 
Queensland, reproduced with permission from the copyright holder, 
The University of Queensland. 
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2.1 High Performance Liquid Chromatography 
High performance liquid chromatography (HPLC) is a separation technique that, in 
this thesis, was used to quantify disaccharide units of corneal GAGs. After extraction 
and cleavage of the GAGs into their constituent disaccharides, separation occurs by 
applying the GAGs to a column packed with a polymer capable of binding charged 
molecules. Disaccharides elute from the column at different time points as a function 
of their charge. Once disaccharides leave the column, they are detected with a UV 
detector. In addition, the model of HPLC system used here was equipped with a 
fluorophore reactor that coupled fluorophores to the disaccharides for a more 
sensitive means to detect the disaccharides. Below, the HPLC systems is described, 
along with rationale behind the necessary reagents and experiment parameters.  
2.1.1 Components!of!an!HPLC!System!
Figure 2-15 shows an image of the Dionex UltiMate 3000 HPLC system used for 
experiments in this thesis. The system is comprised of a solvent rack and pump, 
autosampler, column compartment, UV detector, post-column reactor, and 
fluorescence detector. The solvent rack holds buffers necessary for all parts of the 
experiment and contains a degassing mechanism to prevent the accumulation 
bubbles in buffers. The pump controls the flow rate of solutions and ratio of running 
buffer to elution buffer that enters the column. The autosampler houses vials of 
experimental and control solutions and contains an automated needle that uptakes 
each sample for application to the column. In addition to containing the column 
itself, the column compartment houses a heating element for elution to occur at a 
specific temperature. After passing though the column, separated samples travel 
through a flow cell in the UV detector, which produces signal visible on the analysis 
software. A single wavelength of light is passed through the flow cell, and changes in 
the transmission of light through the sample is recorded by a detector, which sends 
the data to the analysis software for observation. Disaccharides in this thesis are 
visible in the UV detector because they contain a 4,5 unsaturation (i.e. double bone 
between C-4 and C-5) that absorbs UV light. Therefore, the more concentrated the 
disaccharides, the more UV light absorbed in the UV detector, in turn showing a 
higher peak on the detection software. After UV detection, disaccharides travelled 
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through a post-column reactor that served to couple fluorophores to disaccharides 
in real time. The presence of a fluorophore on disaccharides renders them visible to 
the fluorescence detector, which also relays signal correlating to concentration of the 
disaccharides to the analysis software.  
 
Figure 2-15: HPLC setup. A solvent rack, pump, autosampler, column compartment, 
UV detector, post-column reactor, fluorescence detector, and analysis software 
comprise the HPLC system used in thesis. Buffers in the solvent rack include the 
running buffer, elution buffer, and fluorophore coupling reagents. The pump 
regulates how much buffer reaches the column. Experimental samples and 
disaccharide standards are injected into the column by the autosampler. UV and 
fluorescence detectors generate signal on the analysis software in real time as 
separated disaccharides pass through their respective compartments.  
 
2.1.2 Column!Separation!
Experiments in Chapter 6 were conducted using a CarboPac PA1 column, the 
stationary phase of which contains positively charged quaternary ammonium 
functional groups. Running buffer was composed of an ion-pairing reagent, 
tetrabutylammonium (TBA), and an organic solvent, acetonitrile (AcN). Elution was 
achieved using sodium chloride (NaCl) in addition to TBA and AcN (see Chapter 6, 
section 6.2.4 for exact concentrations). Two mechanisms have been proposed to 
describe how an ion-pairing reagent facilitates separation. In the first instance, it is 
thought that ions originating from the ion-pairing reagent bind to charged species in 
the experimental sample to form a neutral molecule in the mobile phase (i.e. the 
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running/elution buffer), which then interacts with the hydrophobic stationary phase 
(i.e. the column) (Horvath et al. 1977, Jones et al. 2010, Fasciano and Danielson 2016). 
Alternatively, others have suggested that the ion-pairing reagent firstly adsorbs to 
the stationary phase, and the introduction of the charged analyte in the mobile 
phase displaces the bound ion-pairing reagent in what is referred to as dynamic 
anion exchange (Figure 2-16) (Bidlingmeyer et al. 1979, Jones et al. 2010, Fasciano 
and Danielson 2016). 
 
 
Figure 2-16: Mechanism of dynamic anion exchange. Negatively 
charged ion-pair reagent (“counter ions” above) interacts with the 
positively charged stationary phase. Negatively charged ions from 
the sample displace the bound ion-pair reagent, thus constituting 
sample adsorption. Negatively charged sample ions dissociate (i.e. 
elute) from the column surface when salt, such as NaCl, is applied. 
Taken from Levin 1997. 
 
2.1.3 PostOcolumn!Derivatization!
The term post-column derivatization refers to the coupling of a fluorophore to 
separated compounds for fluorescence detection. This coupling reaction takes place 
at 125°C in the post-column reactor, immediately following UV detection. Coupling 
reagents included equal parts 2-cyanoacetamide and NaOH (see Chapter 6, section 
6.2.4 for exact concentrations), as these reagents have been successful in GAG 
disaccharide-fluorophore coupling in previous studies (Toyoda et al. 1999, Ha et al. 
2005, Vongchan et al. 2005, Sinnis et al. 2007).  
This image has been redacted to 
avoid copyright infringement. The 
interested reader should visit the 
website provided in the references 
list to view the original figure. 
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2. CHAPTER 3 
3. Electron Microscopy Analysis of 
Ultrastructural Organization in the WT and 
Mutant Mouse Corneal Stroma 
3.1 Introduction 
As mentioned in Chapter 1 (section 1.1.4.2), current literature suggests that the 
enzymes CGn6ST, β4GalT4, and β3GnT7 work sequentially to elongate KS-GAGs, and 
that KSGal6ST acts following elongation to create the highly sulfated KS motif 
(Akama et al. 2002). To expand on those in vitro studies, transgenic mice that lack the 
murine ortholog of the human CGn6ST-encoding gene, Chst5, have been developed 
and their corneal morphology characterized. Two notable results of those studies 
were that: 1) KS levels drop to virtually nil in the corneal stroma when observed by 
electron microscopy and 2) large, oversulfated proteoglycans appeared, which were 
susceptible to chondroitinase ABC yet resistant to keratanase digestion. It was 
posited that the concurrent appearance of these elongated PGs in the absence of 
properly formed KS-PGs points to an intrinsic, compensatory mechanism to uphold 
corneal structure and thus transparency (Hayshida et al. 2006, Parfitt et al. 2011). 
While a tremendous amount has been learned in recent years about KS synthesis and 
the role of CGn6ST, there are still many questions to be answered regarding KS 
biosynthesis. In particular, it would be of great interest to know if abolishing the 
action of other glycosyltransferases or sulfotransferases known to be involved in KS 
biosynthesis has a similar effect on corneal make-up as has been described in the 
Chst5-null mouse cornea. The discovery of murine genes that encode KSGal6ST 
(Chst1) and β3GnT7 (B3gnt7) has facilitated the development of transgenic mice 
lacking the ability to sulfate the C-6 position of galactose residues (in Chst1-null mice) 
or unable to glycosidically link GlcNAc residues (in B3gnt7-null mice) to the KS-GAG 
backbone (Fukuta et al. 1997, Patnode et al. 2013a, Patnode et al. 2013b, Hoshino et 
al. 2014). Despite the availability of these mice, their corneal ultrastructure has not 
been investigated to date. Therefore, the purpose of this is to use electron 
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microscopy to observe corneal morphology of mice deficient in KSGal6ST (Chst1-
null), β3GnT7 (B3gnt7-heterozygous null and homozygous null), and those that are 
jointly deficient in CGn6ST and KSGal6ST (Chst1/5-double knockout). The Chst5-null 
mouse has been characterized, and it is studied here as a positive control (Hayashida 
et al. 2006). 
Based on the proposed mechanism of KS biosynthesis, the hypothesized corneal KS 
structure for each null mouse is shown in Figure 3-1. Since CGn6ST and β3GnT7 are 
thought to play a role in extending the KS-GAG backbone, the absence of one or 
more of these enzymes in the Chst5-, Chst1/5- (Figure 3-1c), and B3gnt7-null (Figure 3-
1d) mice should result in truncated KS-GAG chains. Conversely, since KSGal6ST is 
thought to sulfate internal galactose residues only after the KS backbone has been 
extensively elongated, it is hypothesized that KS-GAGs will elongate, but will lack the 
di-sulfated disaccharide motif that would normally qualify them as “highly sulfated” 
KS (Figure 3-1b). The structure of normally elongated KS is provided for reference in 
Figure 3-1a.  
 
 
Figure 3-1: Hypothesized structures of mutant KS-GAGs. The structure of normally 
synthesized corneal KS in WT mice (a) is contrasted with hypothesized KS-GAG 
structures for Chst1-null (b), Chst5-null or Chst1/5-null (c), and B3gnt7-null (d) mice. The 
Chst1-null KS-GAG may be elongated but lacking disulfated disaccharides, whereas 
Chst5-, Chst1/5-, and B3gnt7-null KS-GAGs likely assume an abnormally shortened form. 
Blue hexagons represent GlcNAc residues; green hexagons represent galactose 
residues. Sulfate groups are represented by a red “S”, and the KS-GAG reducing end 
(including linkage and unsulfated regions) is represented by the black zig-zag.  
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To clearly observe the KS phenotype induced by genetic mutation, it was necessary 
to rid corneal samples of CS/DS-PGs, which was accomplished by chondroitinase ABC 
preincubation. Electron micrographs were collected throughout the stromal depth of 
each WT and mutant cornea with and without enzymatic predigestion. Tissue 
properties including PG morphology and collagen fibril diameter were examined, 
and, in the latter case, quantified.  
3.1.1 Aims(and(Objectives(
1. Observe WT and Chst5 corneas using electron microscopy to assess 
reproducibility of published PG phenotypes (i.e. Young et al. 2005, Hayashida 
et al. 2006).  
2. Characterize corneal PG and collagen morphology of recently developed 
mouse mutants (Chst1, Chst1/5, B3gnt7-HTZ, and B3gnt7-NULL) to determine 
the role of each mutated sulfo- or glycosyltransferase in KS biosynthesis. 
a. Compare untreated and chondroitinase ABC-digested corneal 
specimens from each WT and mutant genotype to differentiate CS/DS-
PGs from KS-PGs.  
b. Determine whether KS biosynthesis mutations affects collagen fibril 
diameter by measuring this property in electron micrographs.  
3.2 Methods  
3.2.1 Animals(
 Dr. Tomoya Akama of Kansai Medical University (Osaka, Japan) provided corneal 
tissue specimens used in these studies. Table 3-1 shows details of the specimens. 
Prof. Quantock (experiment 1) or I (experiments 2 and 3) travelled to Japan to harvest 
the tissue and conduct preliminary processing required for transport to Cardiff 
University.  
3.2.1 Specimen(Pre9processing((
In all three experiments, Dr. Akama enucleated eyes from freshly euthanized mice. To 
follow, the “pre-processing researcher” (either me or Prof. Quantock) performed the 
remainder of pre-processing steps. The corneas were isolated from the eye globe and  
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 Genotypes  Sex Age (weeks) n (mice, corneas) 
Experiment 1 
(Jan 2013) 
WT  
Chst1-null 
Chst5-null 
 
Male 
 
17 
17 
17 
1, 2 
1, 2 
1, 2 
Experiment 2 
(Jan 2014) 
WT 
Chst1/5-null Female 
20 
11 
1, 2 
1, 2 
Experiment 3 
(Aug 2014) 
WT 
Chst1/5-null* 
B3gnt7-HTZ  
B3gnt7-NULL 
Male 
14 
11 
14  
14 
1, 2 
1, 2 
1, 2 
1, 2 
 Table 3-1: Details of mice used for electron microscopy analysis. *Chst1/5 
specimens were processed in the third experiment because the enzyme digestion 
step in experiment 2 was unsuccessful (see section 3.3.3.2). 
 
placed directly into pre-fixative (4% paraformaldehyde in 0.1 M Sorensen phosphate 
buffer, pH: 7.4) for 10 minutes. Whole corneas were then rinsed twice briefly with Tris 
acetate buffer (1x). Stiffness of the tissue created by pre-fixation allowed each cornea 
to be further dissected into quarters and separated into each of three groups: 
untreated, chondroitinase ABC-digested, or buffer-treated. Each of the groups 
received one corneal quarter, except for the “untreated” group, which received two 
quarters.  
3.2.1.1 Processing.of.Untreated.Corneal.Quarters..
After further dissecting whole corneas into quarters as stated above, those quarters 
in the “untreated” group were placed directly into 0.05% (w/v) CB in 25 mM sodium 
acetate buffer (pH: 5.7) with MgCl2 at critical electrolyte concentration, 0.1 M (Scott 
1980). CB incubation was carried out at room temperature overnight with constant, 
gentle agitation. 
3.2.1.2 Processing.of.Chondroitinase.ABC.and.Buffer;treated.Corneal.Quarters.
Chondroitinase ABC-digestion enzymatically removed CS/DS-PGs to allow for 
visualization of only KS-PGs in electron micrographs. Buffer-treated control tissue 
was incubated in an isotonic buffer under identical conditions (e.g. temperature, 
duration, agitation) to chondroitinase ABC-digested corneas. 
Following dissection into quarters, the chondroitinase ABC-digested and buffer-
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treated corneal pieces incubated at 37°C for four hours in 1x Tris-Acetate buffer 
containing bovine serum albumin (pH: 8) and 10 μl/ml of general protease inhibitor. 
In the chondroitinase ABC-digested group, 1 U/ml chondroitinase ABC was present 
in solution during incubation. Both groups were on a rotator for the entirety of the 
reaction. Following incubation, specimens were rinsed in 25 mM sodium acetate 
buffer containing 0.1 M MgCl2. Staining occurred overnight at room temperature on 
a rotator in 2.5% (w/v) glutaraldehyde in 25 mM sodium acetate buffer (pH 5.7) 
containing 0.05% (w/v) CB, identical to the untreated group. 
3.2.1.3 Post;fixation,.Staining,.and.Transport.
The following morning, fixed and stained specimens of all groups (untreated, ABC-
digested, and buffer-treated) were washed three times (10 minutes/wash) in 0.5% 
(w/v) sodium tungstate. In the second and third experiments, samples were 
transported to Cardiff University at room temperature in this tungstate buffer. In the 
first experiment, however, the dehydration step of the embedding process (see 
section 3.2.3.1) was carried out in Japan, and the samples were instead transported in 
100% ethanol.  
3.2.2 Embedding(and(Sectioning(at(Cardiff(University(
I embedded corneal samples in the first and second experiments. Dr. Rob Young 
performed embedding for the third experiment, as I was still in Japan when the 
specimens arrived to Cardiff University. Sectioning, staining, and imaging the 
specimens was conducted by me in each of the three experiments. 
3.2.2.1 Embedding.
Upon arrival in Cardiff, the corneal quarters of each group were dissected again into 
small blocks ~1 mm wide and 2 mm long. This ensured each reagent could 
completely infiltrate the specimen blocks. Samples were dehydrated using 
increasingly concentrated ethanol solutions (70% - 100%) for 15 minutes each. 
Propylene oxide was used as a transition solvent between ethanol and resin steps by 
washing dehydrated samples twice in 100% propylene oxide (15 min/wash). Samples 
were then placed in a 1:1 mixture of propylene oxide and resin for one hour. Six 
changes (approximately three hours each) of Araldite resin (CY212 monomer) 
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containing DDSA hardener and BDMA accelerator (see Chapter 2, section 2.2.3.3) 
ensured total removal of residual propylene oxide and complete infiltration of resin 
into each specimen block. Corneal quarters were then transferred into molds such 
that layers of the cornea were perpendicular to the block edge. This ensured that 
sectioning the block face would produce full thickness (epithelium through 
endothelium) sections, as opposed to en face sections. Blocks were polymerized at 
60°C for a minimum of 24 hours.  
3.2.2.2 Ultrasectioning.
Ultrathin sections (~90 nm) were created using a microtome equipped with a glass or 
diamond knife. Sections were collected on copper grids (3.05 mm in diameter). 
Collagen contrast was achieved by floating grids on a saturated solution of uranyl 
acetate for 30 minutes. Grids were rinsed three times in 0.2 μm-filtered distilled water 
(5 minutes/rinse) and allowed to dry on filter paper within petri dishes before 
imaging. 
3.2.2.3 Imaging.
Once dry, sections were examined using a JEOL 1010 transmission electron 
microscope operating at 80 keV. 
TEM images were collected from each genotype and tissue preparation protocol 
(untreated, ABC-digested, or buffer-treated) described above. Anterior, mid, and 
posterior stromal regions were documented with collagen oriented in both 
transverse and longitudinal planes for each genotype/processing method 
combination. To allow for comparisons between WT versus mutant genotypes or 
untreated versus chondroitinase ABC-treated tissue, all images in this chapter were 
taken at 20,000x magnification. Scale bars represent 100 nm, unless otherwise stated. 
3.2.3 Quantification(of(Collagen(Fibril(Diameters(
To investigate whether or not mutations in KS biosynthesis affected collagen 
fibrillogenesis, a series of high magnification images were collected for those 
genotypes processed in experiment 1 (WT, Chst1, and Chst5).  
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3.2.3.1 Calibration.of.Microscope.and.ImageJ..
Grid position in the y-axis, and therefore the perceived scale of images, can slightly 
vary within the electron microscope. Each time the specimen arm is removed and 
replaced, the exact position of the grid differs from the previous location in the y-axis 
(i.e. grids can be slightly closer to or farther from the camera). Although these 
differences in grid location are extremely small, they have the potential to affect the 
outcome of a quantitative study that measures distances on the tens of nanometer 
scale. To counteract the intrinsic variability of the microscope, grids containing 
catalase crystals were used to calibrate the microscope. This is essential because the 
lattice of catalase crystalline structure is consistently 8.6 nm and can be used as a 
standard before measuring experimental images (Wrigley 1968).  
Images of the catalase crystal were collected at the same magnification of 
experimental images (40,000x). Once imported into ImageJ, images were rotated 
such that the lattice structure was perfectly horizontal. The line tool was then used to 
draw a perpendicular line across 10 lattice repeats (yellow line, Figure 3-2). The 
length of this line in pixels (red arrow, Figure 3-2) was then equated to 86 nm (green 
arrow, Figure 3-2), the known distance of 10 adjacent lattice units.  
 
 
Figure 3-2: Screenshot of ImageJ calibration. An image of catalase crystalline 
structure at 40,000x is rotated such that its lattice is horizontal. A vertical line is 
then drawn to traverse 10 lattice repeats. The length of the line in pixels (red 
arrow) is equated to the known distance of 10 catalase crystal repeats (86.0 
nm, green arrow), according to Wrigley (1968).  
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3.2.3.2 Image.Adjustment.and.Fibril.Measurement.
Once ImageJ had been calibrated, images from each genotype were imported into 
the software. Since the images collected were initially low contrast (Figure 3-3a), 
contrast and brightness were adjusted identically in each image to enhance 
appearance of fibril edges (Figure 3-3b).  
 
 
Figure 3-3: Example of contrast-enhanced images. Images imported into ImageJ 
were low contrast, making it difficult to discern fibril edges (a). Contrast and 
brightness levels were therefore adjusted identically in each image to enhance 
contrast for more clearly defined collagen fibril edges, thus more accurate analysis 
(b). 
 
The line tool used to select crystal lattice in Figure 3-3 was also used in experimental 
images to draw lines traversing individual collagen fibrils. In cases where fibrils 
appeared oval, the narrow axis of the fibril was measured. In addition, since PGs were 
present in the images above, every effort was made to measure edges of the fibrils 
that were not in direct association with a neighboring PG. To avoid an over-
estimation of fibril diameters, fibrils that were completely surrounded by PGs were 
omitted from the study.  
3.3 Results  
3.3.1 Untreated(WT(Corneal(Samples:(Common(Features(of(a(Stromal(
Electron(Micrograph(
This section serves as an introduction to electron microscopy of the mouse corneal 
stroma, in which common features of this tissue are identified and defined in 
untreated WT tissue. Both images in Figure 3-4 show examples of transversely 
a. b. 
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sectioned collagen fibrils, which are encircled in black (Figure 3-4a, b). These fibrils 
appear round when sectioned perpendicular to their axes. However, a slight tilt of 
the collagen fibril axis relative to the sectioning plane can sometimes create an oval 
cross-sectional appearance (not shown). White arrows in Figure 3-4a and 3-4b 
indicate examples of longitudinally sectioned collagen fibrils, which appear striated 
because of their characteristic a-e banding pattern (see section 1.1.3, Figure 1-6). 
Apart from collagen fibrils, two families of PGs are visible in the EM images of Figure 
3-4. First, long PGs that traverse multiple collagen fibrils are generally regarded as 
CS/DS-PGs (red chevrons, Figure 3-4a, b), as Young et al. 2005 showed CS/DS-GAGs 
reach up to 600 nm in length. Another distinctive quality of putative CS/DS-PGs is 
their periodicity along collagen fibril axes. Scott and Haigh (1985) demonstrated that 
CS/DS-PGs frequently associated with d and e bands along collagen fibrils, giving rise 
to a consistent 65 nm interval between the PGs, as signified by the series of red 
asterisks in Figure 3-4b. Secondly, KS-PGs are also subjectively identifiable based on 
their apparent length in EM images. Black arrowheads in the images identify 
examples of KS-PGs, which usually appear as relatively low-contrast filaments 
radiating outward from collagen fibril axes toward the next-nearest collagen fibril.  
Overall, Figure 3-4a appeared to contain a higher number of PGs, as compared to 
Figure 3-4b. This is likely due to a slight difference in processing. Since 4a is from 
experiment 1, it was dehydrated in Japan and transported to Cardiff in ethanol. 
Image 4b is from experiment 3, and those samples were transported to Cardiff in 
tungstate buffer then dehydrated after arrival. Dehydration prior to transport 
appeared to facilitate superior preservation of PG filaments. This minor fluctuation in 
PG content across the two experiments demonstrates the importance of comparing 
images from tissue processed only within the same experiment, hence the need for 
processing a WT control in each of the three experiments conducted in this chapter. 
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Figure 3-4: Typical features of the WT mouse corneal stroma. Untreated 
WT images from experiment 1 (a) and 3 (b). Collagen fibrils are observed 
in both transverse (black circles) and longitudinal (white arrows) 
orientation. CS/DS-PGs tend to bridge multiple collagen fibrils (red 
chevrons), whereas KS-PGs are shorter, only reaching to the next-nearest 
fibril (black arrowheads). Red asterisks demonstrate the periodicity 
characteristic of CS/DS-PGs.  
* * * * 
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3.3.2 Collagen(and(Proteoglycan(Phenotypes(in(Three(Stromal(
Locations:(Anterior,(Mid,(and(Posterior(
Each genotype was imaged in anterior (defined as within 20 μm of the epithelium), 
mid, and posterior (defined as within 20 μm of Descemet’s membrane) zones of the 
corneal stroma with collagen in both transverse and longitudinal section. This 
comparison among stromal areas is necessary, as recent studies have shown that 
mice deficient in KS-PG core protein lumican only show an affected phenotype (i.e. 
coalesced collagen fibrils of variable diameters) in posterior stromal regions 
(Chakravarti 2000). Additionally, x-ray diffraction studies of MCD (Palka et al. 2010) 
and Chst5-null (Hayashida et al. 2006) corneal tissue show decreased interfibrillar 
spacing, leading to a relatively thin stroma. The aim of collecting images in three 
stromal zones of sulfo- or glycosyltransferase deficient mouse corneas was to 
determine if these genetic mutations generated widespread or location-specific 
morphological changes that mirrored the condensed collagen fibril packing or varied 
fibril diameters described in the literature.  
3.3.2.1 Qualitative-Observation-of-Collagen-Fibrils-in-Transverse-Images-
Within a given genotype, collagen interfibrillar spacing was subjectively compared in 
anterior, mid, and posterior stromal zones. Contrary to MCD and Chst5-null 
phenotypes described above, spacing between collagen fibrils appeared to increase 
as a function of stromal depth in both WT and mutant corneal tissue. This was 
observed in all three experiments, occurring primarily in buffer-treated and 
chondroitinase ABC-digested tissue samples. Figure 3-5 contains images from 
experiment 1 that exemplify this relationship. Collagen fibrils appeared more distant 
from each other in those images collected from the posterior stroma (Figure 3-5c, f), 
as compared to middle (Figure 3-5b, e) or anterior (Figure 3-5a, d) regions. Additional 
examples of this effect can be found in Appendix I, Figures A1-1 (a–c, m–o); A1-2 (a–
c, g–i, m–o); A1-3 (g–i, m–o); A1-4 (g i), A1-5 (g–i); A1-6 (g–i, m–o); A1-7 (a– c, g–i, m–
o); and A1-8 (g – i).  
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a. b. c. 
e. 
100 nm 
f. d. 
 
Figure 3-5: Example images showing increased interfibrillar spacing in posterior 
stroma. Chondroitinase ABC-digested WT tissue (a-c) and buffer-treated Chst5 tissue 
(d-f) show increased collagen interfibrillar distance in posterior regions (c, f), as 
compared to their anterior (a, d) or middle (b, e) counterparts.  
 
Because increased interfibrillar spacing of the deep stroma was observed in WT and 
mutant tissue alike, it is unlikely the trend was a result of genetic modification of the 
mice. Rather, the literature suggests the posterior stroma is more susceptible to 
swelling (Castoro et al. 1988, Lee and Wilson 1981, Meek et al. 2003a). Since the 
increased interfibrillar spacing was primarily observed in those corneas that 
underwent buffer- or enzyme-incubation for four hours prior to CB fixation, it is likely 
swelling played a role in artifactually increasing interfibrillar distances posteriorly.  
Quantitative studies have been conducted on interfibrillar spacing using electron 
micrographs as a means for measurement (Craig and Parry 1981, Doughty 2012, 
Freund et al. 1995). However, this technique has faced criticism for the variability of 
results throughout the literature (Boote et al. 2003), which is why no quantification of 
interfibrillar distance was carried out on electron micrographs in this thesis. 
Diameters of collagen fibrils were also observed in transverse images of the corneal 
stroma. This aspect of the tissue will be more thoroughly investigated and discussed 
in section 3.3.6.  
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a. 
d. e. f. 
100 nm 
b. c. 
3.3.2.2 Proteoglycan-Phenotypes-in-the-Anterior,-Mid,-and-Posterior-Stoma-
In addition to examining interfibrillar spacing and collagen phenotype, proteoglycan 
content and morphology were qualitatively assessed in anterior, mid, and posterior 
areas of the stroma. Below are two sets of images taken from the untreated Chst1 
specimen in experiment 1 (Figure 3-6, a-c) and the chondroitinase ABC-digested 
B3gnt7-NULL sample of experiment 3 (Figure 3-6, d-f). In the untreated Chst1 set, no 
obvious difference was noted between the three regions imaged. All three areas 
contained what appeared to be approximately the same PG composition, with 
numerous putative CS/DS-PGs observed along collagen fibril axes (Figure 3-6, a-c).  
Similarly, when anterior, mid, and posterior regions of the chondroitinase ABC-
digested B3gnt7-NULL specimen were qualitatively analyzed, each area possessed a 
comparable phenotype. In this particular example, following chondroitinase ABC 
digestion, no residual PGs were observed in any region of the B3gnt7-NULL corneal 
sample (Figure 3-6, d-f).  
 
 
Figure 3-6: Example images showing consistency of PG phenotypes in different 
stromal regions. Anterior, mid, and posterior sets of images from experiment 1 
Chst1 (a-c) tissue and experiment 3 B3gnt7-NULL (d-f) tissue. Proteoglycan 
phenotypes appeared consistent throughout the depth of the stroma in images 
above and in Figures A1-1 – A1-8 in Appendix I, implying effects of genetic 
alteration were widespread, rather than localized to a specific area of the cornea.  
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Anterior, mid, and posterior images from each genotype in all three experiments 
were analyzed in this manner, and not a single genotype showed a region-specific 
phenotype. When PGs with unusual morphology were observed in one stromal 
region, they were consistently observed in the remaining two regions. Similarly, 
action of the chondroitinase ABC enzyme did not appear to be limited to a certain 
stromal region; when PGs were digested from enzymatic incubation, they were 
decreased equally throughout the depth of the cornea. Therefore, proteoglycan 
phenotype did not appear to be contingent on stromal location. Those images of 
genotypes not shown in the above figure can be found in Appendix I, Figures A1-1 – 
A1-8. 
3.3.3 Outcomes(of(Chondroitinase(ABC(Digestion(of(Samples(in(
Experiments(1(–(3(
Selected images from the untreated and chondroitinase ABC-digested groups of 
experiments 1-3 are compared here to assess whether or not the chondroitinase ABC 
digestion appeared “successful” in each experiment. “Successful” chondroitinase 
ABC-treatment is defined in this preliminary assessment as an appreciable loss of PG 
content in the digested tissue, as compared to the untreated counterpart. Results are 
divided up into sections based on experiment number.  
3.3.3.1 Experiment-1:-WT,-Chst1,-and-Chst5-
Representative images of the untreated and chondroitinase ABC-digested WT 
specimen (experiment 1) comprise Figure 3-7. Whereas the untreated sample (Figure 
3-7a) shows numerous PGs that resemble CS/DS in their morphology, the 
chondroitinase ABC-digested tissue appeared to lack putative CS/DS-GAGs (Figure 3-
7b). Short filaments, likely to be KS-PGs based on previous studies, were still visible. 
However, a clear decrease in GAG content was apparent, suggesting the 
chondroitinase ABC enzyme digestion was successful. The same effect was observed 
in Chst1-null (Appendix I, Figure A1-2, a-f versus m-r) and Chst5-null (Figure A1-3, a-f 
versus m-r) tissue. 
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Figure 3-7: Experiment 1 example images showing decreased PG content following 
chondroitinase ABC preincubation. WT tissue from experiment 1 showed an 
appreciable decrease in PGs following chondroitinase ABC digestion (b), as 
compared to the untreated counterpart (a).  
-
3.3.3.2 Experiment-2:-Chst1/5-
Images of the Chst1/5 sample from experiment 2 are shown in Figure 3-8, with and 
without chondroitinase ABC enzyme digestion. Both untreated and chondroitinase 
ABC-digested samples looked similar, with elongated PGs in both images. The same 
result can be seen in additional Chst1/5 images in Appendix I, Figure A1-4, a-f versus 
g-l). 
 Since no clear decrease in PGs was observed, it was thought that the chondroitinase 
ABC enzyme digestion was unsuccessful. It is possible that the elongated PGs 
observed in the chondroitinase ABC-digested sample were simply resistant to its 
cleavage as a result of the Chst1/5 mutation. In any case, the Chst1/5 experiment had 
to be repeated to confirm these results, hence the re-evaluation of the Chst1/5 
specimen in the third experiment. Because of the uncertain results in experiment 2, 
the remainder of analyses in this chapter were not conducted on tissue processed in 
experiment 2. Only those data from experiment 1 and 3 are presented and discussed.  
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Figure 3-8: Experiment 2 example images showing unchanged PG content in untreated and 
chondroitinase ABC-digested specimens. Both untreated (a) and chondroitinase ABC-digested 
(b) corneal tissue from the Chst1/5 sample show many elongated PGs, suggesting an 
unsuccessful chondroitinase ABC incubation. This genotype was processed in experiment 3 to 
confirm these results. 
3.3.3.3 Experiment-3:-WT,-Chst1/5,-B3gnt7MHTZ,-and-B3gnt7MNULL-
Representative images of B3gnt7-NULL tissue processed without and with 
chondroitinase ABC digestion in experiment 3 are shown below. While distinctly 
long, branched §  PGs were visible in the untreated sample (Figure 3-9a), the 
chondroitinase ABC-digested sample (Figure 3-9b) showed virtually no residual PGs. 
WT (Appendix I, Figure A1-5, a-f versus m-r), Chst1/5 (Figure A1-6, a-f versus m-r), and 
B3gnt7-HTZ (Figure A1-7, a-f versus m-r) tissue also showed this drop in PG content. 
These data indicated a successful chondroitinase ABC digestion experiment.  
 
Figure 3-9: Experiment 3 example images showing decreased PG content following chondroitinase 
ABC preincubation. The decreased number of PGs in the enzyme digested specimen (b) compared 
to the untreated control (a) suggested the chondroitinase ABC successfully removed CS/DS-PGs.  
                                                        
§ Please note that the term “branched” used here and throughout this thesis refers to the radial 
offshoots observed in some PG aggregates in electron micrographs. This usage is not meant to imply 
that the individual glycan chains are branched. 
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While the comparison of chondroitinase ABC-digested tissue to untreated tissue 
indicated adequate removal of CS/DS-PGs in experiments 1 and 3, this cannot be 
concluded without analysis of the buffer-treated images. The next section will 
compare the above chondroitinase ABC-digested images from experiments 1 and 3 
to their buffer counterparts to determine whether or not the loss of PGs observed 
here was a result of reaction conditions or targeted chondroitinase ABC action.  
3.3.4 Effects(of(Buffer(Incubation(on(Proteoglycan(Content(
Buffer-treated tissue served as an important control to ensure that any 
morphological change observed in chondroitinase ABC-digested tissue (e.g. 
decreased proteoglycan content) was a product of chondroitinase ABC action, rather 
than an artifact introduced by immersion in the buffer. If, for example, the buffer-
treated images showed a substantial decrease in proteoglycan content similar to 
what was observed in chondroitinase ABC-digested images, it could be inferred that 
the chondroitinase ABC enzyme reaction conditions caused non-specific leaching of 
proteoglycans, particularly those modified with KS-GAGs (Slack et al. 1992, Kangas et 
al. 1990, Quantock et al. 1991). However, if buffer-treated tissue maintained a high 
number of proteoglycans after incubation and appeared morphologically similar to 
untreated tissue, the loss of PGs observed in chondroitinase ABC-digested images 
could be attributed to the targeted digestion of CS/DS-PGs by chondroitinase ABC 
enzyme activity. Figures 3-10 and 3-11 show chondroitinase ABC-digested images 
from experiment 1 (WT) and 3 (B3gnt7-NULL) alongside their buffer-treated 
counterparts.  
3.3.4.1 Experiment%1:%WT,%Chst1,%and%Chst5%
Buffer treated tissue from experiment 1 showed many PGs associated with collagen 
fibrils at regular intervals, implying CS/DS-PGs were left intact during buffer 
incubation (Figure 3-10a). This result contrasted with the chondroitinase ABC-
digested tissue, which, as previously mentioned, lacked the long-chain PGs generally 
regarded as CS/DS-PGs (Figure 3-10b). Chst1 (Appendix I, Figure A1-2, g-l versus m-r) 
and Chst5 (Figure A1-3, g-l versus m-r) results paralleled those of the WT shown 
below.  
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Figure 3-10: Experiment 1 example images showing normal PG content in buffer-treated 
specimen. Putative CS/DS-PGs remained intact in buffer-treated WT tissue (a), whereas WT 
tissue digested with ABC showed a marked decrease in long-chain PGs (b).  
 
3.3.4.2 Experiment%3:%WT,%Chst1/5,%B3gnt7>HTZ,%and%B3gnt7>NULL%
B3gnt7-NULL tissue that was incubated in buffer showed many long PGs traversing 
across and aligning with collagen fibrils (Figure 3-11a). However, chondroitinase 
ABC-digested B3gnt7-NULL tissue showed no discernible PGs. This implied that the 
chondroitinase ABC reaction conditions did not generate appreciable leaching of 
stromal PGs, rather, the decrease in PG content noted in the digested image (Figure 
3-11b) can be attributed to specific CS/DS cleavage. WT (Appendix I, Figure A1-5, a-f 
versus m-r), Chst1/5 (Figure A1-6, a-f versus m-r), and B3gnt7-HTZ (Figure A1-7, a-f 
versus m-r) also reflected this result. 
 
 
Figure 3-11: Experiment 3 example images showing normal PG content in buffer-treated 
specimen. B3gnt7-NULL tissue from experiment 3 that was incubated in buffer maintained a 
phenotype similar to the untreated specimen (a), with many long PG filaments adorning the 
stromal extracellular matrix. However, the chondroitinase ABC-digested B3gnt7-NULL specimen 
showed no such phenotype (b), indicating enzymatic preincubation successfully digested PGs. 
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All buffer-treated images from experiments 1 and 3 were compared to their 
chondroitinase ABC digested counterparts. The selected images described in Figure 
3-10 and 3-11 represented results observed overall. In both experiments, all 
genotypes showed putative CS/DS-GAGs in buffer-treated controls and a marked 
decrease in PG content in chondroitinase ABC digested tissue. The presence of 
putative CS/DS-PGs in images of buffer treated tissue allowed me to rule out the 
possibility of non-specific PG loss in chondroitinase ABC digested images. The 
decrease in PG content seen in chondroitinase ABC digested tissue could therefore 
be attributed to targeted degradation of CS/DS-GAGs. In the next section, KS-PG 
phenotypes across WT and mutant genotypes are assessed and compared.  
3.3.5 Phenotype(of(KSDPGs(in(WT(and(Mutant(Mouse(Corneas((
The primary aim of this chapter was to observe phenotypes of KS-PGs in mutant 
corneas relative to those of the WT. This section therefore serves to discuss the 
similarities and differences between PGs in WT compared to mutant corneal tissue. 
Again, genotypes are grouped based on the experiment in which they were 
originally processed, embedded, and imaged. 
3.3.5.1 Experiment%1:%WT,%Chst1,%and%Chst5%
Images of untreated and chondroitinase ABC-digested WT, Chst1, and Chst5 tissue 
from experiment 1 comprise Figure 3-12. Both WT and Chst1 specimens exhibited 
similar phenotypes when both CS/DS- and KS-PGs were visualized in the untreated 
samples. Both images showed remarkably long PGs that spanned up to five collagen 
fibrils across (black arrows, Figure 3-12a, c). When the WT and Chst1 specimens were 
subjected to chondroitinase ABC preincubation, however, these long-chain PGs were 
no longer evident (Figure 3-12b, d). Although the chondroitinase ABC-digested WT 
and Chst1 corneas did not show putative CS/DS-PGs, they did feature shorter 
electron-dense filaments that resisted chondroitinase ABC digestion (black 
arrowheads, Figure 3-12b, d). These are thought to be KS-PGs, and their presence in 
the Chst1 specimen implied that elongation of KS-PGs continued in absence of 
KSGal6ST, which is encoded by the murine gene, Chst1.  
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Figure 3-12: Comparison of PG phenotypes in untreated and chondroitinase ABC- 
digested WT and mutants of experiment 1. Putative CS/DS-PGs (black arrows) were 
observed in images of untreated WT (a), Chst1 (c) corneal stromas, but a uniquely bold 
and branched family of PGs was observed in the untreated Chst5 specimen (white 
arrows, e). Whereas both WT and Chst1 corneal stromas showed residual PGs after 
chondroitinase ABC predigestion (black arrowheads, b, d), these putative KS-PGs 
dropped below observable levels in the Chst5 specimen (f). 
 
When CGn6ST was inactivated in the Chst5 mutant mouse, its corneal proteoglycan 
phenotype differed from that of both the WT and Chst1 discussed above. The 
untreated tissue contained unusual PGs, which appeared thicker than those in the 
WT or Chst1 specimens. The unique family of PGs possessed periodic off-shoots 
radiating outward from the PG axis, giving rise to what has been termed a 
“caterpillar-like” appearance (Hayashida et al. 2006) (white arrows, Figure 3-12e). 
Since these pronounced PGs were susceptible to chondroitinase ABC digestion, it is 
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believed that they are comprised of mainly CS/DS disaccharides. Furthermore, in 
addition to the disappearance of the large, branched PGs in chondroitinase ABC 
images (Figure 3-12f), putative KS-PGs dropped to an unobservable level. This lack of 
KS-PGs in the Chst5 specimen suggested that biosynthesis of KS-GAGs was disrupted 
in absence of CGn6ST and confirmed that the phenotypes published in the literature 
were reproducible under these experimental conditions. 
Whereas previous studies have described the WT and Chst5 knockout and its corneal 
phenotype (Young et al. 2005, Hayashida et al. 2006, Parfitt et al. 2011), these are the 
first electron micrographs of the Chst1 knockout corneal stroma. 
3.3.5.2 Experiment%3:%WT,%Chst1/5,%B3gnt7>HTZ,%and%B3gnt7>NULL%
Chst1/5, B3gnt7-HTZ, and B3gnt7-NULL corneas were observed and compared to a 
WT standard in experiment 3. Figure 3-13 shows untreated (left column) and 
chondroitinase ABC-digested (right column) tissue from these mice.  
Whereas PGs found in the untreated B3gnt7-HTZ (Figure 3-13e) appeared similar to 
the WT (Figure 3-13a) control, the untreated Chst1/5 and B3gnt7-NULL samples took 
on a proteoglycan phenotype reminiscent of the Chst5 in experiment 1. Elongated, 
branched “caterpillar-like” structures were visible in images of untreated specimens 
(white arrows, Figure 3-13c, g). Also paralleling the Chst5 specimen, those uniquely 
enlarged PGs found in Chst1/5 and B3gnt7-NULL corneas were susceptible to 
chondroitinase ABC digestion and did not appear in their chondroitinase ABC-
treated counterparts (Figure 3-13d, h). Furthermore, chondroitinase ABC-digested 
tissue of the Chst1/5 and B3gnt7-NULL mice lacked discernible chondroitinase ABC-
resistant PGs, implying a corrupt KS-GAG biosynthetic pathway in absence of 
KSGal6ST and CGn6ST or β3GnT7, respectively.  
Because CS/DS-PGs appeared unaffected by a single B3gnt7 allele mutation in the 
untreated B3gnt7-HTZ cornea, it was expected that KS-PGs would maintain a normal 
phenotype and resemble KS-PGs in the chondroitinase ABC-digested WT sample (3- 
13b). Interestingly, the contrary was observed: the B3gnt7-HTZ specimen that was 
treated with chondroitinase ABC lacked observable KS-PGs (Figure 3-13f), indicating 
dysfunctional KS-GAG biosynthesis.  
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Figure 3-13: Comparison of PG phenotypes in untreated and chondroitinase ABC-
digested WT and mutants of experiment 3. The untreated B3gnt7-HTZ specimen (e) 
contained PGs phenotypically similar to those of the untreated WT control (a). Chst1/5 
and B3gnt7-NULL specimens, however, contained abnormally long, branched PGs 
(white arrows in c, g). Whereas short PGs remained following chondroitinase ABC 
digestion in the WT specimen (black arrowheads in b), these filaments were not 
readily observed in the Chst1/5 (d), B3gnt7-HTZ (f), or B3gnt7-NULL (h) specimens.  
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3.3.6 Quantification(of(Collagen(Fibril(Diameters((
Several studies have shown that abnormally developed KS-PGs lead to atypically 
thick collagen fibrils (Chakravarti et al. 1998, Chakravarti et al. 2000, Liu et al. 2003). 
However, those defects in collagen architecture resulted from knocked out KS core 
proteins, rather than malformed KS-GAGs. Whereas unusually thick collagen fibrils 
were detected in posterior regions of human MCD tissue (Palka et al. 2010), a slight, 
but statistically significant, reduction in corneal collagen fibril diameter was reported 
in the Chst5-null mouse cornea, as compared to that of the WT (Hayashida et al. 
2006). Collagen fibril diameters in electron micrographs of WT, Chst1, and Chst5 
mouse corneas were measured to advance understanding of the influence of KS-
GAGs on corneal collagen fibrillogenesis.  
3.3.6.1 Reproducibility%of%Fibril%Measurements%
Collagen fibril diameters were measured using ImageJ software as described in 
section 3.2.4. First, WT fibrils (n=445) were measured on two consecutive occasions, 
using the same images, to determine the reproducibility of the measurements. The 
mean fibril diameter of the first set of measurements, WT-1, was 23.31±2.80 nm 
(Figure 3-14a). The second set of measurements, WT-2, the mean fibril diameter was 
21.81±2.69 nm (Figure 3-14b). Overlaying WT-1 and WT-2 histograms (Figure 3-14c) 
illustrated the difference in the distribution of measured fibril diameter. Further 
statistical analysis relied on the two sets (WT-1 and WT-2) being normally distributed. 
Therefore, the data were tested using the Lilliefors test (Lilliefors 1967) in MATLAB 
(‘lillietest’). Both distributions were from the family of normal distributions (p > 0.5 
and p = 0.22, respectively), therefore both data sets could be represented by a 
normal probability density function (PDF). The fitted curves were performed in 
MATLAB (‘dfittool’) and are shown overlaid on their respective histogram (Figure 3-
14a, b) and overlaid in Figure 3-14d. Inferential statistics were used to determine 
whether or not there was a significant difference between the two distributions. To 
do this, a paired t-test was used, since the aim was to compare the consistency of 
measurement on the same WT sample. The results of the t-test indicated the two 
distributions were significantly different [t(444)=103.1, p <0.001]. 
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Figure 3-14: Statistical analysis of reproducibility of collagen fibril 
measurements. Histogram and fitted normal probability density function 
showing the initial (a) and repeated (b) measurement of WT corneal collagen 
fibrils diameters (n=445). The overlay of WT-1 and WT-2 histograms (c) 
demonstrated the shift in measurements. The two distributions can be 
represented by their normal PDFs, making the shift on measurement more 
apparent (d).  
 
Because collecting individual fibril diameter measurements involved a subjective 
decision of what was considered a fibril edge, the discrepancy between WT-1 and 
WT-2 data above were likely due to learning effects. As I gained experience with 
measuring individual fibrils throughout the initial analysis of WT images, my 
subjective definition of what constituted a fibril edge became more conservative, 
leading to the significantly thinner mean fibril diameter in the repeated 
measurements. Because of this subjective change and potential learning effects, only 
the second set of fibril diameters (WT-2) were used for comparison with subsequent 
mutant collagen fibril diameters in Figure 3-15, as they represented the “informed” 
data set.  
a. b. 
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3.3.6.2 WT,%Chst1,%and%Chst5%Fibril%Diameter%Comparison%
Chst1 (n=537) and Chst5 (n=503) collagen fibrils had a mean diameter of 21.08±2.63 
nm (Figure 3-15b) and 20.87±2.41 nm (Figure 3-15c), respectively. The Lilliefors test 
demonstrated these Chst1 and Chst5 data were also from the family of normal 
distribution (p>0.5 and p=0.12, respectively), thus permitting all fibril diameter 
measurements to be represented by normal probability density distributions (Figure 
3-15d).  
 
 
Figure 3-15: Statistical analysis of WT compared to mutant fibril diameters. 
Histograms of WT-2 (n=445) (a), Chst1 (n=537) (b), and Chst5 (n=503) (c) 
collagen fibril diameters. Since all three data sets were in the family of normal 
distribution, the underlying data could be represented by normal PDFs (d).  
 
To determine whether or not there were any statistically significant differences 
between WT-2 and the mutants, the distributions were analysed with a one-way 
analysis of variance (ANOVA) (Coolican 2009) using GraphPad Prism software. There 
a. b. 
c. d. 
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was a significant effect of genotype on fibril diameter [F(2, 1482) = 17.14, p=<0.0001]. 
However, a Bartlett’s test for equal variance that was run alongside the ANOVA 
(Brown and Forsythe 1974) was also significant (p = 0.04), indicating the three 
genotype distributions had unequal variance, most likely due to the unequal sample 
sizes in each group (n=445, 537, and 503, respectively). Since these data violated one 
of the assumptions relied upon for one-way ANOVA analysis, the results of the 
ANOVA should be disregarded.  
To proceed, the data had to be transformed such that the variances within each 
group did not significantly differ. Common transforms applied to data include log10, 
square-root, or inverse transformations (Coolican 2009). In this chapter, the inverse 
transform was chosen for its simplicity. To transform the data, the reciprocal of each 
fibril diameter was calculated, and the one-way ANOVA was then re-run on the 
transformed data. Bartlett’s test was satisfied (p = 0.12) using the inverse of fibril 
diameter measurements, thus the ANOVA result could be relied on for significance 
testing. The results for the inverse-transformed data indicated there was a significant 
effect of genotype on fibril diameter [F(2, 1482) = 14.31, p=<0.0001]. To determine 
which genotypes were significantly different from each other, post-hoc testing was 
conducted using Bonferroni’s multiple comparison test (Bland and Altman 1995). 
Results of post-hoc tests showed both Chst1 (p ≤ 0.001) and Chst5 (p ≤ 0.001) fibril 
diameters were significantly thinner than those of the WT specimen. However, fibril 
diameters of the two mutants did not differ significantly when compared to each 
other (p = ns).  
3.4 Discussion 
Images of sulfotransferase- or glycosyltransferase-deficient mouse corneas that were 
collected and presented in this chapter revealed curious results and further develop 
the existing hypothesis of KS-GAG synthesis. First, in mouse corneas missing activity 
of CGn6ST (Chst5) or both sulfotransferases (Chst1/5), no proteoglycans were present 
at levels detectable by EM following enzymatic removal of CS/DS PGs. This result 
contrasted with the same experiment performed on tissue lacking the action of only 
KSGal6ST (Chst1) because short chain PGs resistant to chondroitinase ABC remained 
visible at levels comparable to the WT control.  
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The above data could be explained by two potential mechanisms. The first of which 
indulges the idea of Akama et al. (2002), who posited that GlcNAc sulfation by 
CGn6ST is necessary for chain elongation. This hypothesis presumes that KS-PGs 
were not observable in CGn6ST-deficient mouse tissue because KS-GAG chain 
elongation ceased when GlcNAc residues at the non-reducing terminus remained 
unsulfated. Images in this chapter support this hypothesis because, in cases where 
activity of the CGn6ST enzyme was abolished (i.e. Chst5 and Chst1/5), no KS-PGs were 
visualized by cupromeronic blue staining. Furthermore, this hypothesis predicted a 
preservation of elongated KS-PGs in Chst1 mice because KSGal6ST has been shown 
to sulfate internal galactose only after the chain has been elongated (Fukuta et al. 
1997, Hoshino et al. 2014). Therefore, Akama et al. (2002) supposes that even in the 
absence of KSGal6ST, the KS-GAG was elongated and contained singly sulfated 
repeating disaccharides. In short, results in this chapter indicated that CGn6ST is 
important for elongation of KS-GAGs, whereas KSGal6ST was only necessary for 
creating densely sulfated (i.e. containing di-sulfated disaccharides) KS-GAGs. 
While the above hypothesis is probable, it is important to consider an alternative. 
The second possible mechanism to explain the absence of KS-PGs in Chst5 and 
Chst1/5 tissue requires consideration of the sulfation-binding property of the 
cupromeronic blue stain used in EM. Since the stain binds proteoglycans via their 
sulfate groups, it becomes reasonable to envisage that the absence of KS-PGs 
observed in tissue without CGn6ST activity could be because there were simply no 
sulfate groups along the KS-GAG backbone to which the dye could bind. In this case, 
the hypothesis is that cells can continue producing the unsulfated form of KS, termed 
poly-N-acetyllactosamine, which is comprised of alternating unsulfated GlcNAc and 
galactose monosaccharides. The lack of sulfation in this scenario would render the 
GAGs invisible to the electrophilic cupromeronic blue dye and electron microscopy 
altogether. Indeed, Nakazawa et al. (1984), Lewis et al. (2000), and Young et al. (2007) 
reported the presence of KS-GAGs in an unsulfated form in human macular corneal 
dystrophy tissue, a disease with a phenotype similar to the knockouts studied here.  
The synthesis of poly-N-acetyllactosamine as opposed to KS is easier to imagine in 
the Chst1/5 specimen because both sulfotransferases involved in KS biosynthesis—
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CGn6ST and KSGal6ST—are knocked out, thus preventing the transfer of sulfate 
moieties onto the KS backbone. In the case of the Chst1 knockout, however, the 
question becomes, if poly-N-acetyllactosamine synthesis could continue without 
CGn6ST activity, why wouldn’t KSGal6ST continue to sulfate internal galactose 
residues, creating a KS-GAG sulfated only on galactose residues? A possible answer 
lies in the study that first characterized KSGal6ST where Fukuta and colleagues (1997) 
first described the specificity of KSGal6ST. They noticed that KSGal6ST tends to add 
SO4- to galactose residues adjacent to sulfated GlcNAc residues. They noted that 
galactose near an unsulfated GlcNAc could act as an acceptor for KSGal6ST, but 
much more infrequently. In the case of the Chst5 and Chst1/5 mutants, sulfated 
GlcNAc residues would be rare, owing to abolished activity of CGn6ST. Therefore, 
KSGal6ST would have few sites where preferential sulfation could occur. It is 
unknown whether the infrequent sulfation of galactose near unsulfated GlcNAc by 
KSGal6ST would sufficiently bind cupromeronic blue for visualization with EM. If not, 
this alternative mechanism could explain why KS-PGs were undetectable in Chst5- 
and Chst1/5-null corneas. 
A mechanism resulting in a lack of KS-PGs in the B3gnt7-NULL corneal stroma of 
chondroitinase ABC-digested tissue seems more straightforward. Because there was 
no enzyme to add GlcNAc residues to the carbohydrate backbone normally 
comprised of GlcNAc and galactose in alternating fashion, the system halts, likely 
resulting in only the KS linkage region bound to its core protein.  
With regard to the collagen fibril diameter analysis, the average WT collagen fibril 
diameter measured here (~22 nm) aligned with data published by Chakravarti et al. 
(2006). In addition, results reported in section 3.3.6.2 corresponded to those 
published by Hayashida et al. (2006) in that the corneal collagen fibril diameters from 
the Chst5-null specimen were found to be slightly thinner than those of the WT 
specimen. While correlations between the literature and these newly collected data 
should speak to the robustness of methods in use here, uncertainty arose from the 
fact that PGs were stained in images from which these values were derived. The close 
association of PGs to collagen fibril surfaces meant that the already challenging task 
of discerning a collagen fibril edge was further convoluted by determining whether 
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the perceived collagen edge included the thickness of nearby PGs. Ideally, this 
analysis would be performed again without PG staining. The absence of PGs from 
electron micrographs would enhance contrast of fibril edges and quell any possibility 
of overestimating fibril diameter by inadvertently measuring PGs tangential to fibrils 
of interest. Alternatively, x-ray diffraction can be used to determine average collagen 
fibril diameter from unfixed corneal tissue, alleviating the underestimation of fibril 
diameters that originates from shrinkage that occurs during EM processing. Fibril 
diameters were not analyzed from specimens in experiments 2 or 3 because of these 
uncertainties.  
Not only are the above data informative on the KS-GAG biosynthetic process, they 
also offer insight into cellular mechanisms regulating corneal architecture. The 
simplest explanation for the appearance of the enlarged CS/DS proteoglycans in 
tissues which lack normal KS-PG expression is the need to compensate for missing 
KS-PGs. The dense negative charges typically found on KS-GAG are, in part, credited 
for the hydrophilic nature of the cornea. Therefore, without negatively charged KS-
GAGs, the specific organization of the corneal stroma is compromised in that the 
water necessary to maintain collagen fibril spacing may not be attracted into the 
stroma. It is logical to reason that the extended length and girth of CS/DS-PGs 
observed here were produced in effort to maintain the hydrophilicity of the stroma, 
thus preserving corneal clarity and normal vision. Despite the reasoning that 
supports this hypothesis, the exact composition of the elongated PGs is not totally 
understood. The fact that they are digested by chondroitinase ABC strongly suggests 
they are CS/DS in nature; however, it is unclear whether this is a single CS/DS-PGs 
with modifications, or an aggregate of many CS/DS-PGs. Both cases have been 
suggested in work performed by Parfitt and colleagues (2011). 
A potential means to determine the nature of this anomalous PG could be via 
monoclonal antibodies. One particular antibody that has been developed can 
selectively discern forms of chondroitin sulfate and dermatan sulfate, following 
enzymatic digestion of either glucuronic acid—GalNAc (CS) bonds or iduronic acid—
GalNAc (DS) bonds. Such experiments are undertaken and described in the next 
chapter. 
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3. CHAPTER 4 
4. Immunohistochemical Localization of 
Glycosaminoglycans in Mutant Corneas 
4.1 Introduction 
Electron micrographs in Chapter 3 of this thesis revealed that the mutant mice under 
investigation had differential KS-PG phenotypes. One mutant, namely the Chst1 
specimen, appeared to maintain a KS-PG phenotype similar to that of WT corneal 
tissue following enzymatic removal of CS/DS-PGs. Conversely, KS-PGs were absent 
from electron micrographs of Chst5, Chst1/5, and B3gnt7 corneal samples. As 
explained in the Discussion section of Chapter 3, one weakness of using EM to 
visualize corneal PGs was that the electrophilic dye was non-specific, binding any 
polyanionic structure in the tissue (Scott 1972, Scott 1980). Therefore, discerning 
between KS-PGs and CS/DS-PGs in EM images relied on chondroitinase ABC 
predigestion. While this chondroitinase ABC digestion method has been widely used 
in previous electron microscopy studies to differentiate between families of corneal 
PGs (Hayashida et al. 2006, Scott and Haigh 1985, Young et al. 2005), perhaps a more 
targeted approach to staining and observing changes in GAG content is via 
immunohistochemistry. The advantage of immunohistochemistry is its exploitation 
of the antigenic specificity that is characteristic of monoclonal antibodies, which 
fluorophore-containing secondary antibodies bind for visualization. The GAG-specific 
monoclonal antibodies used in this chapter ensured that only the GAG of interest 
was imaged in each experiment, as opposed to the “blanket” and sulfate level-
dependent labelling achieved by cupromeronic blue in electron microscopy.  
The “low sulfated” form of KS was labelled with the mouse monoclonal antibody 1B4 
(Mehmet et al. 1986). This antibody was preferred to the traditionally used 5D4 
antibody (Caterson et al. 1983) because recent immunohistochemistry experiments 
conducted on mouse corneas demonstrated the “highly sulfated” KS epitope was not 
present in sufficient quantities for immunolocalization (Young et al. 2005). The 
primary goal of labelling low sulfated KS in these immunohistochemistry 
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experiments was to confirm results collected in EM images. Since WT and Chst1 
genotypes showed putative KS-PGs in electron micrographs, it is hypothesized that 
these two specimens will show stromal fluorescence when probed with 1B4 
antibody. Conversely, since EM images of corneal tissue belonging to affected 
genotypes (i.e. Chst5, Chst1/5, and B3gnt7) appeared devoid of KS-PGs, it is 
hypothesized that low-sulfated KS will not be detected with 1B4 in these 
experiments.  
In addition to confirming EM observations of KS-PGs, experiments in the present 
chapter further investigated the nature of anomalously long, branched PGs found in 
electron micrographs of affected genotypes. In addition to those data collected in 
Chapter 3, previous studies show that a hallmark trait of the branched PGs is their 
susceptibility to chondroitinase ABC, implying they are comprised of CS/DS-GAG 
motifs (Hayashida et al. 2006, Parfitt et al. 2011). Therefore, 2B6, which is an antibody 
that labels chondroitin-4-sulfate/dermatan sulfate (C4S/DS) neoepitopes following 
their liberation by chondroitinase ABC (ABC) (Yamagata et al. 1968), was used here to 
observe whether those affected genotypes show increased fluorescence when 
labelled for CS/DS-GAGs, as compared to unaffected genotypes (i.e. WT and Chst1). 
Should the affected genotypes appear with a more intense CS/DS-GAG signal, it 
would support the notion that the unique PGs seen in electron micrographs were 
indeed isoforms of CS/DS. In addition to simultaneous labelling of C4S and DS, these 
GAGs will be labelled independent of each other to investigate if one GAG was 
particularly upregulated to form the unique PGs. This targeted labelling was 
achieved by application of chondroitinase AC (AC) or chondroitinase B (B) to liberate 
either C4S or DS (Michelacci and Dietrich 1975) neoepitopes, respectively. If, for 
example, increased fluorescence in affected genotypes is observed when AC 
digestion precedes 2B6 labelling, but the same trend does not occur when 
chondroitinase B digestion precedes 2B6 labelling, it could be inferred that the 
unique PGs are a result of C4S upregulation, rather than increased synthesis of DS.  
Whether or not results produced by these experiments align with hypotheses 
explained above, valuable insight can be gained by immunolocalization of corneal 
GAG epitopes in WT and mutant mice.  
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4.1.1 Aims(and(Objectives(
1. Immunolocalize low-sulfated KS in WT and mutant mouse corneas to 
determine if affected genotypes lack KS-GAGs. 
2. Probe WT and mutant corneal tissue for CS/DS-GAGs to determine if affected 
genotypes show increased signal compared to unaffected genotypes.  
3. Immunolabel only DS-GAGs in WT and mutant corneas to determine if DS-
GAGs comprise a major portion of the anomalous PGs, and thus produce 
increased fluorescence in affected genotypes.  
4. Localize CS-GAGs in WT and mutant corneas to observe if affected genotypes 
contain increased CS content, relative to unaffected genotypes.  
4.2 Methods  
4.2.1 Whole(Eye(Dissection,(Embedding,(and(Shipment(
My collaborator, Dr. Tomoya Akama performed whole eye dissection at Kansai 
Medical University in Osaka, Japan as follows: whole mouse eyes were harvested 
fresh from male and female WT, Chst1, Chst5, Chst1/5, and B3gnt7 mice at 9-12 
postnatal weeks of age (details in Table 4-1).  
 
Genotype Sex Age (weeks) n (mice, corneas) 
WT Female 9 2, 3 
Chst1-null Male 10 1, 2 
Chst5-null Female 10 1, 2 
Chst1/5-null Female 11, 12 2, 3 
B3gnt7-null Female 9 2, 3 
Table 4-1: Age, sex, and number of mouse corneas used for  
 immunohistochemistry studies. 
 
Once isolated from the orbital cavity, whole eyes were embedded in optimal cutting 
temperature (OCT) compound and shipped on dry ice to Cardiff University, where I 
stored them at -80°C until sectioned as described in Chapter 2, section 2.4.3.  
4.2.2 “Complexing”(the(Primary(and(Secondary(Antibodies(
As discussed in Chapter 2, section 2.4.4.1, primary and secondary antibodies were 
incubated together overnight at 4°C in 1x PBS with 0.1% TWEEN-20 (PBS-T) and 2% 
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bovine serum albumin (BSA). Control solutions were identical to the experimental, 
except the volume of primary antibody was replaced with buffer (see Table 4-2). This 
overnight incubation step allowed the primary and secondary antibodies to form 
complexes before reacting with the tissue, thus preventing erroneous secondary 
antibody staining (Hierck et al. 1994). 
 
 Dilution Volume in 
Experimental 
Mixture 
Volume in 
Control 
Mixture 
Primary Antibody 
(1B4 or 2B6) 
1:10 150 µl - 
Goat anti-mouse 2° antibody  
(2 μg/µl)  
1:50 30 µl 30 µl 
2x Buffer  
(2x PBS-T + 4% BSA) 
1:2 750 µl 825 µl  
Distilled Water  To make 1500 µl  270 µl 345 µl 
Total: 6 groups x 200 µl = 1200 µl  
Increase to 1500 µl 
- 1200 µl 1200 µl 
Incubate overnight on rotator at 4°C 
The following day, add NMS as specified below: 
Normal Mouse Serum 5 µl/μg of 2° antibody 300 µl 300 µl 
Allow NMS to incubate with mixtures at least 30 min prior to incubation with tissue sections 
Table 4-2: Composition of experimental and control mixtures. Primary antibody, 
secondary antibody, double strength buffer, and distilled water were mixed in 
the above ratios and incubated overnight at 4°C. NMS was added the following 
day to occupy any secondary antibodies unbound to primary antibodies. The 
resultant mixture was applied to five groups of mouse corneas (WT, Chst1, Chst5, 
Chst1/5, and B3gnt7) and one bovine cartilage control. 
(
4.2.3 Immunolabelling(the(Tissue(Sections(
Slides were retrieved from -80°C storage less than two weeks from sectioning and 
allowed to reach room temperature before outlining groups of 4 – 5 corneal sections 
in a hydrophobic border using a wax pen. After allowing the wax borders to 
sufficiently dry, rehydration of sections was achieved by applying PBS-T to the 
circumscribed groups of sections for five minutes. Following rehydration, sections 
were immersed for 30 minutes in 1% Triton in PBS to “clean” tissue and aid in 
reduction of background fluorescence. After rinsing the Triton solution off sections 
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using PBS-T buffer, sections were then enzyme-digested for two hours at 37°C (see 
Table 4-3 for antibody and enzyme predigestion details).  
During the enzyme incubation, heat de-activated normal mouse serum (NMS) was 
added to complexed antibody and control mixtures prepared as described in 
Chapter 2, section 2.4.4.1. Five micrograms of NMS was added for every microgram of 
secondary antibody present in the complexed solutions (e.g. when 60 μg of 
secondary antibody was present, 300 μg of NMS was added to the mixture). The NMS 
served to bind potentially free (i.e. not bound to primary) secondary antibody 
(Goodpaster and Randolph-Habecker 2014, Hierck et al. 1994). NMS reacted for a 
minimum of 30 minutes on a rotator within antibody and control solutions prior to 
applying tissue sections. Following enzyme digestion, sections were rinsed in PBS-T + 
2% BSA. Next, normal goat serum (10%) in PBS-T + 2% BSA was used as blocking 
solution and was applied for 30 minutes at room temperature. After blocking, tissue 
sections were incubated in a generous volume (150 – 200 µl) of antibody and control 
mixtures for four hours at room temperature. PBS-T was used to thoroughly rinse 
away experimental and control mixtures. Finally, a cover slip was placed on groups of 
sections following application of Vectashield dual mountant and DAPI stain. Slides 
were stored at 4°C in foil-wrapped boxes for a maximum of 24 hours before imaging 
as described on the next page. 
 
Antibody Enzyme 
Pre-treatment 
Epitope     Enzyme Buffer References 
2B6 Chondroitinase 
ABC  
(0.4 U/ml) 
C4S/DS 50 mM Tris, 60 mM 
Sodium Acetate, 
0.02% BSA, pH: 7.9 
Takagi et al. 1997, 
Couchman et al. 1984,  
Caterson et al. 1985 
2B6 Chondroitinase AC  
(0.08 U/ml) 
C4S 
2B6 Chondroitinase B  
(2.6 U/ml) 
 
DS 20 mM Tris/HCl, 50 
mM NaCl, 4 mM CaCl2, 
0.01% BSA 
Shibutani et al. 1989, 
Takagi et al. 1997, Sobue 
et al. 1988 
1B4 Keratanase* 
(0.4 U/ml) 
 
Low sulfated 
KS 
20 mM Tris/HCl, 
pH: 7.5 
Caterson et al. 1985, 
Mehmet et al. 1986, 
Young et al. 2005 
Table 4-3: Antibody epitopes and enzyme predigestion details. 
Chondroitinase ABC, AC, and B were used to expose various 2B6 epitopes. 
*Keratanase predigestion was not necessary to reveal 1B4 neoepitope; it was 
only used to confirm results collected with 1B4 (Figure 4-9).  
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4.2.4 Image(Collection(and(Storage(
Brightfield (unstained tissue, black and white), fluorescence (carbohydrate epitopes, 
green), and DAPI (nuclei, blue) images were collected of each specimen with an 
Olympus BX40 fluorescent microscope equipped with an SIS F-View black and white 
digital camera. Olympus Cell^P imaging software was used to capture images in 
JPEG and TIFF format.  
4.2.5 Image(Processing(
4.2.5.1 Extracting/Image/Information/from/TIFF/Files/
Cell^P software permits images to be saved either in JPEG or TIFF file formats. When 
images were saved in JPEG format, the pixel intensities were such that the image was 
subjectively representative of the original microscope image. However, JPEG images 
suffered from reduced resolution because of “lossy” image compression. Conversely, 
when images were saved in TIFF format, they had greater resolution because of 
“lossless” image compression.  However, the pixel intensities in TIFF images were too 
low, and the images were subjectively unrepresentative of the original image. 
Indeed, all TIFF images (brightfield, fluorescence, and DAPI)—irrespective of the 
amount of signal they produced in the microscope—appeared totally black when re-
opened in any image processing software (Figure 4-1a). For this thesis it was 
desirable to use images with the highest possible resolution (i.e. TIFF images rather 
than JPEG images), so a solution was sought to correct the pixel intensity of TIFF 
images. 
TIFF images were initially imported into Adobe Photoshop and adjusted using the 
“auto contrast” function. This process verified that the image information was still 
preserved in the TIFF file. However, while the “auto contrast” function successfully 
made samples visible, they, too, were unrepresentative of the original microscope 
image because the pixel intensities were too high (Figure 4-1b). The JPEG equivalent 
of Figure 4-1a represented the original intensity of the image (Figure 4-1c). 
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Figure 4-1: Comparison of images produced by saving 
in TIFF format in Cell^P software (a), auto-contrasting 
the TIFF in photoshop (b), and comparing those to the 
JPEG (c), which is representative of the image’s original 
appearance. Although the TIFF appeared totally black, 
Photoshop adjustment indicated the file still contained 
information of the imaged sample. 
 
To correct the pixel intensities of the original TIFF files, I wrote a custom script in 
MATLAB using the Image Processing Toolbox. All TIFF images were originally saved 
in 12-bit format, such that any pixel value can range from 0 – 4095 (i.e. 212 possible 
values). The custom script converted the 12-bit image to an 8-bit image (i.e. 256 
possible values, 0 to 255) using the following formula: 
!"#$%!!!"# = ! !"#$%!"!!"#!"#$ !×!255 
In brief, each 12-bit pixel was divided by the maximum possible value (4095) and 
multiplied by 255.  This procedure preserved the relative proportions of each pixel. 
Below, a JPEG representative of the original 12-bit TIFF image and the converted 8-
bit TIFF image are shown in Figure 4-2a and 4-2b, respectively. 
  
a. 
b. 
c. 
Equation 4-1 
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Figure 4-2: Example images following MATLAB processing. A 
JPEG image representative of the original 12-bit TIFF (a) 
appears identical to the 8-bit TIFF produced by the MATLAB 
script (b). A green colormap was also created and applied to 
fluorescent images processed by the MATLAB script (c). 
 
As the JPEG and the 8-bit TIFF images appear identical, this suggests that the 
MATLAB script did not adversely manipulate the experimental images to appear 
falsely dark or bright, compared to when they were originally captured. Finally, a 
green or blue colormap was applied to each of the fluorescence and DAPI images, 
respectively (Figure 4-2c). Brightfield images were left in grayscale. All images in a 
given set (i.e. experimental and control images from all five murine genotypes 
collected from a given antibody/enzyme predigestion experiment) were treated 
identically. Experimental and control groups with bold, black titles were processed 
using this method. 
4.2.5.2 Adjusting/Exposure/Duration/via/Image/Processing/
In three experiments, images were captured and saved using too brief, but known, 
exposure durations, resulting in dimly fluorescent images. Previous studies have 
shown that there is linear relationship between pixel intensity and exposure 
duration, as long the image has not reached saturation (Pang et al. 2012). Therefore, 
the intensity of the pixels can be further modified to equate for exposure duration. 
For example, 1B4-labelled WT and mutant images were collected at 200 ms 
exposure. However, for interpretation and comparison with other 1B4 experiments, 
a. 
b. 
c. 
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these images needed to be captured at 400 ms. To enable a comparison, the 
intensity of the 1B4-labelled WT and mutant images could be doubled. Therefore, I 
wrote a new MATLAB script that scaled pixel intensity for exposure duration, using 
the following formula:  
!"#$%!!!"# = ! !"#$%!"!!"#!"#!!×! !"#$%&'!!"#!"#$%&'!!"# !×!255 
For example, if the original exposure duration was 200 ms, to derive the pixel values 
equivalent to 400 ms exposure duration, each pixel would be divided by 2047.5 
(~2050), rather than 4095 before 8-bit scaling, thus doubling the intensity. This 
halving of the denominator translated to a doubly exposed image because each 
pixel value was twice its original value. Experimental and control groups with bold, 
red titles were processed using this method. Examples of images processed in this 
way are included in Figure 4-3 below.  
 
 
Figure 4-3: Images showing artificially increased exposure by MATLAB 
processing. Each pixel in image A was divided by 4095, which represented 
the original brightness of the image captured at 200 ms (a). Each pixel in 
the middle image was divided by 2050 to effectively double the image 
exposure to 400 ms (b). Each pixel in the right image was divided by 1025 
to effectively quadruple the original exposure to 800 ms (c).  
 
4.2.5.3 Applying/Colormaps/to/Intact/TIFF/Files/
By the end of these fluorescent experiments, the Cell^P issue creating corrupt TIFF 
files that appeared totally black had been resolved by configuring the software to 
“save display as”, which writes images as 8 bit, rather than “save image as”, which 
writes images as 16 bit. Therefore, some experimental and control images in this 
chapter were not processed using the MATLAB script described in section 4.2.6.1 
Equation 4-2 
a. b. c. 4095 2050 1025 
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because images written using the “save display as” option appeared as they were 
originally captured without the post-capture processing steps. However, colormaps 
were still applied in MATLAB since Cell^P produces grayscale images. Experimental 
and control groups with bold, blue titles were processed using this method. 
 
4.3 Results  
4.3.1 Imaging(Low(Sulfated(KS(using(mAb(1B4(
Bovine articular cartilage was used as a positive control throughout the 
immunohistochemistry experiments, as its ECM also contains KS- and CS/DS-GAGs. 
Cartilage was processed alongside the five corneal genotypes, but it is presented in 
separate figures because the cartilage images were external to the KS-GAG 
hypothesis under investigation. Images below show bovine cartilage samples 
probed for low sulfated KS with 1B4 (Figure 4-4). Fluorescence was detected when a 
1:100 dilution of 1B4 was applied to the tissue (Figure 4-4b). However, when the 1B4 
primary antibody was omitted, cartilage appeared devoid of fluorescent staining 
(Figure 4-4e). These results indicated the immunolabelling protocol, including the 
primary/secondary antibody “complexing” step and blocking reagent incubation, 
allowed targeted labelling of the KS epitope without erroneous labelling of 
endogenous IgG within the tissue. Brightfield and DAPI images were included below 
to ensure the dark (even after post-capture processing) “No 1B4” image contained a 
tissue section. 
Corneal sections were also probed for low sulfated KS using a 1:100 dilution of 1B4 in 
Figure 4-5. The left column shows WT and mutant tissue stained with 1B4, whereas 
the right column served as negative controls that did not receive the 1B4 primary 
antibody. Despite both columns of images receiving the same exposure duration 
(400 ms) during image capture, the epithelia of the negative controls (right column) 
appeared fluorescent, whereas those with 1B4 incubation appeared dark (left 
column). The absence of the 1B4 primary antibody in the right column images 
suggested the epithelial staining was a result of non-specific secondary staining,  
rather than KS localization. This differential epithelial staining may bring into  
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Figure 4-4: Bovine cartilage control sections with (a-c) and without (d-f) 
1B4 labelling. Low sulfated KS was detected when the 1B4 primary was 
applied (b), but no staining was observed when 1B4 was omitted (e). These 
results indicated blocking reagents were successful in preventing 
erroneous secondary binding. Brightfield (a, d) and DAPI (c, f) images were 
included to show morphology of the negative control. Both antibody-
labelled images received identical exposure (200 ms) to facilitate 
comparison. 
question whether or not the concentration of secondary antibody was the same 
under 1B4 and “no 1B4” conditions. However, both sets of tissue sections received a 
1:50 dilution of the secondary antibody; thus, a concentration difference could not 
be the source of the dissimilar epithelial staining patterns.  
The only 1B4-labelled genotype with obvious stromal fluorescence was the WT, 
which showed widespread and infrequent punctate fluorescent labelling (Figure 4-
5a). The Chst1, Chst5, Chst1/5, and B3gnt7 (Figure 4-5c, e, g, i, respectively) corneal 
sections all lacked diffuse stromal fluorescence. However, white arrows in Figure 4-5c 
identify two faint punctae within the stroma of the Chst1 specimen, which resembled 
those found in the WT. To view corresponding brightfield and DAPI images, see 
Appendix II, Figures A2-1 (1B4) and A2-2 (No 1B4).  
The introduction of this chapter discussed the potential outcome of this 1B4 
experiment and posited that, because KS-PGs were observed in electron 
micrographs of the WT and Chst1 corneal stromas, the 1B4 antibody may detect low 
sulfated KS in the WT and Chst1 tissue. It is interesting, then, that the image of the 
Chst1 stroma (Figure 4-5c) did not show fluorescence comparable to staining 
observed in the WT (Figure 4-5a).  
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Figure 4-5: WT and mutant mouse corneas labelled with 1B4 at 1:100 
dilution. Stromal fluorescence was apparent in the WT sample (a), but 
mutant tissue appeared to lack the 1B4 epitope (c, e, g, and i). White 
arrows identify fluorescent punctae observed in only WT (a) and 
Chst1 (c) specimens. The right column of images served as negative 
controls that were not incubated with 1B4 antibody. Stromal staining 
in the right column of images was not detected. 
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To test whether the unexpected Chst1 phenotype observed in the previous figure 
(Figure 4-5) was a result of experimental conditions, the 1B4 experiment was 
repeated with a 10-fold increase in concentration of the 1B4 primary antibody.  Now 
labelled with a 1:10 dilution of 1B4 (left column, Figure 4-6), corneal sections show 
enhanced fluorescence as compared to the previous experiment. Corresponding 
brightfield and DAPI images are located in Appendix II, Figure A2-3. 
The WT specimen maintained its phenotype, showing widespread stromal 
fluorescence with bright specks interspersed throughout the stroma (Figure 4-6a). 
The Chst1 specimen, however, showed many more fluorescent punctae with the 
increased concentration of 1B4 (Figure 4-6c). Affected genotypes Chst5, Chst1/5, and 
B3gnt7 all remained as originally observed, without obvious stromal signal (Figure 4-
6e, g, i, respectively).  
The right hand column of negative controls all lacked stromal staining, which 
suggests that the fluorescence observed in WT and Chst1 specimens was indeed a 
product of 1B4 labelling. Brightfield and DAPI images of this control are shown in 
Appendix II, Figure A2-4. As discussed previously, epithelia of negative controls all 
appeared fluorescent. 1B4-labelled images in the left column also showed epithelial 
labelling, which was of comparable intensity to that of the negative controls.  
The enhanced stromal staining of WT and Chst1 specimens, coupled with the 
comparable level of epithelial signal in experimental and control groups, indicated 
that the more concentrated 1B4 conditions used here were suitable for this analysis.  
 
To confirm results collected in Figure 4-6, 1B4 labelling was repeated in two separate 
experiments. As in the experiment discussed above, a 1:10 dilution of 1B4 was 
applied to the left and right columns of Figure 4-7, whereas the middle column 
represented negative controls. Brightfield and DAPI images corresponding to 
fluorescence images in these left, middle and right columns can be found in 
Appendix II, Figures A2-5, A2-6, and A2-7, respectively.  
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Figure 4-6: 1B4 labelling of WT and mutant mouse corneas at 1:10 
dilution. Widespread fluorescence was only observed in the WT (a) 
specimen. Both WT and Chst1 (c) corneas contained fluorescent 
punctae, which are indicated by white arrows. Chst5 (e), Chst1/5 
(g) and B3gnt7 (i) samples showed no signal apart from faint 
epithelial labelling. Negative controls in the right column showed 
epithelial signal but were otherwise free of fluorescence.  
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1B4-treated corneas (Figure 4-7, left and right columns) paralleled results discussed 
previously: The WT fluoresced throughout the depth of the stroma, in addition to its 
occasional brightly fluorescent specks (Figure 4-7a, c). The Chst1 specimen remained 
consistent to previous data, showing numerous fluorescent punctae without the 
diffuse stromal signal observed in the WT specimen (Figure 4-7d, f). Finally, the Chst5, 
Chst1/5, and B3gnt7 specimens incubated with 1B4 (Figure 4-7g, i; j, l; and m, o, 
respectively) did not appear fluorescently labelled, apart from that observed in 
epithelia.  
The images comprising the middle column of negative controls in Figure 4-7 were 
fluorescent in the epithelial layers, but their stromal regions appeared negative.  
 
The consistent presence of fluorescent punctae in the 1B4-labelled WT and Chst1 
samples was an unexpected result of this experiment. It became of interest whether 
or not the bright specks were regularly associated with certain features of the cornea 
(e.g. keratocytes or their nuclei). To investigate this, a Figure 4-8 compares WT and 
Chst1 specimens from previously discussed experiments (Figure 4-7) to their 
brightfield and DAPI image counterparts.  
 
Arrows in brightfield and DAPI images (Figures 4-8a, c, d, f, g, i, j, l) indicated areas 
where fluorescent specks were observed in corresponding fluorescent images 
(Figure 4-8b, e, h, k). When the green fluorescence images were compared to their 
DAPI analogues, no apparent association existed between punctae localization and 
nuclei. For example, the white arrow in Figure 4-8e points directly to a group of the 
fluorescent specks, but when an arrow is placed at this identical location in the DAPI 
image in Figure 4-8f, no adjacent nuclei were observed. The same can be said for 
Figure 4-8h vs. i and Figure 4-8k vs. l. When Figure 4-8b was compared to 8c, 
however, the arrow in the DAPI image does identify a nearby nucleus. This seemed to 
be a coincidence, rather than a systematic relationship between nuclei and 
fluorescent punctae co-localization. 
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Figure 4-7: Additional experiments showing 1B4 labelling in WT and 
mutant mouse corneas. As observed in previously, WT produced diffuse 
stromal fluorescence (a, c). Only WT and Chst1 (d, f) tissue presented with 
fluorescent specks throughout the stroma (white arrows). Chst5 (g, i), 
Chst1/5 (j, l), and B3gnt7 (m, o) samples lacked stromal signal, but showed 
faint fluorescence in the epithelial layer. The middle column contained 
negative controls, which showed epithelial fluorescence but lacked 
stromal signal. 
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Figure 4-8: Identification of regions showing punctate labelling in 
brightfield and DAPI images. Analysis of brightfield images (left column) 
showed bright specks associated with clefts in the tissue in three of four 
instances (red arrows in a, d, j). White arrows, and therefore fluorescent 
punctae, in DAPI images did not consistently align with nuclei. Fluorescent 
images (middle column) were provided for reference. 
 
A trend emerged when the identified areas in fluorescence images were compared 
to those areas in brightfield images. The punctae appeared to localize more 
frequently nearby or inside what were presumed to be clefts in the tissue sections 
(red arrows, Figures 4-8a, d, j). For example, the group of specks pointed out in Figure 
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4-8e corresponded to a split in the tissue just posterior to the epithelium, which is 
visible in Figure 4-8d. Similarly, the punctae in Figure 4-8k appeared inside a long, 
thin split the in the middle of the stroma, as indicated by the red arrow in Figure 4-8j.  
 
The correlation between the location of the fluorescent punctae and putative clefts 
in the section suggested these specks were artifact, rather than actual KS-GAG 
epitopes. Although, if the specks were artifactual and unrelated to KS-GAGs in the 
corneal tissue, it is surprising that they only consistently appeared in WT and Chst1 
genotypes.  
 
One way to investigate whether these features of 1B4-stained tissue were actually 
KS-GAGs was to subject the tissue sections to keratanase digestion. As this 
glycosidase cleaves KS-GAGs (Nakazawa and Suzuki 1975), 1B4 labelling should be 
reduced following its application to the tissue. This enzymatic digestion was 
performed twice on all five corneal genotypes. The results are shown in Figure 4-9. 
 
Left and right hand columns in Figure 4-9 were labelled with 1B4 primary antibody 
following keratanase digestion. The middle column served as negative controls 
because, although it received the keratanase treatment, the 1B4 antibody was 
omitted. Appendix II, Figures A2-8, A2-9, and A2-10 show the corresponding 
brightfield and DAPI images to these left, middle, and right columns. 
All experimental and control images in Figure 4-9 showed epithelial staining similar 
to that which had been observed in previous experiments (Figures 4-5 – 4-7). 
Whereas earlier 1B4 experiments generated signal in WT and Chst1 specimens, the 
addition of keratanase markedly diminished this stromal fluorescence. WT samples 
that had been digested with keratanase showed neither diffuse, nor punctate 
stromal labelling (Figure 4-9a, c). In addition, the speckled phenotype of the Chst1 
corneas, which was observed in the prior 1B4 samples, was not detected following 
introduction of keratanase (Figure 4-9d, f). Finally, Chst5, Chst1/5, and B3gnt7 
specimens maintained a phenotype as described earlier, as their stromal layer lacked 
any discernible fluorescence (Figure 4-9g, i; j, l; and m, o, respectively).  
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Figure 4-9: 1B4 labelling of WT and mutant mouse corneas after 
keratanase predigestion. WT (a, c) and Chst1 (d, f) samples that previously 
showed some form of fluorescence (diffuse, punctate, or both) lost their 
positively stained phenotype with introduction of keratanase. Chst5 (g, i), 
Chst1/5 (j, l) and B3gnt7 (m, o) mutants maintained their previous 
phenotype, lacking stromal staining. Negative controls comprise the 
middle column and also lacked stromal fluorescent signal.  
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The disappearance of the 1B4-labelled punctae following keratanase digestion 
indicated the specks observed in WT and Chst1 samples were not artifacts, but were 
comprised of KS-GAG motifs. This suggests, overall, that the WT and Chst1 specimens 
were the only two genotypes of the five investigated to contain sulfated KS-GAGs. 
Interestingly, localization of KS-GAGs differed in WT and Chst1 samples. The Chst1 
corneas did not produce widespread fluorescence similar to the WT. Instead, its 
fluorescent signal was limited to the brightly fluorescent punctae.  
4.3.2 Imaging(Chondroitin(4(Sulfate(and(Dermatan(Sulfate(using(mAb(
2B6(with(Chondroitinase(ABC(Digestion(
To visualize C4S and DS, bovine cartilage sections were digested as a positive control 
to confirm effectiveness of the methods. Chondroitinase ABC cleavage revealed C4S 
and DS epitopes that were subsequently labelled with 2B6 antibody. Figure 4-10 
below shows these data.  
 
 
Figure 4-10: Bovine cartilage controls labelled with 2B6+ABC 
(a–c) or ABC only (d–f). Cartilage that received 2B6 labelling 
after ABC digestion appeared brightly fluorescent, whereas the 
control that lacked 2B6 incubation appeared dark. Brightfield 
and DAPI images were included to show the morphology of 
the negative control. These data ensured nonspecific labelling 
of the secondary antibody was successfully blocked, allowing 
visualization of only the desired C4S and DS epitopes.  
 
The success of the bovine cartilage controls above permitted the analysis of corneal 
sections treated with 2B6 following ABC digestion (Figure 4-11).   
100 μm 
a. b. c. 
d. e. f. 
BO
VI
N
E 
CA
RT
IL
AG
E 
Chapter 4: Immunofluorescence 
   100 
 
Figure 4-11: WT and mutant corneal tissue labelled with 2B6 after ABC 
digestion. Corneal sections imaged in the left column received ABC digestion 
and subsequent 2B6 labelling. All genotypes appeared uniformly fluorescent 
throughout the stroma. However, the Chst5 (e), Chst1/5 (g), and B3gnt7 (i) 
specimens were slightly brighter than the WT (a) or Chst1 (c) samples. Negative 
controls in the right column were free of stromal fluorescence. Except for the 
WT sample (b), negative controls showed faint epithelial staining. 
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Tissue sections imaged in the left column in Figure 4-11 were digested with ABC and 
labelled with 2B6, whereas the 2B6 antibody was not applied to those sections in the 
right column. All genotypes in the left column produced diffuse stromal fluorescence 
when probed for C4S and DS. Conversely, negative controls in the right column did 
not show stromal fluorescence, although faint epithelial signal was observable. 
Brightfield and DAPI images taken from specimens shown in the left and right 
columns of Figure 4-11 are presented in Appendix II, Figure A2-11 and A2-12, 
respectively.  
The introduction of this chapter hypothesized that affected genotypes (Chst5, 
Chst1/5, and B3gnt7) may show relatively brighter 2B6 fluorescence if the anomalous 
PGs observed in EM images were elongated CS/DS GAGs. On closer observation of 
images in Figure 4-11, the affected genotypes—Chst5, Figure 4-11e; Chst1/5, Figure 
4-11g; B3gnt7, Figure 4-11i—indeed appeared brighter than the remaining 
genotypes. This result supported the initial hypothesis, so an additional 2B6 + ABC 
experiment was performed to confirm these data (Figure 4-12).  
Results collected from the second 2B6 + ABC experiment are shown in Figure 4-12. 
For completeness, two types of controls were run: First, to demonstrate that 2B6 
does not produce fluorescent signal without enzymatic liberation of the desired 
epitope, 2B6 was applied to the left column without any enzyme predigestion (see 
Appendix II, Figure A2-13 for brightfield and DAPI images). All genotypes of this 
control group showed epithelial signal, but lacked stromal staining. Secondly, the 
right hand column of images was a negative control group that was digested with 
ABC, but was not incubated with the 2B6 primary antibody (brightfield and DAPI 
images shown in Appendix II, Figure A2-15). Stromal layers of this negative control 
group all appeared to lack fluorescence, although faint epithelial staining was again 
present. The consistent appearance of epithelial staining in these negative control 
images suggested this was nonspecific labelling or artifact of the methods. However, 
because the epitopes of interest in these experiments are only in the stroma, the 
consistent presence of dim epithelial signal did not interfere with interpretation of 
experimental results.  
Chapter 4: Immunofluorescence 
   102 
 
Figure 4-12: 2B6 + ABC experiment and two forms of negative controls. 
The middle column was the experimental group, receiving both ABC 
digestion and 2B6 labelling. WT and mutant corneal sections all appeared 
fluorescently labelled, although the B3gnt7 (n) appeared more intense than 
other genotypes. Negative control groups either received 2B6 labelling 
without ABC digestion (left column) or ABC digestion without 2B6 labelling 
(right column). None of the negative controls showed stromal fluorescence.  
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The middle column represented the experimental group and was treated with 2B6 
after ABC digestion. As in the previous 2B6 + ABC experiment, all genotypes 
produced widespread fluorescence throughout the full thickness of the stroma. 
However, unlike the previous trial where the three affected genotypes (Chst5, 
Chst1/5, and B3gnt7) appeared noticeably brighter, only the B3gnt7 specimen 
appeared more intense than remaining mutants or WT tissue (Figure 4-12n). 
Brightfield and DAPI images corresponding to the middle column of Figure 4-12 can 
be found in Appendix II, Figure A2-14. 
In comparing the two 2B6 + ABC experiments to each other, it should be noted that 
the exposure durations were different. The images from the first experiment (Figure 
4-11) were captured using 250 ms exposure, whereas images in the second 
experiment were collected at 200 ms (Figure 4-12). Absolute intensity of images in 
both experiments was less important than how the corneal genotypes fluoresced 
relative to each other in individual experiments. Relative brightness of mutants 
compared to WT appeared inconsistent in the two experiments. It was mentioned 
previously that the Chst5, Chst1/5, and B3gnt7 mutants appeared relatively bright in 
Figure 4-11 (images e, g, and i), but only the B3gnt7 specimen appeared notably 
brighter than all other mutant and WT tissue sections when the experiment was 
repeated (Figure 4-12, image k).  Altogether, these data indicated that mutant mice 
did possess stromal C4S- and DS-GAGs, however it remains unclear whether the 
affected genotypes contain increased levels of C4S/DS-GAGs compared to the Chst1 
or WT mice. Nevertheless, independent labelling of DS- and C4S-GAGs was carried 
out in subsequent experiments to further investigate the hypothesis relating to the 
unusual PGs observed in EM images.  
4.3.3 Imaging(Dermatan(Sulfate(Using(mAb(2B6(with(Chondroitinase(
B(Digestion(
To visualize localization of DS-GAGs without simultaneous imaging of C4S, 
chondroitinase B digestion was used prior to 2B6 labelling. This enzyme targets DS 
epitopes because its cleavage relies on the presence of iduronic acid (Michelacci and 
Dietrich 1974; Michel et al. 2004). Below shows the bovine cartilage controls 
performed alongside corneal tissue. The section that received chondroitinase B 
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digestion and 2B6 labelling was brightly fluorescent (Figure 4-13b). Conversely, when 
2B6 was omitted, no fluorescent staining was observed (Figure 4-13e). These images 
indicated the experimental setup for 2B6 + B targeted DS-GAGs for visualization and 
excluded nonspecific secondary labelling.  
 
Figure 4-13: Bovine cartilage controls labelled with 2B6 after chondroitinase B 
digestion. 2B6 labelling subsequent to chondroitinase B digestion produced 
fluorescence in the cartilage section (b), whereas omission of the 2B6 antibody resulted 
in an absence of discernible signal (e). These data suggested only DS-GAGs were 
labelled and erroneous secondary labelling was prevented by the blocking reagent. 
Figure 4-14 shows results of labelling WT and mutant corneal sections with 2B6 
following chondroitinase B digestion, in addition to the relevant negative control 
counterpart (see Appendix II, Figures A2-16 and A2-17, respectively, for brightfield 
and DAPI counterparts). The experimental left hand column, which received 
chondroitinase B digestion and 2B6 labelling, showed full thickness stromal signal in 
each of the genotypes under investigation. WT and mutant tissue appeared to 
produce comparable levels of fluorescence, which suggests the five genotypes 
possessed similar levels of DS-GAGs. Three of the five genotypes—Chst1, Chst1/5, 
and B3gnt7 in Figure 4-14c, g, and i, respectively—contained a number of small areas 
within the stroma that lacked fluorescence. As this feature had not been observed in 
previous experiments, and it only occurred in three of five genotypes, Figure 4-15 
was created to address the nature of these vacant areas.  
Images of negative controls, which were not incubated with 2B6 primary antibody, 
comprise the right hand column in Figure 4-14. These samples appeared free of 
stromal fluorescence. In addition, the epithelial signal observed in experiments 
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previously described was not readily apparent here, except for faint labelling in the 
Chst5 specimen (Figure 4-14f). The absence of obvious epithelial staining in images 
comprising Figure 4-14 can likely be attributed to the brief of exposure duration. 
Only 150 ms of exposure was necessary to view 2B6 + B signal, whereas prior 
experiments warranted 200 – 400 ms for ideal observation.  
Analyzing the composition of the dark spots observed in Figure 4-14 involved 
comparing the fluorescent images to their brightfield and DAPI-labelled 
counterparts. Figure 4-15 is comprised of brightfield, fluorescent, and DAPI images of 
the three genotypes that showed the unique feature. White arrows identified the 
spots in fluorescence images (middle column), and analogous areas are indicated in 
brightfield (left column) and DAPI (right column) images with the same configuration 
of arrows.  
When brightfield images were evaluated for trends linking the dark areas to corneal 
features, no overt relationship materialized. Occasionally, dark spots correlated to 
presumed clefts in the tissue sections (red arrows, Figure 4-15a, d). However, the 
spots also corresponded to rather featureless areas of the stroma (blue arrows, Figure 
4-15a, d, g).  
Comparison of fluorescent images to analogous DAPI images provided an insight 
into the origin of the dark areas. In virtually every case, white arrows in DAPI images 
aligned with stained nuclei (Figure 4-15c, f, and i), suggesting stroma surrounding 
nuclei did not take up 2B6 staining. An extension of this hypothesis implied that the 
remaining two genotypes in Figure 4-14, which did not feature the spots (WT and 
Chst5), were devoid of DAPI-labelled stromal nuclei. An additional figure was created 
to explore this. 
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Figure 4-14: WT and mutant corneal tissue labelled with 2B6 following 
chondroitinase B digestion. Corneal sections in the left column were first digested 
with chondroitinase B, then labelled with 2B6. Diffuse stromal fluorescence was 
observed in WT and all mutant tissue. Dark areas were observed in Chst1 (c), 
Chst1/5 (g), and B3gnt7 (j) images, which were further investigated in Figure 4-15. 
The right column shows corneal sections that were not labelled with 2B6 following 
chondroitinase B digestion and, therefore, lacked any observable stromal signal.  
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Figure 4-15: Brightfield (left column), fluorescence (middle column), and 
DAPI (right column) images of those 2B6 + B-treated genotypes that 
showed stromal dark spots. When white arrowheads that corresponded to 
the unstained areas were placed in brightfield images, they occasionally 
aligned with clefts in the tissue (red arrowheads, a, d) and sometimes 
identified featureless areas of the stroma (blue arrowheads, a, d, and g). No 
consistent relationship to the darks spots was apparent in the brightfield 
images. However, those arrows in the DAPI images consistently aligned 
with nuclei. Thus, the dark areas in the fluorescent images were likely due 
to the presence of nuclei rather than the DS-GAGs required for 2B6 
binding. 
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Fluorescence and DAPI images of WT and Chst5 tissue are presented in Figure 4-16. 
Data from Figure 4-15 implied nuclei might not be present in stromal layers of these 
samples. However, white arrows in the following DAPI images (Figure 4-16b, d) 
indicate these corneal samples indeed contained nuclei throughout the stroma. It is 
unclear why nuclei correlated to dark spots in the previous three genotypes, but the 
two present genotypes did not take on the same phenotype.  
 
 
Figure 4-16: WT and Chst5 corneal sections labelled with 2B6 
after chondroitinase B treatment or DAPI staining. White 
arrows indicate nuclei observed in WT (b) and Chst5 (d) 
images. Arrows in fluorescent images were placed in idential 
locations to nuclei, but no unstained regions appeared to 
associated with nuclei as observed in the previous Figure 4-
15.  
 
This 2B6 + B experiment was performed a second time to assess the repeatability of 
this nuclei effect and further study the relative fluorescent signal of the corneal 
genotypes labelled for DS-GAGs. Results from the second 2B6 + B trial are shown in 
Figure 4-17, with brightfield and DAPI images of left and right columns shown in 
Appendix II, Figures A2-18 and A2-19, respectively.  
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Figure 4-17: WT and mutant corneal tissue digested with 
chondroitinase B and incubated with (left column) or without 
(right column) 2B6 antibody. Left hand corneal sections all 
fluoresced evenly throughout the stroma, whereas right hand 
negative controls showed no fluorescent signal. The Chst1 (d) and 
Chst1/5 (j) samples treated with 2B6 + B appeared slightly dimmer 
than the WT (a), Chst5 (g), or B3gnt7 (m) samples. 
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As observed in the first 2B6 + B experiment (Figure 4-14), WT and mutant tissue 
sections that were digested with chondroitinase B and labelled with 2B6 fluoresced 
uniformly throughout the stroma (left column, Figure 4-17). In this instance, WT, 
Chst5, and B3gnt7 (Figure 4-17a, e, and i, respectively) genotypes produced a slightly 
brighter fluorescent signal than Chst1 or Chst1/5 samples. This result contrasted with 
the previous 2B6 + B experiment, in which all corneal genotypes appeared to have 
comparable levels of fluorescence. Furthermore, in the current 2B6 + B experiment, 
the Chst1 specimen was the only sample that contained dark areas reminiscent of 
those observed in Chst1, Chst5, and B3gnt7 samples noted and discussed above 
(Figure 4-15). To observe whether the dark spots present in the Chst1 cornea were 
similarly correlated to nuclei staining, Figure 4-18 was created below.  
 
Figure 4-18: Analysis of dark spot localization in brightfield and DAPI 
images of 2B6 + B-labelled specimen. Arrowheads in the brightfield 
image consistently identified clefts in the tissue (a), which implied the 
dark spots observed in the fluorescent image were artifacts introduced 
by the sectioning process (b). Arrowheads in the DAPI image did not 
reveal a pattern between the unstained areas and nuclei location (c). 
White arrowheads in Figure 4-18b point out the small, dark areas of interest. The 
same formation of arrows was then placed in brightfield and DAPI images. 
Arrowheads in the brightfield image consistently aligned with bright white areas in 
the section (Figure 4-18a), which were thought to be artifacts produced by the 
cryosectioning process. Unlike in Figure 4-15, arrows in the DAPI image did not 
correlate to nuclei, suggesting the spots were an anomaly of the previous 2B6 + B 
experiment. 
Data collected from tissue sections digested with chondroitinase B and labelled with 
2B6 showed all mutant corneas indeed contained DS-GAGs, which were observable 
independent of concomitant C4S labelling (as is achieved with chondroitinase ABC 
predigestion). The two 2B6 + B experiments analyzed here provided inconsistent 
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results when it came to determining the relative amounts of DS-GAGs in unaffected 
vs. affected genotypes. All genotypes appeared equally fluorescent in the first 
experiment, however the second experiment showed slightly more intense signal in 
Chst1/5 and B3gnt7 specimens. The identity of the anomalous GAGs observed in EM 
images remains elusive.  
4.3.4 Imaging(Chondroitin(4(Sulfate(using(mAb(2B6(with(
Chondroitinase(AC(Digestion(
To visualize the relative amounts of C4S present in WT and mutant mouse corneas, 
2B6 primary antibody was used subsequent to chondroitinase AC digestion. This 
enzyme excludes DS labelling because AC digestion cleaves glycosidic bonds 
between GalNAc and GlcA (Capila et al. 2002), revealing C4S neoepitope “stubs”. 
Bovine cartilage sections subjected to 0.08 U/ml AC digestion, then incubated with 
(Figure 4-19a-c) or without (Figure 4-19d-f) 2B6 primary antibody, showed 
comparable levels of fluorescence. Since both positive and negative bovine cartilage 
controls appeared faintly fluorescent, positive signal observed in any corneal 
sections could not have been attributed to specific C4S staining. For this reason, 
images of corneal sections were not imaged in this experiment. Instead, the enzyme 
concentration was increased to 0.4 U/ml in a second 2B6 + AC experiment (Young et 
al. 2005).  
 
Figure 4-19: Bovine cartilage samples treated with 2B6 + AC (a–c) or AC 
digestion only (d–f). Both the positive (b) and negative (e) control cartilage 
sections fluoresced, suggesting the signal was nonspecific staining. This result 
prevented collection of reliable data from processed corneal samples.   
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Figure 4-20 shows results of the second 2B6 + AC experiment where AC 
concentration was increased to 0.4 U/ml. In this instance, the positive control that 
was digested with AC and labelled with 2B6 showed fluorescent signal, particularly 
located around lacunae of the cartilage section (Figure 4-20b). The negative control 
that was not incubated with 2B6 showed little fluorescence, primarily at the edge of 
the section. These data indicated the negative control was successfully blocked from 
nonspecific staining, and the 2B6 + AC treatment produced targeted labelling of C4S 
GAGs. Corneal sections were therefore labelled and reported in Figure 4-21.  
 
Figure 4-20: Positive (a–c) and negative (d–f) bovine cartilage controls for 2B6 + 
AC treatment. Cartilage that was labelled with 2B6 after AC digestion showed 
fluorescence mainly around borders of lacunae (b). Tissue that was only 
subjected to AC digestion did not show this effect, suggesting the small amount 
of fluorescence noticeable at the border of the section was an edge effect (e).  
No fluorescence was observed when WT and mutant corneal samples were labelled 
for C4S-GAGs, as shown in the left column of Figure 4-21 on the following page. 
However, the epithelial layer of each genotype faintly fluoresced. Negative corneal 
controls in the right hand column of Figure 4-21 lacked stromal fluorescent signal. 
Brightfield and DAPI counterparts of left and right columns of Figure 4-21 can be 
found in Appendix II, Figures A2-20 and A2-21, respectively. In addition, apart from 
the WT sample, epithelial layers of mutant genotypes appeared faintly fluorescent. 
The absence of 2B6+AC staining suggested that C4S was not present in sufficient 
quantities for immunolabelling. This implies that DS-GAGs are responsible for the 
majority of fluorescent signal produced when C4S and DS are jointly labelled by 2B6 
after chondroitinase ABC predigestion.  
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Figure 4-21: WT and mutant corneal tissue labelled with 2B6 following 
chondroitinase AC digestion. Images in the left column represent WT and 
mutant corneal sections labelled with 2B6 following AC digestion, whereas the 
right hand column of images were negative controls that were not labelled 
with 2B6 following AC digestion. No discernible stromal fluorescence was 
observed in experimental or control images. Although, weak epithelial 
staining was noticeable in the tissue. 2B6 only was not performed as a control 
here because it was previously discussed in Figure 4-12. 
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4.4 Discussion 
Immunofluorescence experiments in this chapter provided a means to visualize 
localization of GAGs in WT compared to mutant mice. When labelled for KS-GAGs 
using 1B4, WT and Chst1 samples showed positive labelling that was susceptible to 
keratanase digestion. However, the two specimens had differential phenotypes. 
While the WT showed uniform stromal fluorescence and occasional bright punctae, 
the Chst1 staining was limited to only fluorescent punctae. Corneas isolated from 
affected genotypes, including the Chst5, Chst1/5, and B3gnt7 samples, appeared to 
lack fluorescent signal altogether, implying an absence of KS-GAGs.   
To understand the implications of these data, the actual antigen to which 1B4 binds 
must be considered. According to Mehmet and colleagues (1986), 1B4 preferentially 
binds KS-GAG epitopes with sulfation occurring on at least four of six adjacent 
monosaccharides (a “tetrasulfated hexasaccharide”). This implies that 1B4 requires at 
least one of three adjacent disaccharides to be disulfated. Importantly, the 
hypothesized KS-GAG structure of the Chst1 knockout mouse does not contain 
disulfated disaccharides because the KSGal6ST that generates the disulfated motif 
via SO4- addition to galactose residues is totally knocked out (Fukuta et al. 1997). 
Therefore, the lack of 1B4 signal throughout the stroma of the Chst1 knockout is 
perhaps unsurprising. This absence of 1B4 signal does not unequivocally mean KS-
GAGs are absent from the extracellular matrix. In fact, the EM data collected on the 
Chst1 specimen in Chapter 3 of this thesis showed observable KS-GAGs throughout 
the extracellular matrix. Perhaps those KS-GAGs observed in electron micrographs 
were not visible here because their sulfation motifs were too infrequent (i.e. singly 
sulfated disaccharides) to be eligible for 1B4 binding, and thus 
immunohistochemical visualization. While this hypothesis justifies the absence of 
widespread stromal labelling, it does not address the remaining punctae visible in 
the Chst1 specimens. Since the specks disappeared following introduction of 
keratanase, it was concluded the punctae were not artifacts. Therefore, perhaps at 
least minor galactose sulfation continued, despite the absence of KSGal6ST. Habuchi 
et al. (1996) demonstrated that chondroitin 6 sulfotransferase, an enzyme that 
typically sulfates the C-6 position of GalNAc residues during chondroitin sulfate 
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synthesis (Habuchi et al. 1993), also has the ability to sulfate galactose residues 
during KS synthesis. The relatively indiscriminate nature of the chondroitin 6 
sulfotransferase enzyme may have provided an alternative pathway through which 
the disulfated KS-GAG motif was synthesized in KSGal6ST-deficient conditions. 
Overall, immunohistochemistry experiments paralleled EM data collected and 
described in Chapter 3.  
In considering results of 2B6 + ABC, 2B6 + B, and 2B6 + AC experiments, only limited 
conclusions could be drawn about the content of CS/DS-GAGs in WT and mutant 
corneas. As outlined in the introduction, the initial hypothesis for these experiments 
predicted that affected genotypes would show enhanced fluorescence when both 
CS and DS-GAGs were labelled. While this effect was observed in the first trial of the 
2B6 + ABC experiment, it proved unreliable, as only the B3gnt7 sample appeared 
appreciably brighter than remaining genotypes in the second 2B6 + ABC experiment. 
This fluctuation in observable signal suggested immunohistochemistry might not be 
the ideal approach for investigating fine structure of GAG chains in the corneal 
stroma. That said, some broad conclusions on CS/DS-GAG content can be made: 
Since chondriotinase ABC digestion prior to 2B6 labelling consistently produced 
stromal fluorescence in WT and mutant tissue, it is reasonable to conclude all corneal 
genotypes investigated here possessed CS/DS-GAGs. These data align with the 
widely published GAG profile of the corneal stroma, which is known to contain a 
substantial portion of CS/DS-PGs (Conrad 1970, Scott and Bosworth 1990, Young et 
al. 2005). In addition, labelling CS/DS-GAGs indicated that disruption of the KS 
biosynthetic pathway via genetic mutation had no effect on CS/DS-GAG distribution, 
as all genotypes—WT and mutant—showed uniform stromal fluorescence.  
When DS-GAGs were labelled independent of CS-GAGs, all genotypes consistently 
showed diffuse fluorescence, implying an even distribution of DS-GAGs throughout 
the stroma. On the other hand, when only CS-GAGs were labelled, no discernible 
signal was generated. These results suggested that fluorescent signal in the ABC-
digested samples was predominantly from labelling of DS-GAGs. However, 
previously published immunohistochemistry data performed on WT mouse corneas 
showed signal throughout the stroma when labelled with 2B6 following AC 
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digestion, as was attempted here (Young et al. 2005). Despite using identical 
concentrations of the AC enzyme (0.4 U/ml), I was not able to repeat those results 
achieved by Young and colleagues (2005).  
Despite the application of various antibodies and enzymatic pretreatments to 
corneal tissue in this chapter, an exhaustive investigation of all corneal ECM GAGs 
was not possible. Those that remain elusive include the highly sulfated KS epitope, 
chondroitin-6-sulfate (C6S), and chondroitin-0-sulfate (C0S). Antibodies for these 
epitopes exist, however it has been shown that monoclonal antibodies 5D4 and 3B3, 
which are specific to highly sulfated KS and C6S, respectively, fail to produce 
fluorescent staining when applied to WT mouse corneal tissue. Similarly, the 1B5 
epitope specific to C0S generates only faint stromal fluorescence when applied to 
mouse corneal tissue (Young et al. 2005). For these reasons, an alternative method 
should be used determine the presence of these epitopes in WT and mutant corneal 
sections.  
 In addition to an inability to characterize all ECM GAGs present in the corneal stroma, 
immunohistochemistry does not offer any information on GAG chain length. This 
aspect of KS-GAGs is of interest to determine if their absence in EM and 
immunohistochemical experiments is due to a lack of sulfation, as opposed to 
disrupted elongation. Since both cupromeronic blue (in EM) and monoclonal 
antibody (with 5D4 or 1B4) staining relies on sulfation of KS-GAGs for visualization, it 
cannot be concluded from the present data if KS-GAGs are elongated but improperly 
sulfated, or if their synthesis is prematurely halted as a result of missing biosynthetic 
enzymes. Both scenarios result in unobservable KS-GAGs in EM or 
immunohistochemistry experiments. In the next chapter, Western blot is used to 
assess chain length of KS-GAGs via observation of their molecular weight distribution 
patterns following electrophoretic separation.  
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4. CHAPTER 5 
5. Investigation of Keratan Sulfate Chain Length 
and Sulfation Patterns via Western Blot 
5.1 Introduction 
The previous chapter used monoclonal antibodies specific to KS- and CS/DS-GAGs to 
compare corneal GAG content in mutant mice to that of WT. These data showed that 
WT corneal tissue contained low sulfated keratan sulfate throughout the cornea, but 
all mutants showed a notable decrease or total absence of this 1B4 staining. The 
Discussion section of Chapter 4 explained that two weaknesses of the 
immunohistochemistry assay were 1) an inability to detect highly sulfated KS with 
5D4 antibody and 2) an inability to determine the effect of these genetic mutations 
on KS chain length. The data collected for this chapter serves to address both of these 
weaknesses using Western blot, a technique known to be more sensitive than 
immunohistochemistry assays. First, the 5D4 antibody was used to probe WT corneal 
extracts to confirm the presence of this epitope in the tissue. In addition, B3gnt7-
heterozygous- (HTZ) and homozygous-NULL (NULL) tissue were prepared alongside 
the WT to determine if the amount of the highly sulfated KS epitope is affected by a 
single (HTZ) or double (NULL) allele mutation of the B3gnt7 gene.  
This chapter also investigates whether or not synthesis of the KS-PG core protein 
lumican is affected by B3gnt7 mutations. To this end, corneal extracts were digested 
with peptide N glycosidase F (PNGase F), an enzyme known to cleave N-linked 
glycans between the linkage GlcNAc and asparagine residues to which they are 
bound (Plummer and Tarentino 1991, Tretter et al. 1991) (Figure 5-1a, grey arrow). 
Therefore, in the corneal extracts used here, PNGase F should cleave the entire KS-
GAG side chain from lumican core proteins, thus allowing analysis of only lumican 
molecular weight and relative quantity in WT and mutant mice (Figure 5-1b).  The 
importance of this experiment relates to the MCD phenotype, which, as explained in 
section 1.1.6, results from a defect in KS biosynthesis. Abnormally thick collagen 
fibrils have been reported to appear in the posterior stroma of human post mortem 
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MCD corneas (Palka et al. 2010), despite studies attributing corneal collagen fibril 
diameter regulation to collagen type V (Marchant et al. 1996) and proteoglycan core 
proteins lumican and decorin (Rada et al. 1993), rather than to their GAG side chains. 
Similarly, lumican-deficient mice present with hazy corneas, and, when observed by 
electron microscopy, show abnormally thick collagen fibrils with irregular 
interfibrillar spacing (Chakravarti et al. 2000, Quantock et al. 2001, Kao and Liu 2002). 
Whereas both human MCD tissue and lumican-null mouse tissue have shown 
collagen fibrils with atypical diameters, mouse models of MCD, such as the Chst5-null 
mouse, did not parallel this phenotype. Instead, collagen fibril diameter, in addition 
to lumican expression, remained normal in absence of CGn6ST in the Chst5 knockout 
(Hayashida et al. 2006). Because the EM data collected in Chapter 3 showed that the 
phenotype of the B3gnt7-NULL mouse closely resembled that of the Chst5-null 
mouse, it is predicted that lumican expression in the B3gnt7-NULL mouse will be 
unaltered compared to the WT, as Hayashida and colleagues (2006) reported for the 
Chst5-null mouse. 
              
Figure 5-1: Schematic of KS-GAGs before and after enzyme digestion. (a)  
Pink and grey arrows identify Endo β Gal and PNGase F cleavage sites, 
respectively. (b) PNGase F digestion leaves lumican core protein without 
side chains. (c) Endo β Gal cleavage leaves the linkage region and lumican 
core protein intact. 
a. 
b. c. 
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The final element of this chapter uses another glycosidase, Endo β Galactosidase 
(Endo β Gal), to analyze the degree of galactose sulfation in the mutant KS-GAG 
chains. Cleaving the β-1,4 glycosidic linkage between un-sulfated galactose and 
GlcNAc (regardless of its sulfation) (Figure 5-1a, pink arrows), Endo β Gal offers 
information about the number of sulfated galactose residues along the KS-GAG 
chain (Nakagawa et al 1980, Scudder et al. 1986). When galactose is frequently 
sulfated along the GAG chain, Endo β Gal is unable to cleave efficiently, leaving KS-
PGs mostly intact, appearing as high molecular weight smear patterns in assays such 
as Western blot used here. If, however, galactose sulfation is sparse, Endo β Gal can 
digest more frequently along the KS GAG backbone, leaving little more than the 
linkage region of KS-GAG undigested (Figure 5-1c) (Funderburgh et al. 1991). We can 
infer qualitatively if galactose sulfation is affected by the B3gnt7 mutation based on 
its susceptibility to digestion by this enzyme. 
 
5.1.1 Aims(and(Objectives((
1. Establish Western blot experimental set up able to detect highly sulfated KS 
and lumican with 5D4 and anti-lumican antibodies, respectively.  
2. Determine if KS chain length is affected by single (HTZ) or double (NULL) 
B3gnt7 allele mutation in untreated WT, HTZ, and NULL extracts. 
3. Use PNGase F digestion of corneal extracts to observe whether lumican core 
protein exists at similar molecular weight and relative quantity in HTZ and 
NULL as it does in WT.  
4. Use Endo β Gal digestion to observe whether galactose sulfation differs in 
HTZ and NULL extracts, as compared to WT.  
 
5.2 Methods  
5.2.1 Animals(
All mice in this chapter were raised and genotyped by our collaborator, Dr. Tomoya 
Akama, at Kansai Medical University (KMU) in Osaka, Japan. To perform these 
experiments, I travelled to KMU for a month-long research placement. Dr. Akama 
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enucleated whole eyes from WT, HTZ and NULL mice at 9-12 weeks of age (details 
below, Table 5-1). 
 
Genotype Sex Age (weeks) n (mice, corneas) 
WT 
 
Female 12 
6, 12 
Female 12 
Male 12 
Male 12 
Male 11 
Female 11 
B3gnt7-HTZ  
 
Male 14 
6, 12 
Male 14 
Male 14 
Female 11 
Female 11 
Female 11 
B3gnt7-NULL 
Female 38 
6, 12 
Female 34 
Male 34 
Male 33 
Female 33 
Female 33 
Table 5-1: Age, sex, and number of mouse corneas used for Western blot assays. 
 
Chst1, Chst5, and Chst1/5 knockouts discussed in other chapters of this thesis were 
not explored here because Dr. Akama had already collected data on those genotypes 
prior to my research placement. 
5.2.2 Protein(Extraction(
Whole corneas were dissected from each of three genotypes: WT (n=10), HTZ (n=10), 
and NULL (n=10). Isolated corneas were manually minced using two scalpel blades, 
placed into a tube containing 750 µl homogenizing solution (8 M Guanidine 
Hydrochloride [GuHCl]; 1 M Tris/Hydrochloride [Tris/HCl], pH: 8.0; 0.5 M EDTA; 50 mM 
PMSF; and 1x Proteinase Inhibitors), and subjected to a bench-top homogenizer 
fitted with a metal blade. Once pulverized, samples were incubated on a rotator at 
4°C overnight in the GuHCl extraction solution noted above. Following incubation, 
samples were centrifuged the next day at 15,000 RPM, 4°C for 15 minutes. 
Supernatants were collected and stored at 4°C for future use. The remaining pellets 
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were further extracted by adding an additional 750 µl homogenizing solution, briefly 
vortexing, and incubating overnight on a rotator at 4°C. Samples were centrifuged a 
second time as above, and the supernatants from each extraction were combined for 
further preparation. To desalt, supernatants were placed into dialysis cassettes (pore 
size: 20 kDa) and dialyzed in a one liter solution of 6 M urea with 50 mM Tris/HCl (pH: 
8.0) at 4°C for four hours. A stir bar was included in the beaker to ensure the urea 
solution was homogenous throughout the 4-hour incubation. Next, the used urea 
solution was replaced with two liters of fresh 6 M urea solution, and samples were 
allowed to dialyze again overnight at 4°C, with constant agitation from a stir bar. 
Dialysis encouraged the removal of small molecules (<20,000 Daltons), such as salts 
and ions, from the desired protein sample. Concentrating protein samples was 
achieved by centrifuging the samples in filtered tubes (pore size: 30 kDa) at 4°C, 3500 
RPM for 15 minutes. Centrifugation was repeated until only ~100 µl of each sample 
remained within the filter.  
5.2.3 Determining(Unknown(Protein(Concentrations(
 Following centrifugation, protein concentration of the WT, HTZ, and NULL samples 
was quantified using Pierce bicinchoninic acid (BCA) Protein Assay kit (Pierce 
Biotechnology, Rockford, IL, USA). Increasingly concentrated bovine serum albumin 
(BSA) solutions, which ascended in 0.25 steps (0, 0.25, 0.5, … 2.0 μg/µl), were used to 
create a standard curve. Using a clean, dry pipette tip for each uptake, 1 µl of each of 
the 11 samples (3 genotypes with unknown concentration and 8 BSA solutions with 
known concentrations) was pipetted into its own well of a 96-well microtiter plate. 
This was performed in duplicate for each sample. Next, ~5 ml of reaction buffer was 
prepared as specified in Table 5-2.  
 
 Volume 
Pierce BCA Protein Assay Reagent A  
200 µl/well x 22 wells = 4,400 µl 
Increase to 5,000 µl  
5,000 µl (5 ml) 
Pierce BCA Protein Assay Reagent B 
This should be a 1:50 ratio to solution A 
100 µl 
Table 5-2: Preparation of Pierce BCA Protein Assay reaction buffer. Volume of 
Reagent A was based on allowing 200 µl of final reaction buffer per sample-
containing well. Reagent B volume must be present in a 1:50 ratio to Reagent 
A, per the manufacturer-provided instructions.  
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A multi-channel pipette was used dispense 200 µl of the reaction buffer into each 
well that contained protein sample. Wells were covered with tape to prevent 
evaporation during the 30 minute incubation at 37°C. Following incubation, tape was 
removed from the microtiter plate, and a plate reader (MultiskanTM FC Microplate 
Photometer, Thermo Scientific) was used to measure absorbance of the sample-
containing wells. Known BSA concentrations were plotted against respective 
absorbance measurements in Microsoft Excel, and the equation of the resulting 
standard curve was used to derive protein concentration of the WT, HTZ, and NULL 
samples.  
5.2.4 Methanol/Chloroform(Protein(Precipitation(
Before either glycosidase reaction could be carried out, the buffer in which the 
protein samples were dissolved was changed from urea to 1% SDS. To do so, a 
volume equaling 30 μg of protein was brought to 100 µl by adding DW (see Table 5-3 
for exact volumes). Next, 4x ice-cold methanol (MeOH, 400 µl) was added to each 
sample, and a vortex was used to mix. Once mixed, samples were centrifuged at 
15,000 RMP briefly to return the full volume of sample to the bottom of the tube. 
Next, 100 µl of chloroform was added to the sample, which was subsequently mixed 
and centrifuged as previously described. Finally, 300 µl of distilled water were added 
to each sample and thoroughly mixed for 10 seconds.  Samples were centrifuged at 
15,000 RMP for 2 minutes to separate the hydrophilic (MeOH/DW) and hydrophobic 
(chloroform) layers. Careful not to disturb the precipitated protein located at the 
interface of the separated layers, the top aqueous layer was removed with a pipette. 
Another 300 µl of ice-cold MeOH was added to the hydrophobic layer; the mixture 
was vortexed for 10 seconds and centrifuged at 15,000 RPM for 2 minutes. A pipette 
was used to remove all remaining solution from the protein pellet at the base of the 
tube. Protein pellets were air-dried by leaving tubes open. Once dried, 20 µl of 1% 
SDS buffer was used to re-suspend the protein. Resulting protein samples in 1% SDS 
were assayed for protein concentration with Pierce BCA Protein Assay Kit, as 
described above.  
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 WT HTZ NULL 
Starting protein concentration in Urea  3.80 μg/µl 2.69 μg/µl 3.48 μg/µl 
 
Sample volume (to equal 30 μg protein)  7.89 µl 11.14 µl 8.63 µl 
Distilled Water (to equal 100 µl)  92.11 µl 88.86 µl 91.37 µl 
Ice-cold MeOH 400 µl 400 µl 400 µl 
Vortex briefly, centrifuge at 15,000 RMP briefly to collect sample in bottom of tube 
Chloroform 100 µl 100 µl 100 µl 
Vortex briefly, centrifuge at 15,000 RMP briefly to collect sample in bottom of tube 
Distilled Water 300 µl 300 µl 300 µl 
Vortex 10 sec; centrifuge 15,000 RMP for 2 minutes  
(Protein film will be between at interface of two solution layers) 
Remove upper phase aqueous layer with pipette 
Ice-cold MeOH 300 µl 300 µl 300 µl 
Vortex 10 sec; centrifuge 15,000 RMP for 2 minutes  
(Protein pellet will be at base of tube) 
Pipette off supernatant, leaving pellet intact; allow pellet to air dry 
Re-suspend pellet in desired buffer 
1% SDS 20 µl 20 µl 20 µl 
Determine new protein concentration 
Resulting protein concentration in 1% 
SDS  
1.67 μg/µl 0.97 μg/µl 1.67 μg/µl 
Table 5-3: Summary of methanol/chloroform precipitation protocol. Protein samples 
dissolved in dialysis urea buffer were precipitated with MeOH and chloroform, then re-
suspended in the desired 1% SDS buffer. This protocol preceded both PNGase F and Endo β 
Gal reactions.  
 
5.2.5 PNGase(F(Digestion((
Peptide-N-Glycosidase F (PNGase F) digestion was used to separate KS-GAG chains 
from their lumican protein core in all three samples. WT, HTZ, and NULL extracts were 
digested with PNGase F according to manufacturer's instructions: Following re-
suspension of protein samples into 1% SDS as described above, 1 µl of the 
manufacturer’s denaturing buffer was added to a volume of sample equal to 5 μg of 
protein (see table 5-4). This mixture was brought to a final volume of 10 µl by 
addition of Millipore-filtered distilled water. Next, the samples were denatured by 
incubating at 100°C for 10 minutes. Following denaturation, samples were digested 
with 1 U of PNGase F at 37°C overnight. Samples were prepared for electrophoresis 
the next day as described in section 5.2.8. 
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 WT HTZ NULL 
Protein concentration in 1% SDS buffer 1.67 μg/µl 0.97 μg/µl 1.67 μg/µl 
 
Sample (volume equal to 5 μg protein) 3.00 µl 5.15 (~5.00) µl 3.00 µl 
Denaturing buffer (manufacturer-
provided) 
1 µl 1 µl 1 µl 
Distilled Water (to make 10 µl) 6 µl 4 µl 6 µl 
Incubate at 100°C for 10 minutes 
10x G7 reaction buffer 2 µl 2 µl 2 µl 
10% NP 40 2 µl 2 µl 2 µl 
PNGase F 1 µl 1 µl 1 µl 
Distilled Water  5 µl 5 µl 5 µl 
Final PNGase F Sample Volume 20 µl 20 µl 20 µl 
Incubate at 37°C overnight 
Table 5-4: PNGase F reaction details. Protein samples dissolved in 1% SDS were denatured and 
treated with PNGase F using manufacturer-provided reagents.  
 
5.2.6 Endo(β(Galactosidase(Digestion(
To gain insight into the degree of galactose sulfation along the KS-GAG backbone of 
HTZ and NULL corneal extracts, Endo β Gal was used. To begin, the corneal protein 
extract solvent was changed from urea to 1% SDS buffer as described in section 5.2.4. 
Once re-suspended, 1 unit (0.5 µl) of Endo β Gal was added to a 5 μg protein solution 
that had been diluted with millipore-filtered water to equal 10 µl (see table 5-5). In 
addition to the protein sample, 1 µl proteinase inhibitors and 50 mM sodium acetate 
were included in the enzyme mixture. The final volume of the sample was diluted 
with Millipore-filtered distilled water to equal 100 µl and allowed to incubate 
overnight at 37°C. The following morning, samples were precipitated using acetone 
(see section 5.2.7). Dried precipitates were re-suspended in sample buffer specific for 
electrophoresis (see section 5.2.8). 
5.2.1 Acetone(Precipitation(
Because the sample volume required for Endo β Gal digestion (100 µl) was greater 
than that permitted by the electrophoretic gel sample wells (30 µl), WT, HTZ, and 
NULL extracts had to be concentrated by acetone precipitation following Endo β Gal 
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digestion. This was achieved by adding 4x (400 µl) cold acetone (Table 5-6) to the 
Endo β Gal reaction mixture. Next, samples were vortexed and centrifuged at 15,000 
 WT HTZ NULL 
Protein concentration in 1% SDS buffer 1.67 μg/µl 0.97 μg/µl 1.67 μg/µl 
 
Sample (volume equal to 5 μg protein) 3.00 µl 5.15 (~5.00) µl 3.00 µl 
Proteinase Inhibitors (1:100) 1 µl 1 µl 1 µl 
0.5 M Sodium Acetate 10 µl 10 µl 10 µl 
Endo β Gal 0.5 µl 0.5 µl 0.5 µl 
Distilled Water (to make 100 µl) 85.5 µl 83.5 µl 85.5 µl 
Incubate overnight at 37°C 
Precipitate protein using acetone (section 5.2.7) 
Prepare for SDS-PAGE/Western blot (section 5.2.8) 
Table 5-5: Summary of Endo β Gal reaction conditions. Samples were digested at 37°C 
overnight using Endo β Gal in presence of proteinase inhibitors and sodium acetate. 
Following digestion, samples were precipitated and prepared for electrophoresis.  
(
RPM for 15 minutes at 4°C. The protein pellet collected at the base of the tube, and 
the upper phase solution was removed with a pipette. Samples were air dried at 
room temperature and re-suspended in the electrophoresis sample buffer specified 
by the manufacturer (see section 5.2.8). 
 
 WT HTZ NULL 
Endo β Gal Sample 100 µl 100 µl 100 µl 
Cold Acetone (4x) 400 µl 400 µl 400 µl 
Vortex briefly; centrifuge 15,000 RMP for 15 minutes at 4°C 
Discard supernatant, air dry pellet 
Re-suspend pellet in electrophoresis sample buffer (table 5-6)  
Final Endo β Gal Sample ~5 μg pellet ~5 μg pellet ~5 μg pellet 
Table 5-6: Summary of acetone precipitation protocol. Corneal extracts previously 
digested with Endo β Gal were precipitated using acetone and re-suspended in 
electrophoresis sample buffer. 
(
5.2.2 Western(Blot(
Untreated and enzyme digested protein samples were prepared for electrophoresis 
by adding manufacturer-provided 4x NuPAGE® LDS sample buffer and 10x reducing 
agent. Millipore-filtered distilled water was used to bring samples to desired volume 
(see table 5-7 for details). Samples were then denatured by heating to 100°C for 2 
minutes. Samples were then loaded into a 4 - 12% Bis-Tris Invitrogen polyacrylamide 
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gel. Constant voltage (200 V) was applied for 45 minutes, or until samples reached 
the bottom of the gel.  
 
 Untreated PNGase F Endo β Gal 
WT HTZ NULL WT HTZ NULL WT HTZ NULL 
Protein Sample  
(5 μg equivalent) 
1.3 µl 1.8 µl 1.4 µl 20 µl ~5 μg pellet 
4x LDS 7.5 µl 7.5 µl 7.5 µl 
10x Reducing Agent 3 µl 3 µl 3 µl 
Distilled Water 18.7 µl 18.2 µl 18.6 µl - 20 µl 
Final Volume 30.5 µl 30.5 µl 30.5 µl 
Denature at 100°C for 2 minutes 
Load into 4 – 12% Bis-Tris gel; apply 200 V for 45 minutes 
Transfer to PVDF membrane; Probe for desired epitope 
 Table 5-7: SDS-PAGE gel sample summary. Manufacturer-provided buffers were added to 
Untreated, PNGase F, and Endo β Gal samples. The samples were subjected to 
electrophoresis and transferred to a membrane for visualization of desired epitopes. 
 
Immediately after electrophoresis, protein samples within the acrylamide gel were 
transferred to an Invitrolon™ PVDF membrane at 30 V for 1 hour. Blocking the 
protein-laden membrane was achieved at room temperature using 5% skim milk to 
immerse the membrane for 1.5 hours. Primary antibodies 1B4, 5D4, and anti-lumican 
were diluted 1:1000 in 5% skim milk, applied to the membrane for 1 hour, and 
visualized low sulfated KS, high sulfated KS, or lumican core protein, respectively. 
Phosphate buffered saline containing 0.1% TWEEN (PBS-T) was used to rinse excess 
antibody from the membrane (3x, 5 minutes each). Horseradish peroxidase (HRP) 
antibodies, which recognized mouse immunoglobulin-M (IgM), mouse IgG, and goat 
IgG, were used in conjunction with primary antibodies 1B1, 5D4, and anti-lumican, 
respectively. Secondary antibodies were diluted 1:2000 in 5% skim milk and applied 
to the membrane surface for 1 hour. To develop the membranes, 400 µl of Luminata 
Forte Western HRP substrate was applied to the membrane surface for 2 minutes 
when 5D4 antibody was used. To develop membranes that had been probed with 
1B4 or anti-lumican primary antibodies, chemi-lumi One chemiluminescence 
substrate was applied to the membrane for 2 minutes. 
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5.2.3 Image(Capture(
Chemiluminescent images were captured using LAS 3000 Mini camera and software. 
Exposure time ranged from 1 - 10 minutes, depending on the amount of signal 
produced by the membrane (i.e. the more signal produced by the membrane, the 
shorter the exposure duration). In addition, a digital image was collected of the 
protein standard marker using visible light. This was so the two images could be 
overlaid, allowing the digitalization and insertion of the protein molecular weight 
standard. 
5.2.4 (Stripping(and(ReRprobing(PVDF(Membrane((
 In some cases, a protein-laden membrane, which had been probed for highly 
sulfated KS then imaged, was stripped of its primary/secondary antibody reaction 
and re-probed for lumican. This process allowed for economical use of our limited 
volumes of tissue extract and facilitated direct comparison between the distributions 
of highly sulfated KS and lumican core protein epitopes. Immediately following 
image capture, PBS-T was used to briefly rinse membranes, cleansing them of excess 
chemiluminescent substrate. Next, the membrane was immersed 50 ml of stripping 
solution (62.5 mM Tris/HCl, 2% SDS, 100 mM β-mercaptoethanol, and Millipore-
filtered water (exact volumes below, Table 5-8).  
 
 Volume (ml) Final Concentration 
1 M Tris/HCl 3.125 62.5 mM 
10% SDS 10 2% 
β-Mercaptoethanol 0.35 100 mM 
Distilled Water (to make 50mL) 36.525 - 
Table 5-8: Reagent details of membrane stripping solution. The above solution 
was used to dissociate primary/secondary antibody complexes from a PVDF 
membrane, thus allowing the same membrane to be re-probed with another 
antibody. 
 
The membrane and stripping solution were enclosed in an airtight container and 
incubated for 30 minutes in a 50°C water bath under constant agitation. After 
incubation, the stripped membrane was rinsed three times in PBS-T, then blocked, 
probed, and imaged as previously described (sections 5.2.8, 5.2.9). In cases where the 
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5D4-labelled membrane was stripped and re-probed for lumican, results are 
presented side-by-side in the same figure as a/b pairs. 
5.3 Results  
5.3.1 Establishing(a(Functional(Experimental(Set(Up(
Untreated WT, HTZ, and NULL samples were first probed for low sulfated KS using 
1B4 antibody. This experiment aimed to determine if corneas were successfully 
extracted and if the experimental set-up was functional. The 1B4 epitope was chosen 
as this positive control because Young et al. (2005) demonstrated low sulfated KS was 
present in murine WT corneal extracts using the same 1B4 antibody. As shown in 
lanes 1 and 2 of Figure 5-2, the WT and HTZ samples produced a smear pattern from 
~188 – 60 kDa, whereas, the NULL sample in lane 3 showed less signal overall and 
was separated into faint, discrete bands at ~100, 65, 47, and 20 kDa. 
        1B4 
Figure 5-2: WT, B3gnt7-HTZ, and -NULL corneal extracts 
probed for low sulfated KS using 1B4 antibody. The WT and 
B3gnt7-HTZ specimens in lanes 1 and 2, respectively, show 
smear patterns from ~188 – 60 kDa. The B3gnt7-NULL 
specimen in lane 3 shows separate bands at ~100, 65, 47, and 
20 kDa. These bands are indicated with black arrows, as some 
may appear faint. 
|--Untreated--| 
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The smear pattern produced by the WT was comparable to that published by Young 
and colleagues (2005). Our reproducing this result confirmed that our experimental set 
up was functional and allowed us to begin analyses on highly sulfated KS and lumican, 
which were not tested for via immunohistochemistry in Chapter 4.  
When untreated samples were probed for highly sulfated KS using 5D4, all three 
extracts showed similar band patterns (Figure 5-3a). Four discrete bands were visible in 
each lane at ~60, 50, 48, and 25 kDa. Despite using the same amount of protein (5 μg) 
in each lane, the WT showed more 5D4-reactive substrate than either HTZ or NULL. 
When stripped and re-probed for lumican, the WT and HTZ samples showed smear 
patterns from ~188 – 45 kDa (Figure 5-3b, lanes 1, 2). The NULL sample, however, 
produced a narrower smear at lower molecular weights (~65 – 45 kDa) (Figure 5-3b, 
lane 3). These experiments showed our methods were appropriate for the 5D4 and 
anti-lumican antibodies of choice, thus fulfilling our first aim outlined in section 5.1.1. 
Our subsequent experiments examined molecular weight distributions of 5D4 and 
anti-lumican epitopes in untreated, PNGase F-, and Endo β Gal-digested extracts. 
a.         5D4         b. Anti-Lumican 
 
Figure 5-3: Untreated WT, B3gnt7-HTZ, and -NULL extracts probed with 5D4 and anti-
lumican. (a) All three lanes show similar bands at ~60, 50, 48, and 25 kDa. Despite 
using 5 μg of protein extract in each lane, the WT (lane 1) appears to contain more 
5D4-reactive substrate. (b) Lanes 1 and 2, which contained WT and HTZ samples, 
respectively, showed high molecular weight smear patterns from ~188 – 45 kDa. 
Whereas, the NULL specimen in lane 3 showed narrower smear from ~65 – 45 kDa.  
|--Untreated--| |--Untreated--| 
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5.3.2 Qualitative(Analysis(of(KSRGAG(Chain(Length(in(Untreated(
Extracts((
After establishing a working system in the preliminary experiments described above, 
electrophoresis on untreated extracts was repeated to compare KS-GAG chain length 
of WT, HTZ, and NULL mouse corneas. Labelling with 5D4 in Figure 5-4a showed WT 
and HTZ extracts had similar highly sulfated KS phenotype:  Dense bands were 
observed at ~60, 50, 48, and 25 kDa. In addition, a smear pattern from ~188 – 50 kDa 
was visible, although at a lower intensity than the discrete bands.  The NULL 
specimen did not produce a smear pattern as observed in the WT and HTZ lanes; 
instead, it showed three separate bands at ~60, 48, and 25 kDA. NULL bands at 50 
and 25 kDA appeared notably more intense than analogous bands of the WT and 
HTZ samples. When probed for lumican in Figure 5-4b, WT and HTZ samples again 
showed a similar phenotype, with high molecular weight smear patterns appearing 
from ~150 – 45 kDa. The lumican-labelled NULL specimen contrasted with WT and 
HTZ, as its smear pattern was narrower and appeared from ~60 – 45 kDa.  
                                       a.           5D4               b.  Anti-Lumican 
 
Figure 5-4: Untreated WT, B3gnt7-HTZ, and –NULL corneal extracts labelled with 
5D4 (a) and anti-lumican (b). (a) WT and HTZ (lanes 1, 2) show similar molecular 
weight distributions of highly sulfated KS, whereas the NULL (lane 3) appears to 
contain a lower molecular weight form of highly sulfated KS. (b) WT and HTZ 
samples produced high molecular weight smear patterns, whereas the NULL 
appeared as a narrower, lower molecular weight smear when probed for lumican.  
|---Untreated---| |---Untreated---| 
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The molecular weight position of the 5D4 epitope correlates to the KS-GAG chain 
length: The longer the KS-GAG chain, the higher its molecular weight position in an 
electrophoretic gel. This also applies to the lumican epitope because both low and 
highly sulfated KS-GAG side chains that are covalently linked to lumican prevent the 
core protein from moving into its low molecular weight position in the gel. Results 
from both 5D4 and anti-lumican assays indicated WT and HTZ extracts had KS chains 
of comparable molecular weights, and thus contained similarly elongated KS-GAG 
chains. The high molecular weight smear patterns observed in lanes 1 and 2 of Figure 
5-4a are found throughout the literature when corneal extracts are probed for KS 
using 5D4 (Akhtar et al. 2008, Hayashida et al. 2006, Young et al. 2005). This is likely 
because KS contains a variable number of repeat disaccharides, even when isolated 
from a single tissue (Funderburgh et al. 1996). Because the pattern of the 5D4 
epitope reported here correlated with that already published, it can be inferred that 
the highly sulfated KS epitope was intact in the WT corneal tissue. By extension, the 
similarity between WT and HTZ samples indicated that KS-GAG was normally 
synthesized in the HTZ mouse, suggesting a single allele mutation of the B3gnt7 
gene did not disrupt KS-GAG synthesis. However, the same cannot be said for the 
NULL sample. Both 5D4 and anti-lumican results showed a lower molecular weight 
pattern when compared to WT and HTZ, suggesting the presence of an unusually 
truncated form of the KS-GAG. In addition to fulfilling the second aim of this chapter 
(section 5.1.1), these data support the hypothesis that chain elongation of the KS-
GAG backbone cannot continue without addition of GlcNAc via β3GnT7 action. 
5.3.3 PNGase(F(and(Lumican(Production(
PNGase F digestion allowed analysis of lumican core protein independent of its KS-
GAG side chains. Three faint bands at ~60, 48, and 25 kDa were visible in WT, HTZ, 
and NULL samples when probed for highly sulfated KS (Figure 5-5a, lanes 4 - 6‡). 
However, labelling with anti-lumican antibody (Figure 5-5b) showed a single band at 
                                                        
‡Lanes are labeled 4 – 6 because they were originally run in tandem with lanes 1 – 3 of Figure 5-4 and 
lanes 7 – 9 of Figure 5-6. For simplicity, results were separated according to their enzymatic 
pretreatment (or lack thereof). The background of the molecular weight standard appears disjointed 
to the background of experimental lanes because the standard was repositioned from the left edge of 
the intact immunoblot to a lane adjacent to those in question. The intact result can be found in 
Appendix III, Figure A3-1. 
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~38 kDa in each sample, which parallels previous data indicating lumican’s molecular 
weight is ~38 kDa (Funderburgh et al. 1993, Kao et al. 2006).  
 
                                a.          5D4          b.  Anti-Lumican  
Figure 5-5: PNGase F-treated WT, B3gnt7-HTZ, and –NULL, 
corneal extracts labelled for highly sulfated KS (a) and 
lumican (b). (a) Faint signal is visible at ~48 and 25 kDa, 
which may arise from background labelling of endogenous 
mouse IgG heavy (50 kDa) and light chains (25 kDa). The 
origin of the 60 kDa labelling is unclear. (b) Identical bands at 
~38 kDa correspond to the known molecular weight of 
lumican.  
 
The discrepancy between the 5D4 and anti-lumican results may arise from the 
difference in secondary antibody isotype and the animal in which those antibodies 
were raised. For example, the secondary antibody used to detect 5D4 was goat-
raised and was specific to mouse IgG. However, the secondary antibody used to 
detect the anti-lumican primary was donkey-raised and specific to goat IgG. Because 
the 5D4 antibody is a mouse monoclonal antibody, and the protein samples in 
question were isolated from mouse tissue, the secondary antibody may be non-
specifically binding IgG endogenous to the tissue. This nonspecific binding would 
explain two of the faint bands because the heavy and light chains that comprise IgG 
are 50 and 25 kDa, respectively. This type of background was also cited by Young et 
al. (2005) as a source of signal at 50 and 25 kDa. This heavy/light chain contamination 
|---PNGase F---| |---PNGase F---| 
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is not evident in the anti-lumican result because the secondary antibody was specific 
to goat IgG, rather than mouse. The discreet nature of the band at 60 kDa implies this 
band is also nonspecific binding of the secondary. It is unlikely that the 5D4 epitope 
would generate a distinct band, as GAGs generally create smear patterns as a result 
of their variable lengths.  
The anti-lumican result demonstrates two things: First, because lumican distribution 
following PNGase F digestion appears identical in WT, HTZ, and NULL specimens, it 
was concluded that the approximate molecular weight and quantity of lumican is 
not altered as a result of B3gnt7 mutation. Secondly, this result further supports the 
hypothesis that total absence of functional β3GnT7 prematurely arrests KS-GAG 
synthesis because the cleavage of KS-GAGs from lumican results in a loss of the 
smear pattern phenotype observed in the untreated samples. Since the only 
difference between the untreated and PNGase F samples is the cleavage of KS from 
lumican, those smear patterns produced by the untreated sample, which are not 
observed in the PNGase F samples, can be attributed to the KS-GAGs still present 
along the lumican core protein. 
5.3.4 Endo(β(Galactosidase(and(Galactose(Sulfation(
Cleaving KS-GAGs in WT, HTZ, and NULL samples with Endo β Gal offered a means to 
qualitatively analyze degree of galactose sulfation in each genotype. Comparable 
banding patterns were produced in all three samples when labelled for highly 
sulfated KS with 5D4 (Figure 5-6a). Four bands were observed at ~60, 50, 48, and 25 
kDa, which closely resembled patterns produced by the 5D4-labelled untreated WT, 
HTZ, and NULL samples (Figure 5-4a). Lumican labelling showed WT and NULL 
samples produced a single band at ~45 kDA, whereas the HTZ remained a smear 
pattern from ~188 – 45 kDA (Figure 5-6b). 
The presence of a smear pattern in the lumican-labelled HTZ sample above would 
usually suggest that those KS-GAGs linked to lumican contained a higher number of 
sulfated galactose residues, thereby preventing digestion of elongated KS-GAGs by 
Endo β Gal. However, given the HTZ sample produced a phenotype similar to the WT 
in each assay performed and described above, it seemed unlikely the HTZ would 
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                                        a.          5D4          b.  Anti-Lumican 
Figure 5-6: Endo β Gal-digested WT, B3gnt7-HTZ, and –NULL 
corneal extracts. (a) 5D4-labelled extracts showed bands at  
~60, 50, 48, and 25 kDa (the 25 kDa band is very faint in WT 
and HTZ samples). (b) WT and NULL samples showed narrow 
bands at ~45 kDa, whereas the HTZ produced a smear 
pattern at ~188 – 45 kDa.  
 
adopt a phenotype unlike that of either the WT or NULL in this experiment. In 
examining the reaction conditions of the samples to identify possible reasons for the 
anomalous result, it was noted that the starting protein concentration of the HTZ 
(0.97 μg/µl) samples was markedly lower than that of either the WT or NULL samples 
(both 1.67 μg/µl) (see Table 5-4). In order to create a new, more concentrated HTZ 
sample for a repeat experiment, 50 μg of HTZ extract (in urea buffer) was precipitated 
using methanol and chloroform as described in section 5.2.4. The resulting 
precipitate was suspended in 1% SDS. The outcome of this HTZ re-suspension 
provided a protein concentration of 1.06 μg/µl, which was very similar to that of the 
previous experiment (0.97μg/µl). Nevertheless, Endo β Gal digestion was performed 
a second time on the newly precipitated HTZ sample alongside original WT and NULL 
samples. Anti-lumican labelling in Figure 5-7 below showed a result identical to that 
of Figure 5-6b. WT and NULL formed condensed bands, whereas the HTZ remained a 
smear pattern. 
|---Endo β Gal---| |---Endo β Gal---| 
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Anti-Lumican 
      
 
Figure 5-7: WT, B3gnt7-HTZ, and -NULL tissue were 
subjected to Endo β Gal digestion and labelled for 
lumican in a repeat experiment. The WT (lane 1) and 
NULL (lane 3) samples showed condensed bands at ~45 
kDa, indicating the enzyme digestion was successful. 
However, the HTZ (lane 2) sample remained a smear 
pattern from ~ 100 – 45 kDa.  
The fact that the HTZ sample maintained a smear pattern phenotype in a second 
experiment would typically suggest this result was not a product of experimental 
error, but was indeed an accurate reflection of the nature of the GAGs in the sample. 
However, the disparity in the protein concentrations of the WT and NULL samples 
(both 1.67 μg/µl), compared to the HTZ (1.06 μg/µl), may have created an 
incomparable result if the enzyme was less efficient when SDS is more concentrated 
(i.e. when protein was less concentrated). To correct for the difference in protein 
concentration across the extracts, 95 μg of protein (in urea buffer) from each of the 
three samples were precipitated using methanol and chloroform as previously 
described. The samples were re-suspended in 1% SDS, and new protein 
concentrations were analyzed with Pierce BCA Protein Assay Kit. Table 5-9 below 
summarizes these protein concentrations. 
 
|---Endo β Gal---| 
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 WT HTZ NULL 
Protein 
Concentration 
1.98 μg/µl 1.73 μg/µl 1.56 μg/µl 
Table 5-9: Protein concentrations of samples re-suspended 
in 1% SDS. These samples were used in subsequent Endo β 
Gal experiments.  
 
Resulting protein concentrations tabulated above were more comparable to each 
other than those used in previous experiments. Therefore, a third Endo β Gal 
digestion was performed using the above samples.* When probed with 5D4, this 
third Endo β Gal digestion (Figure 5-8a, next page) showed labelling similar to that of 
the first Endo β Gal experiment (Figure 5-6), as four bands at ~62, 52, 50, and 27 kDa 
were identified in each of the three samples. When stripped and re-labelled for 
lumican, all three genotypes showed a condensed band at ~45 kDa (Figure 5-8b, on 
next page). The ~45 kDa band was observed in WT and NULL samples in all three 
Endo β Gal digestion experiments. This result aligned with published studies in 
which bovine (Funderburgh et al. 1990), avian (Jost et al. 1991), and murine 
(Funderburgh et al. 1995) corneal KS-PGs were digested with Endo β Gal. 
Interestingly, the HTZ sample only showed the dense ~45 kDa band in this third 
Endo β Gal digestion, likely because the HTZ sample was at a comparable 
concentration (1.73 μg/µl) to the WT and NULL (1.98 and 1.56 μg/µl, respectively) in 
the third experiment. Whereas, the HTZ sample was relatively dilute (~1 μg/µl, 
compared to 1.67 μg/µl in WT and NULL) when Endo β Gal failed to completely 
digest the HTZ KS-GAGs. Therefore, this third experiment is likely the most accurate 
reflection of the nature of the KS-GAGs in the HTZ sample. These results would 
suggest overall that there is not an appreciable difference in degree of galactose 
sulfation along KS-GAGs of the WT, HTZ, or NULL specimens.  
                                                        
* Untreated and PNGase F samples were also prepared to confirm results show in Figures 5-4 and 5-5. 
All lanes (3 untreated, 3 PNGase F, and 3 Endo β Gal) can be found in Appendix III, Figure A3-2.  
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5.4 Discussion 
Data collected in this chapter offer insight into the KS-GAG structure and lumican core 
protein production within B3gnt7-HTZ and –NULL specimens. Electrophoresis of 
untreated corneal extracts showed the WT and HTZ specimens contained elongated KS-
GAGs, whereas those in the NULL were much shorter. When lumican core proteins were 
separated from their N-linked side chains via PNGase F, all three samples showed the 
same low molecular weight, narrow band, indicating lumican production was not 
altered as a result of B3gnt7 mutation. Finally, when conditions for Endo β Gal were 
appropriate, all three samples showed similar molecular weight bands, thus 
demonstrating all three genotypes contained an unsulfated galactose residue at a 
similar location along the KS backbone where the Endo β Gal enzyme could cleave. 
GAGs released from Endo β Gal digestion could be further assayed to assess whether or 
not the WT and mutant KS-GAGs contained a comparable number of galactose sulfation 
sites along their backbones.  
                                         a.            5D4         b.  Anti-Lumican 
Figure 5-8: Third and final Endo β Gal assay. (a) 5D4 patterns appeared similar 
to previous experiments with bands at ~62, 52, 50, and 27 kDa. (b) Anti-lumican 
labelling showed all three samples were equally susceptible to Endo β Gal 
digestion, as comparable bands were produced at ~45 kDa by all three samples.  
|---Endo β Gal---| |---Endo β Gal---| 
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Because 5D4 recognizes the highly sulfated KS-GAG epitope, it was logical to select 5D4 
for analysis of KS chain length via Western blot. However, complications arose from 
using mouse 5D4 antibody on mouse corneal extracts. For example, when extracts were 
probed with 5D4, faint smear patterns and four dense bands appeared in untreated 
samples (Figure 5-4a). However, only the smear patterns and two bands could be 
explained by the literature: Smear patterns represented the range of KS-GAG chain 
lengths, and, as previously discussed in section 5.3.3, the 50 and 25 kDa signals were 
likely due to labelling of endogenous IgG heavy and light chain constituents. That leaves 
the appearance of bands at 60 and 48 kDa unique to the results collected here. In 
considering potential sources of this labelling, it could be reasoned that the remaining 
two bands were simply a combination of each KS core protein substituted with a single 
KS-GAG chain of average length. Specifically, keratocan and lumican both have a 
molecular weight of 37 kDa (Corpuz et al. 1996, Funderburgh et al. 1993), and, if they had 
a single average-length KS-GAG side chain of 21 kDa (Funderburgh et al. 1996), the 
combined molecular weight would appear at ~58 kDa. Therefore, the dense band 
labelled by 5D4 at 60 kDa in Figure 5-4a could be representative of the highly sulfated 
KS-GAGs linked to keratocan and lumican. Furthermore, mimecan, the third corneal KS 
core protein, has a molecular weight of 25 kDa (Funderburgh et al. 1997), and it would 
weigh ~46 kDa if it was substituted with a single average length KS-GAG. Therefore, the 
5D4 labelling at 48 kDa could be highly sulfated KS linked to mimecan core protein.  
While the hypothesis above is rational, it is unlikely for three reasons. First, if KS-GAGs 
linked to lumican were collecting at 60 kDa as hypothesized above, a similar band at 60 
kDa should visible in assays labelled with anti-lumican. However, untreated samples 
labelled for lumican showed even smear patterns (Figure 5-4b). Secondly, if the bands at 
60 and 48 kDa observed in untreated samples were representative of KS-PGs, their 
position should be susceptible to the glycosidases used in this chapter. However, when 
samples pre-treated with PNGase F were probed with 5D4, three of the four bands (60, 
48, and 25 kDa) remained in the same position as they were found in the untreated 
samples, albeit at slightly lower intensity (Figure 5-5a). Similarly, all four bands observed 
in the untreated samples were also evident in Endo β Gal-digested samples when 
labelled with 5D4 (Figures 5-6a, 5-8a). Third, it should be considered that Dunlevy et al. 
(1998) showed that three of five N-linkage sites within sequences of chick corneal 
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lumican and keratocan were occupied by KS-GAG side chains. The presence of three KS-
GAGs on a single core protein would markedly increase the proteoglycan molecular 
weight position in an electrophoretic gel. Therefore, it might be expected that higher 
molecular weight bands (or smears) would represent keratocan- and lumican-linked KS, 
rather than the discrete band at 60 kDa suggested above. In the case of mimecan, only 
one KS-GAG side chain has been reported to link to the core protein, so the possibility of 
a 48 kDa band containing KS-GAGs linked to mimecan remains. 
Perhaps KS chain length was more accurately analyzed by the anti-lumican antibody 
because the 5D4 antibody not only produces uncertain staining patterns, it also requires 
a minimum pentasulfated hexasaccharide in the KS-GAG chain to visualize these GAGs 
(Mehmet et al. 1986). Therefore, if the degree of sulfation or KS-chain length dropped 
below this minimum requirement as a result of the B3gnt7 mutation, it would have been 
undetectable by 5D4. However, anti-lumican does not require a specific GAG motif. 
Instead, labelling the core protein provided an unbiased way of determining KS-GAG 
length because molecular weight distribution of lumican is a direct result of its KS-GAG 
side chains. This was demonstrated in the experiments reported here when lumican took 
on a smear pattern appearance when left untreated (Figure 5-4b), but after cleavage of 
its KS-GAGs with PNGase F, it appeared as a narrow band in its known molecular weight 
position (Figure 5-5b). Detecting the position of lumican excludes analysis of those KS-
GAGs that modify keratocan and mimecan, however the majority of corneal KS is bound 
lumican (Funderburgh et al. 1991, Funderburgh et al. 1993). Additional experiments on 
the B3gnt7-NULL tissue using anti-keratocan and anti-mimecan could be performed to 
determine if similarly truncated KS-GAGs modify keratocan and mimecan. 
While valuable information was acquired from Western blot analysis of KS-GAGs and 
core proteins, one criticism of this technique is the lack of specificity of the data. To 
determine the exact number of repeat disaccharides comprising WT, HTZ, and NULL KS-
GAGs, a technique capable of carbohydrate identification and quantification should be 
used. High performance liquid chromatography (HPLC) is one such technique equipped 
with the capacity to separate and quantify specific structural components of a mixture, 
such as the corneal extracts studied here. The next chapter uses HPLC separation to 
quantify the KS- and CS/DS-GAG content of mutant and wild type mice. 
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5. CHAPTER 6 
6. Preliminary Analysis of Chondroitin Sulfate 
for Future Quantification of GAGs in WT 
and Mutant Corneas 
6.1 Introduction 
Electron microscopy, immunohistochemistry, and Western blot techniques used in 
previous experimental chapters provided a means to qualitatively assess GAG 
composition of the WT and mutant mouse corneas under investigation in this thesis. 
While those data are useful for visualizing GAG localization and relative abundance, 
characterization of the fine structure of CS and/or DS should be performed to 
determine the effect of interrupted KS biosynthesis on CS/DS expression. Specifically, 
the literature suggests the anomalous PGs observed in EM images of affected 
genotypes (Chst5-, Chst1/5-, and B3gnt7-null) are an oversulfated form of CS/DS-GAGs 
(Nakazawa et al. 1984, Plaas et al. 2001). Therefore, HPLC analysis of CS and DS 
populations isolated from mutant corneas can provide information on the relative 
abundance of differentially sulfated disaccharide units. Thus, an increase in overall 
sulfation of CS/DS can be quantified. The relative increase in peaks associated with 
oversulfated CS disaccharides in comparison to undersulfated peaks would provide 
evidence for the increase in sulfation in Chst5-, Chst1/5-, and B3gnt7-null mice 
corneas, compared to those of the wild type. Total GAGs were isolated from WT and 
mutant corneas and subjected to chondroitinase ABC treatment in order to produce 
the disaccharide units. These digested corneal extracts were planned to be analyzed 
by HPLC using reverse phase ion pairing chromatography coupled with post-column 
derivatization, the eluate of which can be analysed using the fluorometer. 
Before WT and mutant corneal extracts could be characterized in this way, however, 
experimental conditions had to be optimized using commercially available 
chondroitin sulfate standards. Optimization is achieved when chromatograms 
produced by the standards are reproducible in that their constituent peaks elute at a 
consistent retention times and their amplitudes (i.e. signal) correlate to 
concentration of the standard (i.e. increasing concentration of the standard results in 
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amplified signal). When these conditions are met, elution position and intensities of 
peaks produced by separation of corneal extracts can be compared to the profiles of 
standards to determine the presence or absence of various disaccharides in the 
experimental samples.  
In addition to HPLC analysis, a colorimetric assay that exploits the preferential 
binding of dimethylmethylene blue (DMMB) to sulfate groups along GAG chains 
(Farndale et al. 1982, Farndale et al. 1986) was conducted on WT and mutant corneal 
extracts. Both KS- and CS/DS-GAGs that are at least a tetrasaccharide in length are 
visible to DMMB, therefore the assay indicates the combined KS- and CS/DS-GAG 
content within the corneal extracts. These data are also presented and discussed 
here.  
6.1.1 Aims(and(Objectives(
1. Establish working methodology for fluorescent detection of disaccharides 
using HPLC separation of C0S (∆di-0S) standard. 
2. Apply chondroitinase ABC-digested C4S and C6S standards, and a 
commercially available C0S (∆di-0S) standard, to optimize an elution gradient 
that will resolve resultant ∆UA-GalNAc(4S) and ∆UA-GalNAc(6S) peaks. 
3. Conduct preliminary experiments using DMMB to quantify the total amount 
of sulfated GAG content in WT and mutant corneal extracts.  
6.2 Methods  
These experiments were conducted at the University of Cincinnati, where I travelled 
to collaborate with Drs. Vivien Coulson-Thomas and Tarsis Gesteira.  
6.2.1 Specimens(and(CS(Standards(
Dr. Tomoya Akama kindly provided all mouse corneal tissue used in this chapter. 
Details of the animals used for this study are tabulated below (Table 6-1). Corneas 
were isolated, snap frozen, and shipped on dry ice from Kansai Medical University to 
University of Cincinnati, where they were stored at -80°C until they were extracted as 
described in the next section.  
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Genotype Sex Age (weeks) n (corneas) 
WT Male 11 2 
Chst1-null Female 30 2 
Chst5-null Male 26 2 
Chst1/5-null Female 21 1 
B3gnt7-null Male 13 2 
Table 6-1: Details (sex, age, and number) of corneal tissue used for DMMB assay. 
 
Commercially available CS standards were used to optimize the HPLC protocol. C0S, 
C4S, and C6S standards were purchased from Sigma Aldrich (catalogue numbers: 
C3920, C9819, and C4384, respectively). Whereas the C0S standard was comprised of 
Δdi-0S (ΔUA-GalNAc) disaccharides (Nakamichi et al. 2011, Solakyildirim et al. 2010), 
the C4S and C6S standards were polysaccharide chains that required chondroitinase 
ABC predigestion to generate disaccharides prior to HPLC separation (see section 
6.2.3).  
6.2.2 GAG(Extraction(
Prior to my arrival in Cincinnati, my colleague Dr. Vivien Coulson-Thomas prepared 
GAG extracts from the above tissue according to procedures described in Coulson-
Thomas et al. 2015. First, both corneas from a single mouse were immersed in 4 M 
guanidine hydrochloride (GuHCl) containing 0.05 M sodium acetate (NaOAc), pH 6. 
While in solution, dissecting scissors were used to thoroughly mince tissue for ~2 
minutes. Samples were then placed on a rotator and allowed to incubate overnight 
at 4°C. After 24 hours of incubation, samples were centrifuged at 2,500 RPM for 5 
minutes, and the supernatant was collected and stored at 4°C for future use. The 
pellets were re-suspended in the GuHCl-NaOAc solution described above, further 
minced using scissors, and replaced on a rotator for an additional 24 hour incubation 
at 4°C. This process was repeated a third time, however, instead of collecting the 
supernatant following centrifugation, an equal volume of 7 M urea was added to the 
mixture, and the samples were again incubated on a rotator at 4°C for 24 hours. Once 
centrifuged, supernatants were pooled and concentrated by three sequential 
centrifugation steps performed at 3000 g for 40 minutes each using centrifugal filter 
devices. Water was used to replace the volume of solution that passed through the 
filter, thus desalinizing the extracts.  
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6.2.3 Chondroitinase(ABC(Digestion(
Chondroitinase ABC was used to digest corneal extracts and C4S/C6S standards into 
their constituent disaccharides. First, 100 mg of C4S and C6S standards was dissolved 
in 10 ml distilled water (10 mg/ml). Next, 1 U (100 µl) chondroitinase ABC were added 
to 100 µl of each extract or CS standard solution. Finally, chondroitinase ABC was 
activated by addition of 300 µl 0.1 NaOAc buffer (pH: 8.0). Standards and extracts 
incubated overnight at 37°C for a minimum of 24 hours.  
6.2.4 High(Performance(Liquid(Chromatography((
All HPLC experiments were carried out on a Dionex UltiMATE 3000 HPLC system 
fitted with a Dionex CarboPac PA1 column (4 x 250 mm), which was maintained at 
50°C during experimentation. Running buffer contained 1.2 mM 
tetrabutylammonium (TBA) with 8.5% acetonitrile (AcN) and was applied to the 
column at a flow rate of 1.1 ml/min. The elution buffer contained 137 or 200 mM 
NaCl in addition to 1.2 mM TBA and 8.5% AcN. Elution gradient conditions for each 
experiment are represented as dotted lines on their respective chromatograms.  
Chondroitinase ABC digestion of CS standards generates C4S and C6S disaccharides 
that contain a 4,5-unsaturated uronic acid residue (Figure 6-1) (Michelacci et al. 1987). 
Since this double bond absorbs light in the UV range, detection of the disaccharides 
was achieved by irradiating samples with 204 nm UV light (Seldin et al. 1984, Chai et 
al. 1996, Koshiishi et al. 1998, Koshiishi et al. 1999, Lauder et al. 2000).  
Disaccharides were also detected using post-column derivatization and fluorescence 
detection because this method is more sensitive than the UV detection described 
above (Honda et al. 1980, Deakin and Lyon 2008). Fluorescence labelling was carried 
out at 125°C in a post-column reactor. Following UV detection, the disaccharide-
containing eluate was mixed with a 1:1 mixture of 1% 2-cyanoacetamide and 1% 
NaOH at a flow rate of 0.35 µl/min (Toyoda et al. 1999). The fluorophore-labelled 
disaccharides then travelled into the fluorometer, where excitation and emission 
wavelengths were set to 346 and 410 nm, respectively (Staatz 2001).  
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Figure 6-1: (a) General structure of disaccharides generated 
by digestion of CS-GAGs with chondroitinase ABC. A black 
arrow indicates the double bond (i.e. 4,5 unsaturation) that 
enables disaccharides to be detected by UV absorbance. (b) 
Unsulfated (∆UA-GalNAc) and singly sulfated (∆UA-
GalNAc4S, ∆UA-GalNAc6S) disaccharides are differentiated 
by the location of sulfate moieties. Adapted from 
Solakyildirim et al. 2010 and reproduced with permission from 
the copyright holder, Elsevier (License No: 3870250525212). 
  
6.2.5 Dimethylmethylene(Blue(Detection(of(GAGs(
GAG content of WT and mutant corneal extracts was investigated via 
dimethylmethylene blue (DMMB), a colorimetric reagent that binds sulfation 
moieties on GAGs (Farndale et al. 1982, Farndale et al. 1986). DMMB requires GAGs to 
be at least four monosaccharides in length to be detected, so this assay was 
conducted on desalinized WT and mutant extracts prior to chondroitinase ABC 
digestion. DMMB was prepared fresh as described in Table 6-2 (Coulson-Thomas and 
Gesteira 2014):  
Reagent Quantity 
DMMB 16 mg 
Glycine 3.04 g 
NaCl 1.6 g 
0.1 M Acetic Acid 95 ml 
Distilled water to make 1 L (~905 ml) 
Stored in foil-wrapped bottle at room temp. 
Table 6-2: Recipe for DMMB reagent used for colorimetric assay.  
 
Following preparation of the DMMB reagent, C4S and C6S standard solutions were 
prepared in distilled water at 500 μg/ml (C0S ∆di-disaccharides were not used in this 
a. 
b. 
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assay because DMMB requires at least a tetrasaccharide for detection). Dilutions were 
made using distilled water such that the total GAG content in each well ranged from 
0 – 10 μg and equalled 20 µl in volume. WT and mutant corneal extracts, along with 
each concentration of the C4S and C6S standards, were pipetted into a 96 well plate 
(20 µl each), and 200 µl of the DMMB reagent was added to each sample-containing 
well. The plate was shaken briefly, and absorbance was measured using a microplate 
reader equipped with a 540 nm filter within 5 minutes of DMMB addition.  
6.3 Results  
6.3.1 HPLC(Separation(of(CS(Standards(
A number of experimental conditions were modified to separate CS standards during 
data collection for this chapter. These variables included post-column coupling 
conditions, NaCl gradient duration and rate, and quantity (μg) of sample injected 
into the column. Figure 6-2 below summarizes the optimization experiments 
performed in this chapter.  
 
Figure 6-2: Summary of HPLC optimization. Fluorophore coupling was optimized using 
C0S standards. C4S and C6S peaks were inadequately separated in early trials. Following 
adjustment of NaCl gradient settings, NaCl concentration, and volume of each sample 
injected, C4S and C6S standards showed distinct peaks and therefore adequate separation. 
At the time of writing, HPLC experiments on WT and mutant mouse corneas were ongoing. 
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First, C0S disaccharides were tested to determine if experimental conditions were 
suitable for post-column fluorophore coupling. The uncharged nature of C0S 
disaccharides means they interact weakly with the stationary phase, resulting in 
relatively short elution times compared to sulfated alternatives, such as C4S or C6S. 
Figure 6-3 shows chromatograms of this trial produced by UV and subsequent 
fluorescent detection of the same C0S sample. 
 
  
 
The resemblance of the C0S profile above to previously reported C0S standards 
(Solakyildirim et al. 2010, Staatz 2001), in addition to the enhanced detection of the 
post-column labeled disaccharides, implied experimental conditions were 
appropriate for fluorophore coupling and fluorescent disaccharide detection. These 
coupling conditions were therefore used for coupling of C4S and C6S standards to 
fluorophores in subsequent experiments. From this point on, only fluorescence 
chromatograms are shown and discussed because the quantity of injected sample 
c. 
a. b. 
Figure 6-3: UV and fluorescence HPLC 
chromatograms of C0S. UV (a) and post-
column fluorescent (b) detection showed 
a single sharp peak at ~2 minutes prior to 
the introduction of the NaCl gradient. 
Fluorescence detection produced ~29 
mAU of signal. (c) UV and fluorescence 
chromagtograms are overlaid and scaled 
along the same y-axis. 
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was too low for UV detection. This was a strategic decision to preserve as much of 
our limited samples volumes as possible. 
Using the post-column coupling conditions established above, a subsequent 
experiment aimed to separate C4S and C6S standards using a linear gradient of 
elution buffer that contained 137 mM NaCl, which is represented by the black dotted 
line in Figure 6-4.  
 
 
Figure 6-4: Chromatograms from C0S, C4S, and C6S standards. (a) C0S showed a 
single 80 mAU peak at 5 minutes (~20 mM NaCl). (b) C4S showed four peaks at ~2, 
5, 23, and 27 minutes (~10, 20, 95 and 0 mM NaCl) with 11, 40, 45, and 41 mAU 
intensities, respectively. (c) Four peaks were also present in the C6S standard 
chromatogram at ~2, 5, 23, and 27 minutes (~10, 20, 95 and 0 mM NaCl) with 9, 40, 
50, and 18 mAU amplitudes. (d) Overlaying the chromatograms showed that the 
C0S peak coincided with peak 2 of C4S and C6S profiles. Additionally, peaks 3 and 4 
in C4S and C6S samples eluted at similar times, indicating the presence of common 
disaccharides in the two standards.  
 
Overlaying C0S, C4S, C6S chromatograms in Figure 6-4d showed that the only peak 
present in the C0S sample corresponded to peak 2 of C4S and C6S samples, implying 
a presence of C0S in the C4S and C6S standards. This is not unreasonable to 
conclude, given that commercially available C4S/C6S standards are not purely C4S or 
1 
2 
3 
4 
1 
2 
3 
4 
a. b. 
c. d. 
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C6S. Rather, they are CS polysaccharides that are digested into constituent 
disaccharides via cleavage with chondroitinase ABC. Therefore, it is expected that  
C4S and C6S standards would contain both ∆UA-GalNAc4S and ∆UA-GalNAc6S 
disaccharides. What differentiates these standards from one another is the ratio of 
∆UA-GalNAc4S and ∆UA-GalNAc6S, which was 1:3 and 2:3 for the C6S and C4S 
polysaccharide standards, respectively, per the manufacturer-provided Certificate of 
Analysis for C4S and C6S standards. However, since peaks 3 and 4 in the C4S and C6S 
samples were incompletely separated, further optimization was required to visualize 
this ratio. To facilitate separation of C4S and C6S peaks, the elution buffer NaCl  
 
 
Figure 6-5: Chromatograms of CS standards. (a) C0S showed 5 peaks in total. Peak 
1 eluted at 8 minutes (~60 mM NaCl). Peaks 2 – 5 appeared despite their absence in 
each of the previous C0S profiles. (b) The C4S sample showed three peaks at ~7, 12, 
and 16 minutes (~60, 90, and 110 mM NaCl, respectively), which reached 1.3, 2.3, 
and 3.4 mAU, respectively. (c) Three peaks eluted from the C6S sample, which 
correlated to the elution times of peaks 1 – 3 in the C4S sample. Amplitudes of C6S 
peaks 1 – 3 reached ~ baseline, 2 mAU, and 15 mAU levels, respectively. (d) 
Overlaying C0S, C4S, and C6S chromatograms showed the alignment of C0S peak 1 
with C4S and C6S peak 1; the elution times of peaks 2 and 3 of C4S and C6S also 
appeared to coincide.  
 
1 
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3 
a. b. 
c. d. 
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concentration was increased to 200 mM. Additionally, the NaCl gradient was applied 
more gradually, and the sample injection volumes were reduced (Figure 6-5). 
The patterns of peaks observed in the C0S, C4S, and C6S samples in Figure 6-5a-c 
aligned with published literature in peak number, order, and relative amplitude. 
Specifically, since the C0S sample was a Δdi-0S standard, it was expected that only a 
single peak would arise from unsulfated GlcA-GalNAc disaccharides. Since C4S and 
C6S standards were polysaccharides digested with chondroitinase ABC (as opposed 
to Δdi-4S/Δdi-6S standards), it is unsurprising that three peaks appear. Peak 1 in C4S 
and C6S samples corresponded to the C0S peak, suggesting the presence of 
unsulfated ∆UA-GalNAc disaccharides in the ABC-digested standards (Figure 6-5d). 
C6S has been reported to elute before C4S in mixtures of GAGs (Solakyildirim et al. 
2010, Toyoda et al. 1991), indicating that ∆UA-GalNAc(6S) disaccharides are 
responsible for peak 2, leaving peak 3 to represent ∆UA-GalNAc(4S). 
 
Due to time limitations of my placement in Cincinnati, WT and mutant mouse 
corneal extracts were not analyzed using HPLC at the time of writing. However, the 
data above represent valuable optimization and method development experiments 
that will contribute to future elucidation of mutant corneal disaccharide 
composition. Although there was not enough time for HPLC analysis of WT and 
mutant corneal tissue, there was an opportunity to conduct preliminary experiments 
on total GAG content of those corneas using DMMB. Those data are shown in the 
next section. 
6.3.2 DMMB(Assessment(of(GAGs(in(WT(and(Mutant(Corneas(
Six concentrations (0, 62.5, 125, 250, 375, and 500 μg/ml) of C4S and C6S standards 
were used to create the standard curve shown in Figure 6-6. Each point on the 
scatter plot represents a single absorbance measurement taken from a single CS-
containing well. DMMB is sensitive to sulfated GAGs that are tetrasaccharides or 
longer and contain between ~0.5 – 3 μg total GAG content (Mort and Roughley 2007, 
Coulson-Thomas and Gesteira, 2014). The concentrations above equated to 0, 1.25, 
2.5, 5, 7.5, and 10 μg, respectively, so it was expected that the upper concentrations 
would reach saturation. The plot below shows the first three points within the linear 
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portion of the curve, and the absorbance of the final three points levelling off 
because they reached the upper limit of DMMB sensitivity.  
The straight lines passing through the first three sets of data points represent a 
regression line. Their equations can be found in the legend at the lower right hand 
corner of the graph. R2 values for the C4S and C6S standard curves were 0.9872 and 
0.9844, and thus allowed the calculation of GAG concentration in WT and mutant 
corneal extracts. Those values are reported in Figure 6-7. 
 
 
Figure 6-6: Standard curve used in DMMB analysis. Triplicate 
absorbance measurements were collected from the six C4S (gold) and 
C6S (purple) concentrations used to generate standard curves. Since the 
250, 375, and 500 μg/ml samples reached the upper limit of DMMB 
sensitivity, a regression line was only fit through the linear portion of 
the data (straight lines through 0, 62.5, 125 μg/ml data points). R2 values 
and equations used for calculating GAG content in WT and mutant 
corneal extracts are listed in the legend above.   
 
GAG content was calculated for WT and mutant corneal extracts using C4S (gold) and 
C6S (purple) standards. To reiterate, the mutant corneas tested were of the Chst1, 
Chst5, Chst1/5, and B3gnt7 genotypes. Calculating GAG concentrations from the C4S 
standard curve gave values slightly lower than when using the C6S standard curve. 
However, the relative relationship of GAG concentration across genotypes was the 
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same. For example, in both sets of data, the Chst5 corneal extract contained the 
lowest concentration of sulfated GAGs (5.29 and 7.94 µg/ml), whereas the B3gnt7 
sample had the highest concentration of sulfated GAGs (22.92 and 29.76 µg/ml). 
Because the values above do not exclusively reflect sulfated KS- or CS/DS-GAGs, it is 
impossible to tell from the current data set the quantity of absorbance that arose 
from KS sulfation compared to CS/DS sulfation. That said, data in the literature 
(Hayashida et al. 2006) and in the previous three chapters suggest that KS-GAGs are 
truncated and lack sulfation in affected genotypes above, rendering them 
undetectable by DMMB. By extension, the concentrations reported for the Chst5-, 
Chst1/5, and B3gnt7 samples in Figure 6-7 should only represent sulfated CS/DS-
GAGs. The dissimilarity between GAG concentrations in the three affected genotypes 
therefore implies that the degree of CS/DS compensation varies depending on which 
sulfotransferase/glycosyltransferase is mutated. The above assay should be repeated 
to confirm results shown in Figure 6-7, as the limited sample volume available for 
testing here only allowed a single measurement (hence the absence of standard 
deviations and statistical testing of data in Figure 6-7). In addition, finer steps in the 
linear region of the standard curve should be added to ensure accuracy of calculated 
unknown GAG concentrations.  
6.4 Discussion 
HPLC and DMMB data collected in this chapter represent preliminary studies that lay 
the foundation for future work. In HPLC experiments, chromatograms of C0S, C4S, 
and C6S standards sufficiently separated when the sample injection volume was 
reduced and the NaCl concentration in the elution buffer was increased. That said, 
the use of a mixture containing known concentrations of ∆di-0S, ∆di-4S, and ∆di-6S 
standards should be used for further optimization in future experiments. This would 
make the peaks created from C4S and C6S easily discernible and would circumvent 
the need to rely on ratios of C4S to C6S in digested polysaccharide standards.  
Using the elution profiles of the standards acquired in this chapter for reference, 
many additional experiments could be performed to further characterize GAG 
profiles of WT and mutant corneas. The initial intent of undertaking this technique 
was to determine the 
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Figure 6-7: DMMB analysis of WT and mutant corneal extracts. GAG content 
was calculated for WT and mutant corneal extracts based on the C4S (gold) and 
C6S (purple) standard curves in shown Figure 6-6. The two standards provided 
slightly different values for GAG concentration in each genotype, however the 
relative relationship of GAG content across genotypes remained constant.  
 
nature of the anomalous CS/DS-GAGs observed in electron micrographs of affected 
genotypes. If the anomalous PGs are oversulfated CS/DS-GAGs as predicted, affected 
genotypes should show additional peaks later in the chromatogram (i.e. after the 
elution of C4S and C6S disaccharides), which could represent the presence of 
oversulfated CS/DS-GAGs (∆UA-GalNAc4S6S, UA2S-GalNAc4S, ∆UA2S-GalNAc6S, or 
∆UA2S-GalNAc4S6S). Or, if peaks indicating the presence of oversulfated CS/DS-
GAGs are observable in unaffected genotypes, the amplitude of these peaks is 
hypothesized to increase in affected genotypes. Should the oversulfated peaks 
remain elusive in the WT and mutant corneal samples in future experiments, 
heightened ∆UA-GalNAc(4S) and/or ∆UA-GalNAc(6S) peaks would be expected. 
Indeed, Plaas et al. 2001 showed an increase these disaccharides in human MCD 
corneas using fluorophore-assisted carbohydrate electrophoresis (FACE), the 
phenotype of which closely resembles the affected mouse models under study here. 
Furthermore, Toyoda et al. (1991) described a method to quantify the concentration 
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of CS disaccharides in a biological sample using a calibration curve created with CS 
standards. The integrated area of disaccharide peaks produced by the standards 
could be correlated to their known concentrations, thus allowing the calculation of 
disaccharide concentration in the biological sample. Finally, in future experiments, 
corneal extracts could be pre-treated with various sulfatases prior to HPLC separation 
similar to previously published studies (Murata and Yokoyama 1985, Murata et al. 
1987). For example, chondroitin 6 sulfatase specifically attacks the sulfate moiety 
along C6S GAGs (Yamagata et al. 1968), thus creating additional ∆UA-GalNAc 
disaccharides following digestion of the desulfated GAG with chondroitinase ABC. 
Therefore, theoretically, a ∆UA-GalNAc6S peak that would normally be present in 
corneal extracts would disappear, and a coincident increase in the ∆UA-GalNAc peak 
would be observed, providing further evidence the initial peak was indeed ∆UA-
GalNAc6S. Similarly, those peaks representing oversulfated CS would shift following 
incubation with C6S sulfatase, allowing the elucidation of the fine structure of CS-
GAGs in the WT and mutants. The same experiments could be performed using C4S 
sulfatase (Yamagata et al. 1968) and GlcA(2S) sulfatase (Shaklee et al. 1985).  
In addition to HPLC analysis, the ability of DMMB to complex with sulfation sites 
along KS- and CS/DS-GAGs and induce metachromasia measurable by 
spectrophotometry provides an alternative means to measure total sulfated GAG 
content. To differentiate between absorbance caused by dyed KS-GAGs versus 
CS/DS-GAGs, enzymatic predigestion with either keratanase or chondroitinase ABC is 
required to cleave KS- or CS/DS-GAGs into units smaller than tetrasaccharides, 
thereby rendering them invisible to DMMB. Concentration values acquired from 
intact extracts could be compared to those collected from samples where KS or 
CS/DS has been digested to determine the ratio of sulfated KS to sulfated CS/DS in 
WT and mutant corneas (Farndale et al. 1986). Furthermore, results collected from the 
DMMB assays could be supplemented with microassays using anthrone and 
carbazole, which allow colorimetric detection of hexoses and hexuronic acids, 
respectively (Bebault and Pearce 1991, Cesaretti 2003, Mort and Roughley 2007, 
Coulson-Thomas and Gesteira 2014). Detection of galactoses in KS-GAGs should 
match those values produced by DMMB with chondroitinase ABC preincubation. 
Similarly, detection of iduronic and glucuronic acids by the carbazaole reaction in 
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CS/DS-GAGs should mirror those results of the DMMB assay coupled with keratanase 
predigestion. It should be noted that Plaas and colleagues (2001) showed human 
MCD corneas contained hyaluronan, which was not present in healthy human 
corneas. If hyaluronan is also present in mutant mouse corneas, its glucuronic acid 
content would be inseparable from CS/DS-derived uronic acids in the carbazole 
reaction result. Therefore, HPLC experiments described above should include 
hyaluronic acid standards to investigate whether mutant corneas contain 
hyaluronan, and this should be considered before interpreting carbazole reaction 
results.  
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6. CHAPTER 7 
7. General Discussion 
7.1 Summary 
The overarching aim of this work was to characterize corneal morphology and GAG 
content of recently developed Chst1-, Chst5-, Chst1/5-, and B3gnt7-null mice. These 
genetic defects were hypothesized to affect synthesis of corneal KS-GAGs, as each of 
the mentioned genes encodes a sulfo- or glycosyltransferase involved in KS 
biosynthesis.  
In Chapter 3, electron micrographs of these mutants suggested that the absence of 
CGn6ST (in the Chst5-, Chst1/5-null mice) or β3GnT7 (in B3gnt7-null mice) generated a 
corneal phenotype devoid of discernible KS-GAGs, and concurrently showed an 
atypically branched, elongated family of PGs, which were susceptible to 
chondroitinase ABC. Electron microscopy results collected from these affected 
genotypes differed from the WT and Chst1-null (i.e. unaffected) mouse corneas, 
which showed comparable levels of short- and long-chain PGs that were thought to 
be KS- and CS/DS-PGs, respectively.  
Immunohistochemistry experiments in Chapter 4 using the 1B4 antibody confirmed 
the absence of sulfated KS-GAGs from the corneal stroma of affected genotypes, 
whereas unaffected genotypes showed either punctate (Chst1-null) or punctate and 
widespread (WT) KS localization. When corneal sections were immunolabelled for 
epitopes of CS/DS-GAGs, results were inconclusive. An increased level of fluorescence 
was expected in affected genotypes, but fluorescent signal fluctuated from one 
experiment to the next, implying this method was not sensitive enough to detect the 
changes in PG composition observed in electron micrographs.  
Chapter 5 Western blot data collected from B3gnt7-null corneas implied that KS-
GAGs in this genotype were shorter than those isolated from the WT or B3gnt7-HTZ 
mice. Despite this difference in length of KS-GAGs, production of lumican was 
unchanged by B3gnt7 mutation. 
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To quantify the CS/DS disaccharides in WT and mutant corneal tissue and further 
characterize their fine structure, RPIP-HPLC experiments were conducted in Chapter 
6. However, the limited amount of time allowed for these experiments resulted in 
collection of only preliminary data on CS standards. Chapter 6 data instead served as 
a basis for future experiments. Continuing the HPLC data collection is a top priority in 
identifying the nature of CS/DS-GAGs in the mutants. It is of specific interest to know 
whether the mutants contain increased content of CS/DS-GAGs and if they are in an 
oversulfated form. 
While both electron microscopy and immunohistochemical results suggested a loss 
of KS-GAGs from the corneal tissue of affected genotypes, both the cupromeronic 
blue stain and 1B4 antibody used to detect KS-GAGs were dependent on the 
presence of sulfation moieties. Therefore, the current data do not address whether or 
not KS-GAGs remain in the tissue in their unsulfated form (i.e. as poly-N-
acetyllactosamine). Young et al. 2007 used an antibody specific to unsulfated KS in 
immunogold electron microscopy experiments to show the presence of poly-N-
acetyllactosamine in MCD corneal tissue. This so-called “anti-i” antibody should be 
applied to the mutant tissue here—by either immunogold electron microscopy or 
immunohistochemistry experiments—to determine if the mutant tissue similarly 
contained poly-N-acetyllactosamine within the corneal stroma. The presence of 
unsulfated KS-GAGs in affected murine genotypes (i.e. Chst5-, Chst1/5-, and B3gnt7-
null mice) would suggest that elongation of the KS backbone could proceed 
independent of sulfotransferase activity. Western blot data in Chapter 6 would 
suggest this is not the case because B3gnt7-null tissue stained for lumican generated 
a more narrow, lower molecular weight smear pattern than the WT control. Thus, 
elongated poly-N-acetyllactosamine chains were likely not substituted on lumican 
core proteins. Nevertheless, the application of anti-i to mutant corneal tissue would 
clarify if GAGs invisible to the sulfation-dependent staining methods used here 
indeed remained following mutation of KS biosynthetic enzymes.  
In addition assaying for unsulfated KS, a number of experiments could be performed 
to complement the findings of this thesis. First, the identity of the putative KS-PGs in 
EM images could be confirmed by incubating corneal tissue with keratanase prior to 
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EM processing. The disappearance of the small PGs following keratanase digestion 
would further suggest those PGs are indeed KS in nature. To further understand the 
structural implications of KS biosynthetic pathway mutations, x-ray diffraction could 
be performed on the mutant mice. These data would inform on the organization of 
collagen fibrils, including their interfibrillar spacing and fibril diameters. Given that 
the Chst5-null mouse showed reduced interfibrillar spacing and decreased fibril 
diameters in previous work (Hayashida et al. 2006), it is hypothesized that the 
Chst1/5-null and B3gnt-null would show similar traits. However, the Chst1-null may 
not mirror this phenotype, given KS-PGs were present at similar levels to the WT in 
EM images.  
A more thorough discussion of each of the above experiments and their implications 
can be found in their respective chapters. The next two sections will discuss themes 
of this work that have not yet been addressed, including corneal transparency and 
the possibility of feedback regulation of corneal GAG synthesis.  
7.2 Transparency and the Human MCD Phenotype 
Perhaps the most relevant question this thesis did not experimentally address is 
whether or not the affected mutant mouse corneas remained transparent, despite 
their KS malformation. No apparent clouding was seen during gross observation and 
handling of the mouse corneas during experimentation. However, this could be 
explored in detail using a slit lamp (Chakravarti et al. 1998) or in vivo confocal 
microscopy (Chakravarti et al. 2000). Given the stromal phenotype of affected mouse 
corneas closely models that of human MCD tissue, the grossly intact corneal 
transparency in these mice was surprising. An argument could be made that the 
murine tissue used in these studies was not sufficiently aged to see the hazy 
phenotype that is a hallmark of human MCD. Onset of clinical MCD symptoms has 
been reported anywhere from childhood to the sixth decade of life, although opacity 
formation typically becomes apparent during adolescence (Klintworth 2009). The 11-
20 week old mice used in EM studies in Chapter 3 approximately equates to early 
adulthood in humans (The Jackson Laboratory 2016), implying they should be of 
sufficient age to demonstrate the deleterious effects caused by abnormally formed 
KS-PGs. However, the disparity in KS content between humans and mice should be 
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considered. KS-GAGs are thought to be twice as concentrated as CS/DS-GAGs in 
human corneas (Plaas et al. 2001). Conversely, reduced corneal thickness, thus 
increased stromal oxygen availability, generates an extracellular topography 
relatively poor in highly sulfated KS-GAGs in the murine cornea (Scott and Haigh 
1988). This intrinsically lower KS to CS/DS ratio implies the effect of abnormally 
formed KS-PGs may be less traumatic on overall corneal organization in lower 
mammals like mice, compared to humans. Additionally, the oversulfated CS/DS-PGs 
previously reported (Hayashida et al. 2006, Parfitt et al. 2011) and observed in Chapter 
3 may be more effective at compensating for lost KS-GAGs in mice, where the CS/DS-
GAGs are relied upon more for corneal organization compared to humans.  
Because KS-GAGs do not seem to be critical for transparency in mice, it should be 
considered whether or not the primary function of KS-GAGs is maintaining corneal 
organization to promote transparency. Perhaps the loss of transparency observed in 
humans in MCD is instead a secondary effect of defunct KS biosynthesis. Currently, 
there is evidence to suggest that GAGs, including CS/DS and KS, play an integral role 
in guiding corneal innervation during development. Both CS/DS- and KS-GAGs have 
been shown to be inhibitory on nerve outgrowth, CS/DS more strongly inhibitory 
than KS (Schwend et al. 2012).  The same study revealed that CS/DS-GAGs encourage 
the fasciculation of neurites, whereas KS-GAGs promote defasciculation of nerves 
into fine branches (Schwend et al. 2012). The mutant mice under study in this thesis 
may therefore contain a substantively different nerve pattern as a result of the 
differential proteoglycan phenotypes discovered in the current work. The 
upregulation of CS/DS-GAGs and the concurrent downregulation of KS-GAGs in the 
Chst5-, Chst1/5-, B3gnt7-null corneal tissue may mean that nerves reaching the cornea 
do no properly bifurcate, resulting in atypically unbranched corneal neurites, and 
perhaps decreased corneal sensitivity.  
7.3 Feedback Mechanisms May Regulate Biosynthesis of 
Corneal GAGs 
If KS synthesis is to be understood in a way that is conducive to manipulation in 
pathological cases where its synthesis is too little or too great for normal 
physiological function, the next most important set of experiments should aim to 
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determine the exact mechanism through which compensation for a loss of KS is 
achieved in the knockout tissue or cells under discussion.  
Much research shows that both N-linked glycans (such as KS) and O-linked glycans 
(such as CS/DS) are processed in the Golgi apparatus. In fact, it has been shown that 
these biosynthesis events occur in tandem and even inside the same medial and 
trans vesicles of the Golgi complex (Ratcliffe et al. 1985; Silbert and Sugumaran 2002). 
The spatiotemporal overlap of N- and O-linked biosynthesis events implies there is 
opportunity for one process to influence the other. Indeed, glycosyltransferases have 
been reported as susceptible to topographical cues, including the presence/absence 
of other glycosyltransferases. For example, the β-1,3-N-acetylglucosaminyltransferase 
(β3GnT) family has a total of eight members, and when two of them (β3GnT2 and 
β3GnT8) are present during N-linked processing of poly-N-acetyllactosamine chains 
in human promyelocytic leukemia (HL-60) cells, they form a heterodimer with each 
other that is significantly more efficient at producing poly-N-acetyllactosamine than 
either β3GnT2 or β3GnT8 alone (Seko and Yamashita 2008). If certain combinations 
of glycosyltransferases can encourage the action of one another, perhaps an 
inhibitory relationship between other glycosyltransferase or sulfotransferase 
combinations exists. This could be the case between the β3GnT7 enzyme explored 
here and glycosyltranferases that build CS/DS-GAGs. In other words, perhaps the 
action of CS/DS building enzymes is uninhibited in the absence of β3GnT7, thus 
allowing the production of CS/DS to reach its full potential.  
In considering alternative pathways through which feedback could occur, the 
availability of nucleotide sugar donors and the functionality of their respective 
translocating proteins should be taken into account. Nucleotide sugar transporters 
(NSTs) are transmembranous protein complexes that serve to recruit uridine 
diphosphate-bound sugars from the cytosol, where they are formed, to the lumen of 
vesicles such as the endoplasmic reticulum and Golgi apparatus, where they are used 
for biosynthesis of various polysaccharides (both N- and O-linked). The mechanism 
that powers these NSTs depends on the hydrolysis of uridine diphosphate (UDP) to 
uridine monophosphate and inorganic phosphate (UMP + Pi) following transfer of 
each sugar to its respective substrate. It is thought that the UMP + Pi byproduct 
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within the Golgi is traded for additional UDP-sugar donors in the cytoplasm in an 
antiport fashion via NSTs to continue polysaccharide synthesis (Handford et al. 2006). 
A nucleotide is comprised of nitrogenous base, a pentose sugar, and at least one 
phosphate group (Lodish 2013). In the case of KS nucleotide sugar donors, uracil is 
the nitrogenous base, the pentose is ribose, and two phosphate groups are present 
(pyrophosphate), making each sugar donor uridine diphosphate-N-
acetylglucosamine or -galactose, commonly abbreviated as UDP-GlcNAc/-galactose. 
For reference, adapted figures depicting these sugar donors are shown below with 
the nitrogenous base noted in pink, the pentose in orange, the phosphate in green, 
and the monosaccharide in blue (Figure 7-1).  
Because the biosynthesis of GAG side chains depends on the availability of these 
sugar donors, this could be a logical place in the GAG “assembly line” for a feedback 
mechanism. In fact, one such mechanism has been described in rat liver endoplasmic 
reticulum (ER), where UDP-GlcNAc inside the ER lumen encourages influx of GlcA for 
glucuronidation (i.e. the addition of UDP-GlcA to its substrate). Bossuyt and Blanckert 
(1995) showed that UMP within the ER could be traded for cytosolic UDP-GlcNAc via 
NST action. From there, their work confirmed that once inside, intravesicular UDP-
GlcNAc could be traded out of the ER to recruit additional UDP-GlcA from the cytosol, 
thereby encouraging glucuronidation. Follow up studies by Muraoka and colleagues  
(2007) showed that the NST described by Bossuyt and Blanckert was not limited to 
recruitment of GlcA. Rather, this NST, termed UGTrel7 (Muraoka et al. 2001, Muraoka 
et al. 2007) and later SLC35D1 (Hiraoka et al. 2007), could antiport luminal UDP- 
GlcNAc for both UDP-GlcA and UDP-GalNAc. The implications of this NST in synthesis 
of CS/DS-GAGs was not overlooked, as that same year an Slc35d1-null mouse was 
developed—the phenotype of which confirmed UGTrel7/SLC35D1 to be the 
gatekeeper for nucleotide sugar donors that are eventually incorporated into CS/DS-
GAGs in cartilage and bone (Hiraoka et al. 2007). Activity of SLC35D1 has not to date 
been assessed in the cornea, so whether or not this NST is typically active, or it is 
reserved to cope with stress remains unknown. 
The above mechanism is particularly relevant to this thesis, because the same UDP-
sugar donors are at play. In WT keratocytes, UDP-GlcNAc would theoretically be  
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Figure 7-1: Chemical structures of UDP-GlcNAc (a) and UDP-
galactose (b). Uracil (labelled in pink), ribose (orange), and 
pyrophosphate (green) are common to both structures and are 
collectively referred to as uridine diphosphate (UDP). Respective 
monosaccharides are labelled in blue. Adapted from Edgar181 2009, 
NEUROtiker 2007, copyright restrictions do not apply. 
 
imported into the Golgi, β3GnT7 would add GlcNAc to the growing KS chain, then 
UDP would be hydrolyzed to create UMP + Pi to antiport for more UDP-sugar donors. 
Presumably the NST that recruits UDP-GlcNAc in the B3gnt7-null (or Chst5-, Chst1/5-
null) cornea is still at work importing UDP-GlcNAc but the lack of sulfo- or 
glycosyltransferases to facilitate KS biosynthesis perhaps induces accumulation of 
UDP-GlcNAc and UDP-galactose within the Golgi lumen. Golgi vesicles could 
conceivably respond to this stress by activating SLC35D1, which, as described above, 
would antiport excess luminal UDP-GlcNAc in exchange for UDP-GlcA and UDP-
GalNAc, leading to the overproduction of the CS/DS-PGs we note in the EM images of 
affected genotypes in Chapter 3. This hypothesis is currently speculative, but cell 
a. 
b. 
Chapter 7: Discussion 
   162 
culture experiments could be designed to confirm the presence of SLC35D1 DNA or 
mRNA in WT keratocytes. WT data could then be compared with similar data 
acquired from keratocytes cultured from the Chst1, Chst5, Chst1/5, and B3gnt7-null 
mutant mice.  
The null mice described in this work provide insight into the mechanism that governs 
corneal KS synthesis. Their use in future studies will inevitably aid in elucidating the 
complex interactions between biosynthetic pathways of PG families within the 
corneal extracellular matrix and further inform our understanding of the role of GAGs 
in corneal organization and transparency.  
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Appendix I –Supplementary Electron Microscopy Figures 
Electron micrographs in Chapter 3 were selected from the following library of 
images. Each genotype from experiments 1 and 3 were imaged in anterior, mid, and 
posterior stromal regions taken with collagen oriented in both transverse and 
longitudinal planes. Each genotype was subjected to three processing protocols: 
untreated (where collagen an PGs were stained), chondroitinase ABC-digested 
(where CS/DS-PGs were digested from the tissue), and buffer-treated (where tissue 
was treated identically to the chondroitinase ABC-digested tissue, but did not 
contain active enzyme). All images are shown here because only representative 
images appeared in the EM chapter itself. All scale bars represent 100 nm. 
A1.1 Experiment 1 - WT, Chst1-null, Chst5-null 
 
Figure A1-1: Untreated (a – f), buffer-treated (g – l), and chondroitinase ABC (m – r) WT 
images collected in transverse and longitudinal planes from anterior, middle, and posterior 
stromal regions. Transversely sectioned untreated (a – c) and chondroitinase ABC-digested 
(m – o) images show increased interfibrillar spacing in the posterior stroma, as described in 
chapter 3, section 3.3.2.1. Comparing untreated images (a-f) to corresponding 
chondroitinase ABC-digested images (m-r) showed a marked decrease in long-chain PGs, as 
described in section 3.3.3.1. Buffer-treated images (g-l) showed PG content consistent with 
untreated images (a-i), which was notably greater than that of chondroitianse ABC-treated 
tissue (m-r), as discussed in sections 3.3.4.1. 
 
Figure A1-2: Untreated (a – f), buffer-treated (g – l), and chondroitinase ABC (m – r) Chst1-
null images collected in transverse and longitudinal planes from anterior, middle, and 
posterior stromal regions. Transversely sectioned untreated (a – c), buffer-treated (g – i) and 
chondroitinase ABC-digested (m – o) images show increased interfibrillar spacing in the 
posterior stroma, as described in chapter 3, section 3.3.2.1. Comparing untreated images (a-f) 
to corresponding chondroitinase ABC-digested images (m-r) showed a marked decrease in 
long-chain PGs, as described in section 3.3.3.1. Buffer-treated images (g-l) showed PG 
content consistent with untreated images (a-i), which was notably greater than that of 
chondroitianse ABC-treated tissue (m-r), as discussed in sections 3.3.4.1. 
 
Figure A1-3: Untreated (a – f), buffer-treated (g – l), and chondroitinase ABC (m – r) Chst5-
null images collected in transverse and longitudinal planes from anterior, middle, and 
posterior stromal regions. Transversely sectioned buffer-treated (g – i) and chondroitinase 
ABC-digested (m – o) images show increased interfibrillar spacing in the posterior stroma, as 
described in chapter 3, section 3.3.2.1. Comparing untreated images (a-f) to corresponding 
chondroitinase ABC-digested images (m-r) showed a marked decrease in long-chain PGs, as 
described in section 3.3.3.1. Buffer-treated images (g-l) showed PG content consistent with 
untreated images (a-i), which was notably greater than that of chondroitianse ABC-treated 
tissue (m-r), as discussed in sections 3.3.4.1. 
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Figure A1-2: EXP. 1 – Chst1-null 
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Figure A1-3: EXP. 1 – Chst5-null 
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A1.2 Experiment 2 – Chst1/5-null  
Figure A1-4: Untreated (a – f) and chondroitinase ABC-treated (g – l) Chst1/5-null images 
collected in transverse and longitudinal planes from anterior, middle, and posterior stromal 
regions. Transversely sectioned chondroitinase ABC-digested (g – i) images show increased 
interfibrillar spacing in the posterior stroma, as described in chapter 3, section 3.3.2.1. Unlike 
results from experiment 1 and 3, no decrease in PGs was apparent when comparing 
untreated (a-f) to chondroitinase ABC-digested (g-l) images. Buffer-treated images were not 
collected, as analysis of the Chst1/5 specimen had to be repeated. 
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A1.3 Experiment 3 – WT, Chst1/5-null, B3gnt7-HTZ, B3gnt7-
NULL 
Figure A1-5: Untreated (a – f), buffer-treated (g – l), and chondroitinase ABC (m – r) 
WT images collected in transverse and longitudinal planes from anterior, middle, and 
posterior stromal regions. Transversely sectioned buffer-treated (g – i) images show 
increased interfibrillar spacing in the posterior stroma, as described in chapter 3, 
section 3.3.2.1. Comparing untreated images (a-f) to corresponding chondroitinase 
ABC-digested images (m-r) showed a marked decrease in long-chain PGs, as 
described in section 3.3.3.3. Buffer-treated images (g-l) showed PG content 
consistent with untreated images (a-i), which was notably greater than that of 
chondroitianse ABC-treated tissue (m-r), as discussed in sections 3.3.4.2. 
 
Figure A1-6: Untreated (a – f), buffer-treated (g – l), and chondroitinase ABC (m – r) 
Chst1/5-null images collected in transverse and longitudinal planes from anterior, 
middle, and posterior stromal regions. Transversely sectioned buffer-treated (g – i) 
and chondroitinase ABC-digested (m – o) images show increased interfibrillar 
spacing in the posterior stroma, as described in chapter 3, section 3.3.2.1. Comparing 
untreated images (a-f) to corresponding chondroitinase ABC-digested images (m-r) 
showed a marked decrease in long-chain PGs, as described in section 3.3.3.3. Buffer-
treated images (g-l) showed PG content consistent with untreated images (a-i), 
which was notably greater than that of chondroitianse ABC-treated tissue (m-r), as 
discussed in sections 3.3.4.2. 
 
Figure A1-7: Untreated (a – f), buffer-treated (g – l), and chondroitinase ABC (m – r) 
B3gnt7-HTZ images collected in transverse and longitudinal planes from anterior, 
middle, and posterior stromal regions. Transversely sectioned untreated (a – c), 
buffer-treated (g – i) and chondroitinase ABC-digested (m – o) images show 
increased interfibrillar spacing in the posterior stroma, as described in chapter 3, 
section 3.3.2.1. Comparing untreated images (a-f) to corresponding chondroitinase 
ABC-digested images (m-r) showed a marked decrease in long-chain PGs, as 
described in section 3.3.3.3. Buffer-treated images (g-l) showed PG content 
consistent with untreated images (a-i), which was notably greater than that of 
chondroitianse ABC-treated tissue (m-r), as discussed in sections 3.3.4.2. 
 
Figure A1-8: Untreated (a – f), buffer-treated (g – l), and chondroitinase ABC (m – r) 
B3gnt7-NULL images collected in transverse and longitudinal planes from anterior, 
middle, and posterior stromal regions. Transversely sectioned buffer-treated (g – i) 
images show increased interfibrillar spacing in the posterior stroma, as described in 
chapter 3, section 3.3.2.1. Comparing untreated images (a-f) to corresponding 
chondroitinase ABC-digested images showed a marked decrease in long-chain PGs, 
as described in section 3.3.3.3. Buffer-treated images (g-l) showed PG content 
consistent with untreated images (a-i), which was notably greater than that of 
chondroitianse ABC-treated tissue (m-r), as discussed in sections 3.3.4.2. 
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Figure A1-5: EXP. 3 – WT  
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Figure A1-6: EXP. 3 – Chst1/5-null 
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Figure A1-7: EXP. 3 – B3gnt7-HTZ 
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Appendix II –Supplementary Immunohistochemistry 
Figures 
Chapter 4 featured a number of immunofluorescence images showing corneal 
sections labelled for various GAG epitopes. In most cases, brightfield and DAPI 
images were collected, but were not shown, alongside immuno-lablled results in 
Chapter 2. For completeness, brightfield and DAPI images are collated here to show 
corneal morphology and nuclei localization in WT and mutant mouse tissue.  
 
Figures A2-1 – A2-21: Brightfield images in the left column show full thickness sections of 
mouse corneal tissue. Horizontal white streaks in the brightfield images are thought to clefts 
in the corneal stroma created during tissue processing. The antibody and/or enzyme 
treatment applied to tissue sections is labelled above the middle column of fluorescent 
images. Results of immunofluorescence are fully explained in Chapter 4. DAPI images show 
nuclei throughout the depth of the stroma. In addition, stacked nuclei toward the top of 
DAPI images correspond to the epithelium. 
 
Figures A2-11, A2-12: High background staining and poor focus of DAPI images meant 
nuclei were difficult to distinguish. This issue was resolved in a follow-up experiment, the 
results of which are shown in Figures A2-14 and A2-15, respectively. 
 
Figures A2-12, A2-21: A WT DAPI image (c) and B3gnt7 brightfield image (m) were 
overwritten during image capture, thus their absence from Figure A2-12 and A2-21, 
respectively.    
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Figure A2-1: 1B4-labelled brightfield, fluorescence, DAPI images 
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Figure A2-2: Negative control brightfield, fluorescence, DAPI images 
DAPI 
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Figure A2-3: 1B4-labelled brightfield, fluorescence, DAPI images 
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Figure A2-4: Negative control brightfield, fluorescence, DAPI images 
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Figure A2-5: 1B4-labelled brightfield, fluorescence, DAPI images 
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Figure A2-6: Negative control brightfield, fluorescence, DAPI images 
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Figure A2-7: 1B4-labelled brightfield, fluorescence, DAPI images 
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Figure A2-8: 1B4+KSase-labelled brightfield, fluorescence, DAPI images 
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Figure A2-9: KSase-digested brightfield, fluorescence, DAPI images 
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Figure A2-10: 1B4+KSase-labelled brightfield, fluorescence, DAPI images 
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Figure A2-11: 2B6+ABC-labelled brightfield, fluorescence, DAPI images 
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Figure A2-12: ABC-digested brightfield, fluorescence, DAPI images 
c. 
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Figure A2-13: 2B6-labelled brightfield, fluorescence, DAPI images 
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Figure A2-14: 2B6+ABC-labelled brightfield, fluorescence, DAPI images 
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Figure A2-15: ABC-digested brightfield, fluorescence, DAPI images 
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Figure A2-16: 2B6+B-labelled brightfield, fluorescence, DAPI images 
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Figure A2-17: B-digested brightfield, fluorescence, DAPI images 
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Figure A2-18: 2B6+B-labelled brightfield, fluorescence, DAPI images 
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Figure A2-19: B-digested brightfield, fluorescence, DAPI images 
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Figure A2-20: 2B6+AC-labelled brightfield, fluorescence, DAPI images 
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Figure A2-21: AC-digested brightfield, fluorescence, DAPI images 
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Appendix III –Supplementary Western Blot Figures 
Chapter 5 featured a number of Western blot results showing highly sulfated KS and 
lumican epitopes after treatment with PNGase F or Endo β Gal enzymes. For 
convenience, lanes that were subjected to either of the above enzymes were 
cropped from the original, whole Western result and discussed separately. The intact 
results are shown here.   
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              a.                                              5D4 
                                      
 
             b.                                    Anti-Lumican 
Figure A3-1: Original Western blot showing combined results of 
untreated, PNGase F- and Endo β Gal-treated corneal extracts. Highly 
sulfated KS was stained using 5D4 (a) and lumican was stained using 
anti-lumican (b).  
|----Untreated----|-----PNGase F-----|---Endo β Gal-----| 
|----Untreated----|-----PNGase F-----|---Endo β Gal-----| 
   218 
             a.                                     5D4 
               
 
             b.                             Anti-Lumican 
          
Figure A3-2: Original Western blot showing combined results of 
untreated, PNGase F- and Endo β Gal-treated corneal extracts. Highly 
sulfated KS was stained using 5D4 (a) and lumican was stained using 
anti-lumican (b). 
  
|-----Untreated-----|-------PNGase F-------|-----Endo β Gal-----| 
|-----Untreated-----|-------PNGase F-------|-----Endo β Gal-----| 
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